syndrome	score	normalized_score
DRAVET SYNDROME	2.6655187	100.0
CHILDHOOD ABSENCE EPILEPSY	1.52874085	57.352471397030534
MYOCLONIC-ASTASTIC EPILEPSY	1.219235154	45.741009207701296
EPILEPSY, FAMILIAL TEMPORAL LOBE, 3; ETL3	1.1936939999999998	44.78280343709462
MICROPHTHALMIA-BRAIN ATROPHY SYNDROME	1.15211626	43.22296669687592
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	1.08630949	40.754150027159824
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	1.014284619	38.05205414615925
HEMIDYSTONIA-HEMIATROPHY SYNDROME	1.000541419	37.53646219026713
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	1.0	37.51615023372374
HYPERTRICHOSIS UNIVERSALIS	1.0	37.51615023372374
PAROXYSMAL KINESIGENIC DYSKINESIA	1.0	37.51615023372374
HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA	1.0	37.51615023372374
MYOCLONIC EPILEPSY OF LAFORA	0.93788904	35.18598612720293
LAFORA DISEASE	0.7715289599999999	28.944796373028638
EPILEPSY, LATERAL TEMPORAL LOBE, AUTOSOMAL DOMINANT	0.7706171	28.910586896276513
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.748578964	28.083800875229276
EARLY MYOCLONIC ENCEPHALOPATHY	0.7087289139999999	26.58878041260787
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.676035614	25.362253658171674
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES-PLUS	0.59274141	22.23737578730924
ROLANDIC EPILEPSY	0.5906213	22.157837422037222
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.5635556	21.142436554656328
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.540186244	20.265708284094952
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.5333330000000001	20.00860095260259
EPILEPSY, FAMILIAL TEMPORAL LOBE, 4	0.527027	19.772024109228724
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.516847064	19.39011210088303
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.50925926	19.10544690607498
EPILEPSY, BENIGN NEONATAL, 2	0.50704225	19.022273225845314
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.504116984	18.91252850711571
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.500545554	18.77854220268648
CREST SYNDROME	0.5	18.75807511686187
EPILEPSY, FAMILIAL TEMPORAL LOBE, 7; ETL7	0.5	18.75807511686187
PAROXYSMAL HEMICRANIA	0.5	18.75807511686187
IDIOPATHIC INTRACRANIAL HYPERTENSION	0.5	18.75807511686187
INHALATIONAL ANTHRAX	0.5	18.75807511686187
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.4346148040000001	16.305074280664403
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.42074085000000006	15.784576938064628
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.415131304	15.57412836758564
SPINOCEREBELLAR ATAXIA TYPE 10	0.4088913	15.340027440062606
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.39264330999999997	14.730465406226562
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.37313236	13.998489674823892
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.36819134400000003	13.813121776260658
PERIORAL MYOCLONIA WITH ABSENCES	0.36455991	13.676884352752804
EPILEPSY WITH GRAND MAL SEIZURES ON AWAKENING	0.35751765999999996	13.412686243769365
EPILEPSY, JUVENILE ABSENCE	0.35751765999999996	13.412686243769365
CORNELIA DE LANGE SYNDROME 3	0.355438853	13.33469740805045
CENTRALOPATHIC EPILEPSY	0.35470090000000004	13.307012252437023
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.348537004	13.075766604075973
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.347577154	13.039756727274131
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.345372854	12.957059877313936
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.3448273	12.936592791489327
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.34187389999999995	12.825792593389046
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 5; FAME5	0.34037525	12.769569014841279
COG4-CDG	0.333878554	12.525837991682446
ROLANDIC EPILEPSY-PAROXYSMAL EXERCISE-INDUCED DYSTONIA-WRITER'S CRAMP SYNDROME	0.333333	12.505370905857834
THUMB AGENESIS, SHORT STATURE, AND IMMUNODEFICIENCY	0.333333	12.505370905857834
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIA; MEN2A	0.333333	12.505370905857834
EPILEPSY, ROLANDIC, WITH PAROXYSMAL EXERCISE-INDUCED DYSTONIA AND WRITER'S CRAMP; EPRPDC	0.333333	12.505370905857834
OROFACIODIGITAL SYNDROME TYPE 3	0.333333	12.505370905857834
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.31566591	11.842569703225118
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.30128141399999997	11.302918790252718
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.26993966399999997	10.127096988664908
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.26929041000000004	10.102739478061064
WILLIAMS-BEUREN SYNDROME; WBS	0.26082111999999996	9.785004322048087
PALLISTER-HALL SYNDROME	0.257795244	9.671485103443468
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.25562995400000005	9.590251758503891
WITTEVEEN-KOLK SYNDROME	0.254511633	9.548296659858362
HYPEREKPLEXIA 1; HKPX1	0.2542735	9.539362826454752
ATAXIA-OCULOMOTOR APRAXIA TYPE 1	0.25344828	9.50840374895888
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.2526316	9.477765059386003
DYSTONIA 6, TORSION	0.25	9.379037558430936
HYPERPARATHYROIDISM 2	0.25	9.379037558430936
BARDET-BIEDL SYNDROME	0.25	9.379037558430936
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.25	9.379037558430936
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	9.379037558430936
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.24304515399999999	9.118118511042523
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.237037	8.892715702951175
LENNOX-GASTAUT SYNDROME	0.23257130999999998	8.725180206013935
EPILEPSY, FAMILIAL TEMPORAL LOBE, 2; ETL2	0.22592915000000002	8.475991933577507
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.224847064	8.435396232635698
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.212642793	7.977538968306619
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.210034743	7.879694972689556
HERPES SIMPLEX VIRUS ENCEPHALITIS	0.2051883	7.697875089002378
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.20344828	7.632596237272694
FAMILIAL HYPERALDOSTERONISM TYPE I	0.2	7.50323004674475
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.2	7.50323004674475
MAN1B1-CDG	0.189493073	7.1090505949179805
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.18939175	7.105249346027849
JUVENILE MYOCLONIC EPILEPSY	0.1829753	6.864528843860672
MYOCLONIC EPILEPSY OF INFANCY	0.181285814	6.801145833266899
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.181285814	6.801145833266899
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.172753954	6.4810632917338005
UNILATERAL POLYMICROGYRIA	0.17116626000000001	6.42149912510462
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.17042955399999998	6.393860752130533
NOONAN SYNDROME 6; NS6	0.167212554	6.273171296828645
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.167208419	6.273016167547428
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.166667	6.252704211004036
OLIVER-MCFARLANE SYNDROME	0.166667	6.252704211004036
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.16415611399999996	6.15850543460828
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.16346135	6.1324405640072985
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.160893854	6.036117998346814
SEIZURES, BENIGN FAMILIAL INFANTILE, 1; BFIS1	0.15950570000000003	5.98403980433527
SEIZURES, BENIGN FAMILIAL INFANTILE, 3; BFIS3	0.15950570000000003	5.98403980433527
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.15815151	5.933235808850262
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.157896064	5.923652458337659
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.15266181399999998	5.72728354897679
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.15266181399999998	5.72728354897679
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.14986335299999998	5.622296065677572
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.14583318999999997	5.471099865103178
PHACE SYNDROME	0.14394397299999998	5.400223716307073
EPILEPSY, PHOTOGENIC, WITH SPASTIC DIPLEGIA AND MENTAL RETARDATION	0.14285699999999998	5.3594446739390715
223540 DWARFISM, MENTAL RETARDATION, AND EYE ABNORMALITY;;MOLLICA SYNDROME	0.14285699999999998	5.3594446739390715
GANGLIONEUROMA	0.14285699999999998	5.3594446739390715
COMBINED SAPOSIN DEFICIENCY	0.14285699999999998	5.3594446739390715
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.14089110999999999	5.285692049356097
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.13678895400000002	5.1317949485779275
AICARDI SYNDROME; AIC	0.1359448	5.1001255402935275
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.135574524	5.086234210249585
CHROMOSOME 1P36 DELETION SYNDROME	0.134970183	5.063561662501186
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.1324787	4.970090811968418
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.12093934	4.537178448607396
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.12091581399999998	4.536295843656997
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.11869880399999999	4.453122163427328
POLYMICROGYRIA, BILATERAL PERISYLVIAN	0.11815324999999999	4.432655077602719
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.11309530000000001	4.242900265528057
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.10994303400000002	4.124639380695398
CDKL5-RELATED EPILEPTIC ENCEPHALOPATHY	0.10707894	4.017189599907891
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.10675886400000001	4.005181580605681
BILATERAL POLYMICROGYRIA	0.104660764	3.926468945800306
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.10456669400000002	3.922939801547819
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.09895310400000001	3.7123395157572903
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.09851445400000003	3.695883056457268
%121210 FEBRILE SEIZURES, FAMILIAL, 1; FEB1;;CONVULSIONS, FAMILIAL FEBRILE;  1	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 5; FEB5	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 6; FEB6	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 2; FEB2	0.09812185000000001	3.6811540658109063
FEBRILE SEIZURES, FAMILIAL, 4; FEB4	0.09812185000000001	3.6811540658109063
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.096586434	3.623551168483643
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.096116864	3.6059347098183934
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.09574456900000002	3.5919676346671294
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.0947581	3.5549591154622173
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0947581	3.5549591154622173
1P36 DELETION SYNDROME	0.09460454300000001	3.549198247980778
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0941662	3.532753306138877
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.09157701400000001	3.4356170151798233
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.091575064	3.4355438586868665
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.091470214	3.4316102903348606
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.09062337300000002	3.399840076154785
7Q11.23 MICRODUPLICATION SYNDROME	0.08960572900000002	3.361661990966337
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.08925519400000001	3.3485112672441586
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.0891035	3.342820292350604
WAARDENBURG SYNDROME, TYPE 1; WS1	0.08879295000000001	3.3311696518955207
WAARDENBURG SYNDROME TYPE 1	0.08879295000000001	3.3311696518955207
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.088041419	3.3029751019942197
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.08732713400000001	3.2761778786245257
WAARDENBURG-SHAH SYNDROME	0.08587087000000002	3.2215444596205614
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.08541272	3.204356435390981
MONOSOMY 13Q34	0.08387885400000002	3.1468116880965806
CHILDHOOD APRAXIA OF SPEECH	0.08333330000000001	3.1263446022719714
PIEBALDISM	0.08229944	3.087558155191333
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.08063321400000001	3.025047770251997
POLYHYDRAMNIOS-MEGALENCEPHALY-SYMPTOMATIC EPILEPSY SYNDROME	0.07992843	2.9986069878256716
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.07929445999999998	2.9748228740619975
GUANIDINOACETATE METHYLTRANSFERASE DEFICIENCY	0.07904281	2.9653819348556816
SCHINZEL-GIEDION SYNDROME	0.07886666	2.958773464992011
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.07801007300000001	2.926637618411757
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.07746865400000001	2.9063256618683644
WAARDENBURG-SHAH SYNDROME	0.07746865400000001	2.9063256618683644
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.07746865400000001	2.9063256618683644
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.07692310000000001	2.885858576043755
TIETZ SYNDROME	0.07692310000000001	2.885858576043755
TIETZ SYNDROME	0.07692310000000001	2.885858576043755
ERMINE PHENOTYPE	0.07692310000000001	2.885858576043755
LEIGH SYNDROME WITH NEPHROTIC SYNDROME	0.07692310000000001	2.885858576043755
SYSTEMIC PRIMARY CARNITINE DEFICIENCY	0.07692310000000001	2.885858576043755
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.075449524	2.8305756774469453
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.07197415400000001	2.700193174409169
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.07197415400000001	2.700193174409169
TUBEROUS SCLEROSIS COMPLEX	0.0715302	2.683537729448306
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.07149578	2.682246423557261
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.07142860000000001	2.67972608858456
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.07142860000000001	2.67972608858456
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.06996707399999999	2.624895259598066
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.06896331300000001	2.587238011123314
HYPEREKPLEXIA-EPILEPSY SYNDROME	0.0686937	2.5771231693103487
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.06842189400000001	2.5669260545799215
AICARDI SYNDROME	0.06808763	2.5543857561381955
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.067208119	2.5213898893299826
GITELMAN SYNDROME	0.06712703	2.5183477422236806
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.0667735	2.5050846576315524
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1C	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.0666667	2.5010779327865906
FAMILIAL HYPOCALCIURIC HYPERCALCEMIA	0.0666667	2.5010779327865906
HYPOPARATHYROIDISM-SENSORINEURAL DEAFNESS-RENAL DISEASE SYNDROME	0.0666667	2.5010779327865906
AUTOSOMAL DOMINANT KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
AUTOSOMAL RECESSIVE KENNY-CAFFEY SYNDROME	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 2	0.0666667	2.5010779327865906
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0666667	2.5010779327865906
PSEUDOHYPOPARATHYROIDISM TYPE 1B	0.0666667	2.5010779327865906
FAMILIAL ISOLATED HYPOPARATHYROIDISM DUE TO AGENESIS OF PARATHYROID GLAND	0.0666667	2.5010779327865906
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0666667	2.5010779327865906
AUTOIMMUNE HYPOPARATHYROIDISM	0.0666667	2.5010779327865906
RENPENNING SYNDROME	0.066466079	2.4935514052105505
EMANUEL SYNDROME	0.066445673	2.492785850648881
MEIER-GORLIN SYNDROME 7	0.06602174400000001	2.4768816665964493
MOWAT-WILSON SYNDROME; MOWS	0.065912539	2.4727847154101754
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.065901773	2.472380816536759
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.065286813	2.4493098847890282
BENIGN ADULT FAMILIAL MYOCLONIC EPILEPSY	0.0648148	2.4316017741687577
INFANTILE CONVULSIONS AND CHOREOATHETOSIS	0.0648148	2.4316017741687577
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.063586973	2.3855384319757356
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.063335133	2.3760903647008744
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.063075033	2.366332414025083
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.063045554	2.365226475432343
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.063045554	2.365226475432343
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.062793714	2.355778408157482
AYME-GRIPP SYNDROME; AYGRP	0.062789579	2.355623278876265
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.06259785000000001	2.3484303449081043
HYPOTRICHOSIS 5; HYPT5	0.0625	2.344759389607734
DEAFNESS-ENAMEL HYPOPLASIA-NAIL DEFECTS SYNDROME	0.0625	2.344759389607734
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.0625	2.344759389607734
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.062475459	2.343838705764848
TRISOMY 17P	0.062123873999999996	2.330648590084924
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.059910473	2.24761030564145
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.059910473	2.24761030564145
WHITE-SUTTON SYNDROME; WHSUS	0.059672584	2.2386856261784995
RENPENNING SYNDROME 1; RENS1	0.05920036900000001	2.2209699372958824
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.059127030000000004	2.218218540353891
MYOCLONIC EPILEPSY, FAMILIAL INFANTILE	0.05777791	2.1676047517505697
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.056597679000000005	2.1233270282440717
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.056101154	2.1046993217492718
15Q OVERGROWTH SYNDROME	0.055927839	2.098197210171514
KNIEST-LIKE DYSPLASIA, LETHAL	0.055607790000000004	2.0861902038053612
LETHAL KNIEST-LIKE DYSPLASIA	0.055607790000000004	2.0861902038053612
GLYCOGEN STORAGE DISEASE DUE TO LIVER PHOSPHORYLASE KINASE DEFICIENCY	0.055555600000000004	2.084232235924663
OBESITY DUE TO PRO-OPIOMELANOCORTIN DEFICIENCY	0.055555600000000004	2.084232235924663
CONGENITAL ISOLATED ACTH DEFICIENCY	0.055555600000000004	2.084232235924663
OBESITY DUE TO PROHORMONE CONVERTASE I DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINISM DUE TO SHORT CHAIN 3-HYDROXYLACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.084232235924663
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 5; HHF5	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 6; HHF6	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 7; HHF7	0.055555600000000004	2.084232235924663
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 3; HHF3	0.055555600000000004	2.084232235924663
HYPOINSULINEMIC HYPOGLYCEMIA AND BODY HEMIHYPERTROPHY	0.055555600000000004	2.084232235924663
OBESITY, EARLY-ONSET, WITH ADRENAL INSUFFICIENCY AND RED HAIR; OBAIRH	0.055555600000000004	2.084232235924663
HYPERINSULINEMIC HYPOGLYCEMIA, FAMILIAL, 4; HHF4	0.055555600000000004	2.084232235924663
MECKEL SYNDROME, TYPE 1; MKS1	0.05538642	2.0778852536281214
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.053173019	1.9948469691846473
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.05267669	1.9762266158552932
MEIER-GORLIN SYNDROME 1; MGORS1	0.0526316	1.9745350126412546
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0526316	1.9745350126412546
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.0526316	1.9745350126412546
SEVERE CONGENITAL NEMALINE MYOPATHY	0.0526316	1.9745350126412546
ISOLATED SEDOHEPTULOKINASE DEFICIENCY	0.0526316	1.9745350126412546
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0526316	1.9745350126412546
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0526316	1.9745350126412546
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.051380464	1.9275972065024343
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.051281214000000006	1.9238737285917376
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.051181119000000004	1.9201185495340927
SCHWARTZ-JAMPEL SYNDROME	0.05088634	1.909059576284346
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0494995	1.8570306784942086
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.049421594	1.8541079452940998
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.049076853999999996	1.8411746276625256
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.048559609999999996	1.8217696240510335
CENTRAL CONGENITAL HYPOTHYROIDISM	0.04784493	1.7949575818019963
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.045159573999999994	1.6942133626749643
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 14	0.044925509999999995	1.6854321824866583
MENTAL RETARDATION, X-LINKED 98; MRX98	0.044765932999999994	1.6794454677808113
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.044658403	1.6754113561461792
ZLOTOGORA-OGUR SYNDROME	0.044348699	1.663792454354194
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.044297953999999994	1.6618886973105835
MESOMELIA-SYNOSTOSES SYNDROME	0.0442735	1.660971277372768
MOWAT-WILSON SYNDROME	0.044112849	1.6549442703215702
GRISCELLI SYNDROME	0.043841793	1.6447752927038177
CHRISTIANSON SYNDROME	0.04353051	1.6330971529106137
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.043266764	1.62320241835107
VOGT-KOYANAGI-HARADA DISEASE	0.04316456	1.6193681177325825
ACRODERMATITIS ENTEROPATHICA	0.04316456	1.6193681177325825
CHROMOSOME 17Q12 DELETION SYNDROME	0.04310083	1.6169772134781872
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.04295638	1.611558005576926
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.042756550000000004	1.604061153275721
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.042756550000000004	1.604061153275721
MICROPHTHALMIA WITH LIMB ANOMALIES	0.04275482	1.6039962503358165
H SYNDROME	0.04275482	1.6039962503358165
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.0427032	1.6020596666607516
DISTAL MONOSOMY 12Q	0.04221225399999999	1.5836412627681058
COG2-CDG	0.04221225399999999	1.5836412627681058
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.042021954	1.5765019393786284
TRICHOTHIODYSTROPHY	0.041856054000000004	1.5702780100548537
KABUKI SYNDROME	0.041727178999999996	1.5654431161934823
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.041271154	1.5483348137831485
16P13.11 MICRODELETION SYNDROME	0.040558744	1.5216079331951415
DYSKERATOSIS CONGENITA	0.040545554	1.5211130951735585
TRIOPIA	0.04	1.5006460093489498
MANDIBULOACRAL DYSPLASIA WITH TYPE A LIPODYSTROPHY	0.04	1.5006460093489498
PILI TORTI	0.04	1.5006460093489498
ACQUIRED HYPERTRICHOSIS LANUGINOSA	0.04	1.5006460093489498
EPIDERMOLYSIS BULLOSA SIMPLEX DUE TO PLAKOPHILIN DEFICIENCY	0.04	1.5006460093489498
SPONDYLO-OCULAR SYNDROME	0.04	1.5006460093489498
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.04	1.5006460093489498
ACROMICRIC DYSPLASIA	0.04	1.5006460093489498
MONILETHRIX	0.04	1.5006460093489498
BÖÖK SYNDROME	0.04	1.5006460093489498
LEUKOMELANODERMA-INFANTILISM-INTELLECTUAL DISABILITY-HYPODONTIA-HYPOTRICHOSIS SYNDROME	0.04	1.5006460093489498
ULERYTHEMA OPHRYOGENESIS	0.04	1.5006460093489498
ROMBO SYNDROME	0.04	1.5006460093489498
PIEBALD TRAIT-NEUROLOGIC DEFECTS SYNDROME	0.04	1.5006460093489498
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.03930035	1.474397834837925
EPILEPSY, NOCTURNAL FRONTAL LOBE, 5; ENFL5	0.039272100000000004	1.4733380035938224
NON-DISTAL MONOSOMY 20Q	0.038972359	1.4620928752066156
MENINGIOMA	0.038532620000000004	1.4455955608189883
POLYMICROGYRIA, BILATERAL TEMPOROOCCIPITAL; BTOP	0.038521299999999994	1.4451708779983423
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.03843094	1.441780918663223
14Q11.2 MICRODELETION SYNDROME	0.03843094	1.441780918663223
EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 10; EJM10	0.037883259999999995	1.4212340735032172
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.037799913000000004	1.4181072149296874
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.037799913000000004	1.4181072149296874
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.037582554	1.4099527420310352
LISSENCEPHALY 2; LIS2	0.037582554	1.4099527420310352
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.037037	1.3894856562064262
MCLEOD SYNDROME; MCLDS	0.037037	1.3894856562064262
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.037037	1.3894856562064262
ADULT-ONSET AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.037037	1.3894856562064262
MYOCLONUS AND ATAXIA	0.037037	1.3894856562064262
CANAVAN DISEASE	0.037037	1.3894856562064262
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.037037	1.3894856562064262
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.037037	1.3894856562064262
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.03692799	1.3853960206694482
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.036916502999999996	1.384965072651713
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.036752714	1.3788203399210819
AMISH INFANTILE EPILEPSY SYNDROME	0.03639365	1.3653496409535602
AU-KLINE SYNDROME; AUKS	0.036375083999999995	1.3646531161083206
LELIS SYNDROME	0.03568276	1.3386797849139083
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.03568276	1.3386797849139083
FEBRILE SEIZURES, FAMILIAL, 8; FEB8	0.03566625	1.3380603932735493
JUVENILE ABSENCE EPILEPSY	0.03566625	1.3380603932735493
EPILEPSY, CHILDHOOD ABSENCE, SUSCEPTIBILITY TO, 1; ECA1	0.03566625	1.3380603932735493
PEHO SYNDROME	0.03555847399999999	1.3340170526659594
DUBOWITZ SYNDROME	0.035554339	1.333861923384743
XQ25 DUPLICATION SYNDROME	0.035492423	1.331539073426872
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.035446544	1.3298178699702992
ALPERS-HUTTENLOCHER SYNDROME	0.035365604	1.3267813127703814
HAMAMY SYNDROME; HMMS	0.03523429	1.32185491701859
PSEUDOPROGERIA SYNDROME	0.03490099	1.30935078414569
ECTODERMAL DYSPLASIA 1, HYPOHIDROTIC, X-LINKED; XHED	0.03490099	1.30935078414569
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.034843859000000005	1.3072074489666872
%613608 EPILEPSY, FAMILIAL ADULT MYOCLONIC, 3; FAME3;;CORTICAL MYOCLONIC TREMOR WITH EPILEPSY, FAMILIAL, 3; FCMTE3	0.034820050000000005	1.3063142269457726
JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.034820050000000005	1.3063142269457726
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.034614804	1.2986141871749015
DOORS SYNDROME	0.03461480399999999	1.2986141871749013
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.034344530000000005	1.2884745471866323
3P25.3 MICRODELETION SYNDROME	0.0342031	1.2831686380590765
CEROID LIPOFUSCINOSIS, NEURONAL, 8, NORTHERN EPILEPSY VARIANT	0.034069249999999995	1.2781471013502925
PROGRESSIVE EPILEPSY-INTELLECTUAL DISABILITY SYNDROME, FINNISH TYPE	0.034069249999999995	1.2781471013502925
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.033917913	1.2724695197223717
COFFIN-LOWRY SYNDROME; CLS	0.033207769000000005	1.2458276507307944
ABLEPHARON MACROSTOMIA SYNDROME	0.032983614	1.2374182180751538
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.032803653999999995	1.2306668116790926
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.032803653999999995	1.2306668116790926
SLC35A2-CDG	0.032803653999999995	1.2306668116790926
TUBEROUS SCLEROSIS 2; TSC2	0.032799519	1.2305116823978763
POTOCKI-SHAFFER SYNDROME	0.032799519	1.2305116823978763
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.032799519	1.2305116823978763
TUBEROUS SCLEROSIS-1	0.032799519	1.2305116823978763
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.0322581	1.2101997258544839
257960 OCULOTRICHODYSPLASIA; OTD	0.0322581	1.2101997258544839
TRICHODERMODYSPLASIA-DENTAL ALTERATIONS SYNDROME	0.0322581	1.2101997258544839
ALG13-CDG	0.0322581	1.2101997258544839
FOCAL FACIAL DERMAL DYSPLASIA TYPE I	0.0322581	1.2101997258544839
ULNAR-MAMMARY SYNDROME; UMS	0.0322581	1.2101997258544839
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.0322581	1.2101997258544839
ECTODERMAL DYSPLASIA 11B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD11B	0.0322581	1.2101997258544839
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.0322581	1.2101997258544839
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.0322581	1.2101997258544839
19Q13.11 MICRODELETION SYNDROME	0.0322581	1.2101997258544839
DUBOWITZ SYNDROME	0.0322581	1.2101997258544839
WOOLLY HAIR	0.0322581	1.2101997258544839
WEST SYNDROME	0.0322581	1.2101997258544839
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.0322581	1.2101997258544839
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.031894783999999995	1.1965695082161683
SAY-BARBER-MILLER SYNDROME	0.031882154	1.1960956792387165
YUNIS-VARON SYNDROME	0.031440324000000006	1.1795199185809504
EPILEPSY, IDIOPATHIC GENERALIZED	0.031226909999999997	1.1715134468949702
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.031226080000000003	1.1714823084902766
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.030753990000000002	1.1537713091264379
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.03059843	1.1479352967960794
EDINBURGH MALFORMATION SYNDROME	0.030532620000000003	1.1454663589491982
FOCAL FACIAL DERMAL DYSPLASIA TYPE IV	0.030532620000000003	1.1454663589491982
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.030513204	1.1447379453762603
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.030360473000000002	1.1390080662349134
METACHROMATIC LEUKODYSTROPHY	0.029846799	1.1197369952797556
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.029822163000000002	1.1188127474025977
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.029710972999999998	1.1146413266581099
CARDIOFACIOCUTANEOUS SYNDROME	0.029532364	1.1079406045810145
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.029458900000000003	1.1051845181202444
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.029319583000000003	1.0999578806181327
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.029005553	1.0881766839602365
XQ25 MICRODUPLICATION SYNDROME	0.028998913	1.0879275767226846
HOLOPROSENCEPHALY	0.028880573	1.0834879155040256
15Q13.3 MICRODELETION SYNDROME	0.028864773000000003	1.082895160330333
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.028828139000000003	1.0815207936826707
%614280 EPILEPSY, JUVENILE MYOCLONIC, SUSCEPTIBILITY TO, 9; EJM9	0.028623999999999997	1.0738622842901084
FEBRILE CONVULSIONS, FAMILIAL, 9	0.028623999999999997	1.0738622842901084
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.028557083000000004	1.0713518160649185
CONGENITAL HYPOTHYROIDISM	0.028390484	1.0651016629521302
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.028347630000000002	1.063493945850014
EPILEPSY, PYRIDOXINE-DEPENDENT	0.028341364	1.0632588696526497
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.028341364	1.0632588696526497
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.028323354000000002	1.0625832037869403
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.028323354000000002	1.0625832037869403
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.028323354000000002	1.0625832037869403
MENKES DISEASE	0.028319219000000003	1.062428074505724
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.028178494000000002	1.0571486142640831
VASCULAR EHLERS-DANLOS SYNDROME	0.028074854	1.05326044045386
JACOBSEN SYNDROME	0.027914203000000002	1.047233433402662
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.02791194	1.0471485343546831
CHST3-RELATED SKELETAL DYSPLASIA	0.02791194	1.0471485343546831
SPEECH-LANGUAGE DISORDER 1	0.027777800000000002	1.0421161179623315
GANGLIOCYTOMA	0.027777800000000002	1.0421161179623315
CYANIDE, INABILITY TO SMELL	0.027777800000000002	1.0421161179623315
CUTIS LAXA, AUTOSOMAL DOMINANT 1; ADCL1	0.027777800000000002	1.0421161179623315
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.027777800000000002	1.0421161179623315
GROWTH HORMONE DEFICIENCY, ISOLATED, TYPE IA	0.027777800000000002	1.0421161179623315
CONGENITAL ICHTHYOSIS-MICROCEPHALUS-TETRAPLEGIA SYNDROME	0.027777800000000002	1.0421161179623315
DIMPLES, FACIAL	0.027777800000000002	1.0421161179623315
22Q11.2 DISTAL DELETION SYNDROME	0.027777800000000002	1.0421161179623315
OPHTHALMOPLEGIA, FAMILIAL TOTAL, WITH IRIS TRANSILLUMINATION	0.027777800000000002	1.0421161179623315
OROFACIAL CLEFT 3	0.027777800000000002	1.0421161179623315
TESTICULAR REGRESSION SYNDROME	0.027777800000000002	1.0421161179623315
FEBRILE INFECTION-RELATED EPILEPSY SYNDROME	0.027777800000000002	1.0421161179623315
WAARDENBURG SYNDROME, TYPE IIB	0.027777800000000002	1.0421161179623315
CLEFT CHIN	0.027777800000000002	1.0421161179623315
211930 CAMPTODACTYLY WITH FIBROUS TISSUE HYPERPLASIA AND SKELETAL DYSPLASIA	0.027777800000000002	1.0421161179623315
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 7; FPLD7	0.027777800000000002	1.0421161179623315
DWARFISM, LEVI TYPE	0.027777800000000002	1.0421161179623315
NASAL ALAR COLLAPSE, BILATERAL	0.027777800000000002	1.0421161179623315
208081 ARTHROGRYPOSIS, DISTAL, WITH MENTAL RETARDATION AND CHARACTERISTICFACIES	0.027777800000000002	1.0421161179623315
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.027777800000000002	1.0421161179623315
NASAL BONES, ABSENCE OF	0.027777800000000002	1.0421161179623315
NASAL GROOVE, FAMILIAL TRANSVERSE	0.027777800000000002	1.0421161179623315
EPILEPSY, NOCTURNAL FRONTAL LOBE, TYPE 1	0.027777800000000002	1.0421161179623315
FIBULAR DIMELIA-DIPLOPODIA SYNDROME	0.027777800000000002	1.0421161179623315
FALLOT COMPLEX WITH SEVERE MENTAL AND GROWTH RETARDATION	0.027777800000000002	1.0421161179623315
15Q24 RECURRENT MICRODELETION SYNDROME	0.027777800000000002	1.0421161179623315
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.027777800000000002	1.0421161179623315
PERIVENTRICULAR NODULAR HETEROTOPIA	0.027777800000000002	1.0421161179623315
OSTEOPENIA AND SPARSE HAIR	0.027777800000000002	1.0421161179623315
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.027660994	1.037734006518131
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.027572554	1.0344160781914604
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.027568419	1.0342609489102441
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.027318963	1.0249023201375405
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.027249634000000002	1.0223013629579865
BENIGN OCCIPITAL EPILEPSY	0.027027	1.0139489923668517
FOCAL CORTICAL DYSPLASIA OF TAYLOR	0.027027	1.0139489923668517
APNEA, OBSTRUCTIVE SLEEP	0.027027	1.0139489923668517
EPILEPSY, FAMILIAL TEMPORAL LOBE, 8; ETL8	0.027027	1.0139489923668517
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.02668046	1.000948145664857
AREDYLD SYNDROME	0.02668046	1.000948145664857
OCULOMAXILLOFACIAL DYSOSTOSIS	0.02668046	1.000948145664857
GAPO SYNDROME; GAPOS	0.026554019	0.9962045661131548
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.026402654	0.9905259340330272
ADRENOLEUKODYSTROPHY	0.026398519000000002	0.9903708047518108
RESTRICTIVE DERMOPATHY, LETHAL	0.02623199	0.9841232777695389
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.026010619999999998	0.9758183275922995
JABERI-ELAHI SYNDROME; JABELS	0.025990633000000003	0.9750684922975782
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0258571	0.9700588482084183
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.025709314	0.9645144864299772
CHROMOSOME 18Q DELETION SYNDROME	0.025648209	0.9622220620699454
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.02556845	0.9592298114434538
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.025545554	0.9583708416677026
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.025545554	0.9583708416677026
ECTODERMAL DYSPLASIA SYNDROME	0.025541419000000003	0.9582157123864862
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.025541419000000003	0.9582157123864862
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.025256709000000002	0.9475344892534426
OROFACIAL CLEFT 15	0.02516376	0.9440474006053683
LMNA-RELATED CARDIOCUTANEOUS PROGERIA SYNDROME	0.025	0.9379037558430937
ROTHMUND-THOMSON SYNDROME TYPE 2	0.025	0.9379037558430937
HIDROTIC ECTODERMAL DYSPLASIA, CHRISTIANSON-FOURIE TYPE	0.025	0.9379037558430937
ALOPECIA UNIVERSALIS	0.025	0.9379037558430937
EEM SYNDROME	0.025	0.9379037558430937
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.025	0.9379037558430937
JOHNSON NEUROECTODERMAL SYNDROME	0.025	0.9379037558430937
ABLEPHARON-MACROSTOMIA SYNDROME	0.025	0.9379037558430937
ROTHMUND-THOMSON SYNDROME TYPE 1	0.025	0.9379037558430937
COMBINED IMMUNODEFICIENCY-ENTEROPATHY SPECTRUM	0.025	0.9379037558430937
HIDROTIC ECTODERMAL DYSPLASIA, HALAL TYPE	0.025	0.9379037558430937
601375 ECTODERMAL DYSPLASIA, HIDROTIC, CHRISTIANSON-FOURIE TYPE	0.025	0.9379037558430937
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.025	0.9379037558430937
BARTSOCAS-PAPAS SYNDROME; BPS	0.025	0.9379037558430937
PORPHYRIA, CONGENITAL ERYTHROPOIETIC; CEP	0.025	0.9379037558430937
KERATOSIS FOLLICULARIS-DWARFISM-CEREBRAL ATROPHY SYNDROME	0.025	0.9379037558430937
ABSENT EYEBROWS AND EYELASHES WITH MENTAL RETARDATION	0.025	0.9379037558430937
PARC SYNDROME	0.025	0.9379037558430937
KERATOSIS FOLLICULARIS, DWARFISM, AND CEREBRAL ATROPHY	0.025	0.9379037558430937
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.025	0.9379037558430937
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME	0.025	0.9379037558430937
SPASTIC PARAPLEGIA WITH NEUROPATHY AND POIKILODERMA	0.025	0.9379037558430937
PILI TORTI-ONYCHODYSPLASIA SYNDROME	0.025	0.9379037558430937
2Q37 MICRODELETION SYNDROME	0.024858963	0.93261259056258
RESTRICTIVE DERMOPATHY	0.02471529	0.9272225327100502
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.024317899000000004	0.9123139522525205
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.024145143999999997	0.9058328497188933
TRISOMY 20P	0.02381279	0.8933642071241144
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.023801354	0.8929351724300415
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.023801354	0.8929351724300415
OGDEN SYNDROME	0.023801354	0.8929351724300415
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.023797219	0.8927800431488251
CRONKHITE-CANADA SYNDROME	0.023797219	0.8927800431488251
AYMÉ-GRIPP SYNDROME	0.023588194	0.884938229846221
KNOBLOCH SYNDROME	0.023296239000000003	0.8739852022047343
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.023296099999999997	0.8739799874598516
ACROFRONTOFACIONASAL DYSOSTOSIS	0.0232558	0.8724680866054326
ATYPICAL WERNER SYNDROME	0.0232558	0.8724680866054326
CRANDALL SYNDROME	0.0232558	0.8724680866054326
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.0232558	0.8724680866054326
WOODHOUSE-SAKATI SYNDROME	0.0232558	0.8724680866054326
PSEUDOPELADE OF BROCQ	0.0232558	0.8724680866054326
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.0232558	0.8724680866054326
ALOPECIA ANTIBODY DEFICIENCY	0.0232558	0.8724680866054326
KID SYNDROME	0.0232558	0.8724680866054326
FRONTOFACIONASAL DYSPLASIA	0.0232558	0.8724680866054326
NAGER SYNDROME	0.0232558	0.8724680866054326
OMENN SYNDROME	0.0232558	0.8724680866054326
HYPOTRICHOSIS AND RECURRENT SKIN VESICLES	0.0232558	0.8724680866054326
MARIE UNNA HEREDITARY HYPOTRICHOSIS	0.0232558	0.8724680866054326
LAMELLAR ICHTHYOSIS	0.0232558	0.8724680866054326
HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0232558	0.8724680866054326
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.0232558	0.8724680866054326
ECTODERMAL DYSPLASIA 8, HAIR/TOOTH/NAIL TYPE	0.0232558	0.8724680866054326
BARTSOCAS-PAPAS SYNDROME	0.0232558	0.8724680866054326
HYPOTRICHOSIS 12; HYPT12	0.0232558	0.8724680866054326
AGNATHIA-HOLOPROSENCEPHALY-SITUS INVERSUS SYNDROME	0.0232558	0.8724680866054326
HYPOTRICHOSIS 11; HYPT11	0.0232558	0.8724680866054326
SCHÖPF-SCHULZ-PASSARGE SYNDROME	0.0232558	0.8724680866054326
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.0232558	0.8724680866054326
X-LINKED HYPOHIDROTIC ECTODERMAL DYSPLASIA	0.0232558	0.8724680866054326
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.0232558	0.8724680866054326
BARBER-SAY SYNDROME	0.0232558	0.8724680866054326
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.02297619	0.8619781958385812
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.022826073000000002	0.8563463839139452
MONOSOMY 9P	0.022554323	0.8461513700879308
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.022515503000000003	0.8446949931358577
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.022513204	0.8446087435064703
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.022513204	0.8446087435064703
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.022513204	0.8446087435064703
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.022485283000000002	0.8435612550757946
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.022284654	0.8360344273705528
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.022284654	0.8360344273705528
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.022284654	0.8360344273705528
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.022284654	0.8360344273705528
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.022284654	0.8360344273705528
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.022244154	0.8345150232860868
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.022244154	0.8345150232860868
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.022159674	0.831345658914342
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.021969949000000003	0.8242279073112488
MYOCLONIC EPILEPSY OF UNVERRICHT AND LUNDBORG	0.02196765	0.8241416576818613
RIDDLE SYNDROME	0.021850934000000002	0.8197629226911822
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.021827314	0.8188767912226615
FOCAL FACIAL DERMAL DYSPLASIA TYPE II	0.0217391	0.8155673415459438
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.0217391	0.8155673415459438
TOOTH AGENESIS, SELECTIVE, 4	0.0217391	0.8155673415459438
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.0217391	0.8155673415459438
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.0217391	0.8155673415459438
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.0217391	0.8155673415459438
KERATOSIS PILARIS ATROPHICANS; KPA	0.0217391	0.8155673415459438
GABRIELE-DE VRIES SYNDROME	0.0217391	0.8155673415459438
TOOTH AGENESIS, SELECTIVE, 8; STHAG8	0.0217391	0.8155673415459438
LIMB-MAMMARY SYNDROME	0.0217391	0.8155673415459438
HYPOTRICHOSIS 10; HYPT10	0.0217391	0.8155673415459438
MACROCEPHALY, ACQUIRED, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; MACID	0.0217391	0.8155673415459438
HYPOTRICHOSIS 1; HYPT1	0.0217391	0.8155673415459438
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.02170111	0.8141421029985647
PEROXISOME BIOGENESIS DISORDER 6B	0.021567214	0.8091188405468699
CORNELIA DE LANGE SYNDROME	0.021560298999999998	0.8088594163680037
NEPHROPATHIC INFANTILE CYSTINOSIS	0.02142853	0.8039159507678563
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.021374709000000002	0.8018967940461271
OCULODENTODIGITAL DYSPLASIA; ODDD	0.021374709000000002	0.8018967940461271
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.021305380000000002	0.7992958368665734
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.021305380000000002	0.7992958368665734
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.021305380000000002	0.7992958368665734
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.021305380000000002	0.7992958368665734
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.021299114	0.7990607606692087
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.021286404	0.798583930399738
19P13.3 MICRODUPLICATION SYNDROME	0.021240244	0.7968521849049494
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.021157474000000003	0.7937469731501041
LISSENCEPHALY 5; LIS5	0.021153339	0.7935918438688875
PALLISTER-KILLIAN SYNDROME	0.021116759000000002	0.7922195030933381
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.02102166	0.7886517547222612
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.02101888	0.7885474598246113
ERYTHERMALGIA, PRIMARY	0.02081283	0.7808172570689526
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 4; GEFSP4	0.020740849999999998	0.7781168445751291
MEDIUM CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.020740849999999998	0.7781168445751291
FEBRILE SEIZURES, FAMILIAL, 11; FEB11	0.020740849999999998	0.7781168445751291
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.020633584	0.7740926372041584
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.02061192	0.7732798873254951
NEONATAL LUPUS ERYTHEMATOSUS	0.02061192	0.7732798873254951
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.020545554	0.7707900904990838
GYRATE ATROPHY OF CHOROID AND RETINA	0.020541419	0.7706349612178675
NEVUS COMEDONICUS SYNDROME	0.020541419	0.7706349612178675
KABUKI SYNDROME 1	0.020136993000000002	0.7554624546434434
ICHTHYOSIS, SPLIT HAIRS, AND AMINO ACIDURIA	0.02	0.7503230046744749
FAMILIAL MELANOMA	0.02	0.7503230046744749
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 2	0.02	0.7503230046744749
138920 GRANDDAD SYNDROME;;GROWTH RETARDATION, AGED FACIES, NORMAL DEVELOPMENT, DECREASED SUBCUTANEOUSFAT, AUTOSOMAL DOMINANT INHERITANCE	0.02	0.7503230046744749
CATATRICHY	0.02	0.7503230046744749
HAIRY NOSE TIP	0.02	0.7503230046744749
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.02	0.7503230046744749
SCALP-EAR-NIPPLE SYNDROME; SENS	0.02	0.7503230046744749
STRIATE PALMOPLANTAR KERATODERMA	0.02	0.7503230046744749
JUVENILE HYALINE FIBROMATOSIS	0.02	0.7503230046744749
DISSECTING CELLULITIS OF THE SCALP	0.02	0.7503230046744749
EPIDERMOLYSIS BULLOSA ACQUISITA	0.02	0.7503230046744749
CHONDROECTODERMAL DYSPLASIA WITH NIGHT BLINDNESS	0.02	0.7503230046744749
ALBINISM, OCULOCUTANEOUS, TYPE VI; OCA6	0.02	0.7503230046744749
RINGED HAIR	0.02	0.7503230046744749
SKIN/HAIR/EYE PIGMENTATION, VARIATION IN, 6	0.02	0.7503230046744749
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.02	0.7503230046744749
%152800 LYMPHANGIECTASIA, INTESTINAL	0.02	0.7503230046744749
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.02	0.7503230046744749
WERNER SYNDROME; WRN	0.02	0.7503230046744749
MANITOBA OCULOTRICHOANAL SYNDROME	0.02	0.7503230046744749
INFANTILE MYOFIBROMATOSIS	0.02	0.7503230046744749
AMELOONYCHOHYPOHIDROTIC SYNDROME	0.02	0.7503230046744749
TRICHODISCOMAS, FAMILIAL MULTIPLE	0.02	0.7503230046744749
HAIR WHORL	0.02	0.7503230046744749
RED SKIN PIGMENT ANOMALY OF NEW GUINEA	0.02	0.7503230046744749
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.02	0.7503230046744749
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.02	0.7503230046744749
FAMILIAL MALE-LIMITED PRECOCIOUS PUBERTY	0.02	0.7503230046744749
TRICHODENTOOSSEOUS SYNDROME	0.02	0.7503230046744749
DARIER DISEASE	0.02	0.7503230046744749
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.02	0.7503230046744749
MIDPHALANGEAL HAIR	0.02	0.7503230046744749
VAN BOGAERT-HOZAY SYNDROME	0.02	0.7503230046744749
611426 TENTED EYEBROWS	0.02	0.7503230046744749
INHERITED EPIDERMOLYSIS BULLOSA	0.02	0.7503230046744749
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.02	0.7503230046744749
HYPERTELORISM, TEEBI TYPE	0.01991604	0.7471731487008514
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.019873270000000002	0.7455685829553551
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.019755389	0.7411461416496535
KLEEFSTRA SYNDROME	0.019632243	0.7365261778129714
3-METHYLGLUTACONIC ACIDURIA TYPE 9	0.0194943	0.7313510875012807
1Q44 MICRODELETION SYNDROME	0.019143624	0.7181950740019195
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.019129663	0.7176713110285066
MARSHALL-SMITH SYNDROME; MRSHSS	0.01911954	0.7172915350396906
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.019082104	0.7158870804395407
SALT-AND-PEPPER SYNDROME	0.019082104	0.7158870804395407
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.019082104	0.7158870804395407
GAUCHER DISEASE	0.01905633	0.7149201391834168
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.018944073000000002	0.7107086887066297
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.018944073000000002	0.7107086887066297
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.018944073000000002	0.7107086887066297
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.018944073000000002	0.7107086887066297
LISSENCEPHALY 1; LIS1	0.018944073000000002	0.7107086887066297
ACROOSTEOLYSIS DOMINANT TYPE	0.01889817	0.708986584862451
HAREL-YOON SYNDROME; HAYOS	0.018895613999999998	0.7088906935824536
ALAZAMI-YUAN SYNDROME	0.018588244	0.697359354485114
GOLDBERG-SHPRINTZEN SYNDROME	0.018588244	0.697359354485114
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.018588244	0.697359354485114
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.018584109	0.6972042252038976
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.018553023000000002	0.696037998157732
EPILEPSY, NOCTURNAL FRONTAL LOBE, 2; ENFL2	0.01853655	0.6954199946149318
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 6	0.01849053	0.6936935013811759
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.018440704	0.6918242216796303
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.018402654	0.6903967321632373
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.018402654	0.6903967321632373
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.018402654	0.6903967321632373
GABRIELE-DE VRIES SYNDROME; GADEVS	0.018402654	0.6903967321632373
MERCURY POISONING	0.018398519000000002	0.6902416028820209
JUVENILE HUNTINGTON DISEASE	0.018398519000000002	0.6902416028820209
PRADER-WILLI SYNDROME	0.018398519000000002	0.6902416028820209
MEGALENCEPHALY WITH DYSMYELINATION	0.018398519000000002	0.6902416028820209
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.018398519000000002	0.6902416028820209
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.018122533	0.6798876706436163
22Q11.2 DELETION SYNDROME	0.018087573	0.6785761060314452
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.01804269	0.6768922686605051
COFFIN-SIRIS SYNDROME 1; CSS1	0.017994733	0.6750931066437463
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.017934163	0.6728207534240898
ATAXIA-PANCYTOPENIA SYNDROME	0.0178571	0.6699296463386283
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0178571	0.6699296463386283
SPASTIC PARAPLEGIA TYPE 7	0.0178571	0.6699296463386283
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.0178571	0.6699296463386283
49,XXXYY SYNDROME	0.0178571	0.6699296463386283
PROGRESSIVE NON-FLUENT APHASIA	0.0178571	0.6699296463386283
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.0178571	0.6699296463386283
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.0178571	0.6699296463386283
49,XYYYY SYNDROME	0.0178571	0.6699296463386283
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.017815584	0.668372125845525
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.017692434	0.6637520119442418
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.017688299	0.6635968826630254
GAPO SYNDROME	0.01733905	0.6504944047100477
EPILEPSY, PROGRESSIVE MYOCLONIC, 10	0.01725926	0.6475009910828988
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	0.6468309526397246
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	0.6468309526397246
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	0.6468309526397246
ENDOCARDIAL FIBROELASTOSIS	0.0172414	0.6468309526397246
PALMOMENTAL REFLEX	0.0172414	0.6468309526397246
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	0.6468309526397246
DIASTEMATOMYELIA	0.0172414	0.6468309526397246
269800 SENILE PLAQUE FORMATION	0.0172414	0.6468309526397246
CONGENITAL TRACHEAL STENOSIS	0.0172414	0.6468309526397246
CERVICAL RIB	0.0172414	0.6468309526397246
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	0.6468309526397246
SICKLE CELL ANEMIA	0.0172414	0.6468309526397246
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	0.6468309526397246
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	0.6468309526397246
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	0.6468309526397246
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	0.6468309526397246
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	0.6468309526397246
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	0.6468309526397246
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	0.6468309526397246
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	0.6468309526397246
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	0.6468309526397246
RHEUMATOID ARTHRITIS	0.0172414	0.6468309526397246
ANDROSTENONE, ABILITY TO SMELL	0.0172414	0.6468309526397246
ALCOHOL DEPENDENCE	0.0172414	0.6468309526397246
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	0.6468309526397246
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	0.6468309526397246
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	0.6468309526397246
THUMBS, CONGENITAL CLASPED	0.0172414	0.6468309526397246
MYOPATHY, CONGENITAL	0.0172414	0.6468309526397246
CARDIAC ARRHYTHMIA	0.0172414	0.6468309526397246
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	0.6468309526397246
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	0.6468309526397246
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.0172414	0.6468309526397246
MOTION SICKNESS	0.0172414	0.6468309526397246
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	0.6468309526397246
SPASTIC PSEUDOSCLEROSIS	0.0172414	0.6468309526397246
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	0.6468309526397246
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	0.6468309526397246
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	0.6468309526397246
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	0.6468309526397246
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	0.6468309526397246
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	0.6468309526397246
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	0.6468309526397246
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	0.6468309526397246
MOSAIC TRISOMY 15	0.0172414	0.6468309526397246
JUMPING FRENCHMAN OF MAINE	0.0172414	0.6468309526397246
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	0.6468309526397246
TRANSSEXUALITY	0.0172414	0.6468309526397246
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	0.6468309526397246
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.0172414	0.6468309526397246
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	0.6468309526397246
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	0.6468309526397246
8Q24.3 MICRODELETION SYNDROME	0.017177983	0.6444517909403525
15Q24 MICRODELETION SYNDROME	0.017160803000000002	0.6438072634793371
MITOCHONDRIAL DNA-RELATED CARDIOMYOPATHY AND HEARING LOSS	0.01714688	0.643284926119633
FANCONI ANEMIA	0.017139283999999998	0.6429999534424575
2P15P16.1 MICRODELETION SYNDROME	0.017059384	0.640002413038783
HALLERMANN-STREIFF SYNDROME; HSS	0.01694324	0.6356451372860374
9P13 MICRODELETION SYNDROME	0.01693985	0.6355179575367451
SMITH-MAGENIS SYNDROME	0.016907683	0.634311175532177
PERMANENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6320369840211589
TRANSIENT NEONATAL DIABETES MELLITUS	0.016847064000000002	0.6320369840211589
ZIMMERMANN-LABAND SYNDROME 1	0.016684769000000002	0.6259483004189768
8Q22.1 MICRODELETION SYNDROME	0.016619384	0.6234953069359447
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.016619384	0.6234953069359447
DESANTO-SHINAWI SYNDROME	0.016528253	0.6200764226489951
WIEDEMANN-STEINER SYNDROME; WDSTS	0.016528253	0.6200764226489951
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.016465168999999998	0.6177097538276509
KRABBE DISEASE	0.016417654	0.6159271739492955
EEC SYNDROME	0.0163945	0.6150585250067839
BRANCHIOSKELETOGENITAL SYNDROME	0.016364099	0.6139179965235285
WRINKLY SKIN SYNDROME	0.016313354	0.6120142394799182
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.016301509999999998	0.6115698981965498
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 1; FAME1	0.016301509999999998	0.6115698981965498
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.016301509999999998	0.6115698981965498
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.016301509999999998	0.6115698981965498
MYOCLONIC EPILEPSY, JUVENILE, SUSCEPTIBILITY TO, 4; EJM4	0.016301509999999998	0.6115698981965498
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.016207583	0.6080461187535471
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.016081919	0.6033316892505763
SIMOSA CRANIOFACIAL SYNDROME	0.01607383	0.6030282211113357
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.01607383	0.6030282211113357
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.01607383	0.6030282211113357
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.016060813	0.6025398733837433
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.015859549	0.5949892229231032
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.015840064	0.5942582207357991
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.015835929000000002	0.5941030914545827
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.015666164	0.5877341622101545
2Q23.1 MICRODELETION SYNDROME	0.015662029	0.5875790329289381
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.015587804	0.58479439667784
FOUNTAIN SYNDROME	0.015575829	0.5843451407787911
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.015519393999999999	0.5822279168403508
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.015470953999999999	0.5804106345230292
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.015470953999999999	0.5804106345230292
MENTAL RETARDATION, X-LINKED 41	0.015470953999999999	0.5804106345230292
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.015470953999999999	0.5804106345230292
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.015470953999999999	0.5804106345230292
FONTAINE PROGEROID SYNDROME; FPS	0.01538085	0.5770302793223698
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.01529451	0.5737911349111902
MICROTRIPLICATION 11Q24.1	0.01529451	0.5737911349111902
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.015277409	0.5731495712260433
FUMARASE DEFICIENCY; FMRD	0.015204414	0.5704110798397325
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.015204414	0.5704110798397325
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.015204414	0.5704110798397325
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.015204414	0.5704110798397325
EVEN-PLUS SYNDROME	0.015070924	0.5654030489450328
INTELLECTUAL DISABILITY-EPILEPSY-EXTRAPYRAMIDAL SYNDROME	0.01506573	0.5652081900607188
AMAUROSIS CONGENITA, CONE-ROD TYPE, WITH CONGENITAL HYPERTRICHOSIS	0.015034410000000002	0.5640331842353986
AMAUROSIS-HYPERTRICHOSIS SYNDROME	0.015034410000000002	0.5640331842353986
AUTISM SPECTRUM DISORDER-EPILEPSY-ARTHROGRYPOSIS SYNDROME	0.014925399999999998	0.5599435486984203
NIEMANN-PICK DISEASE TYPE B	0.014925399999999998	0.5599435486984203
CHROMOSOME XP11.23-P11.22 DUPLICATION SYNDROME	0.014925399999999998	0.5599435486984203
MYOCLONIC-ATONIC EPILEPSY	0.014925399999999998	0.5599435486984203
PAROXYSMAL EXERTION-INDUCED DYSKINESIA	0.014925399999999998	0.5599435486984203
OCULODENTODIGITAL DYSPLASIA	0.014852418999999999	0.557205582538213
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.014794673999999999	0.5550392124429666
FG SYNDROME TYPE 1	0.014662913	0.5500960469720209
ALPHA-METHYLACYL-COA RACEMASE DEFICIENCY; AMACRD	0.01465886	0.5499439940151235
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.01465886	0.5499439940151235
PETERS-PLUS SYNDROME; PTRPLS	0.014516142999999999	0.5445898016022173
HIRSCHSPRUNG DISEASE, CARDIAC DEFECTS, AND AUTONOMIC DYSFUNCTION	0.014470489999999999	0.542877076795597
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.014463313	0.5426078233853697
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.014284619	0.5359039124355046
DESMOSTEROLOSIS	0.014249119999999999	0.5345721266183576
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.014244153999999998	0.534385821416297
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.014244153999999998	0.534385821416297
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.014244153999999998	0.534385821416297
MACS SYNDROME	0.01417449	0.5317722963264149
PETERS PLUS SYNDROME	0.014163094	0.5313447622783513
ROIFMAN-CHITAYAT SYNDROME	0.014078314	0.5281641430615363
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.014017974	0.5259004185564334
WILLIAMS SYNDROME	0.01398568	0.5246888720007855
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.0137432	0.5155919558921122
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.013698599999999998	0.513918735591688
EPILEPSY, FAMILIAL TEMPORAL LOBE, 6; ETL6	0.013698599999999998	0.513918735591688
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.013698599999999998	0.513918735591688
EPILEPSY, HOT WATER, 1	0.013698599999999998	0.513918735591688
CONGENITAL CEREBELLAR ATAXIA DUE TO RNU12 MUTATION	0.013698599999999998	0.513918735591688
ABETA AMYLOIDOSIS, ARCTIC TYPE	0.013698599999999998	0.513918735591688
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 24; EIEE24	0.013698599999999998	0.513918735591688
MENTAL RETARDATION, X-LINKED 77	0.013698599999999998	0.513918735591688
609438 MENTAL RETARDATION, KERATOCONUS, FEBRILE SEIZURES, AND SINOATRIALBLOCK	0.013698599999999998	0.513918735591688
OLIVER SYNDROME	0.01353576	0.5078096056876286
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.01353276	0.5076970572369273
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.01352183	0.5072870057148727
MULTIPLE SULFATASE DEFICIENCY	0.013499862999999999	0.5064628884426885
JOUBERT SYNDROME WITH OCULAR DEFECT	0.013462913	0.5050766666915525
JOUBERT SYNDROME WITH RENAL DEFECT	0.013462913	0.5050766666915525
JOUBERT SYNDROME	0.013462913	0.5050766666915525
OGDEN SYNDROME; OGDNS	0.013422734	0.5035693052913116
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.013418599	0.5034141760100952
CEREBROOCULONASAL SYNDROME	0.01332565	0.49992708736202074
FRONTONASAL DYSPLASIA 2; FND2	0.01332565	0.49992708736202074
TETRASOMY 12P	0.01332565	0.49992708736202074
YUNIS-VARON SYNDROME	0.01332565	0.49992708736202074
16Q24.3 MICRODELETION SYNDROME	0.013303478999999998	0.49909531679518887
TENORIO SYNDROME; TNORS	0.013238029	0.4966398847623917
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.013211904	0.4956597753375357
CHAR SYNDROME	0.013211904	0.4956597753375357
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.013211904	0.4956597753375357
CHROMOSOME 9P DELETION SYNDROME	0.013119243999999999	0.4921835288568788
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.013115108999999998	0.4920283995756623
20Q13.33 MICRODELETION SYNDROME	0.013115108999999998	0.4920283995756623
CARTILAGE-HAIR HYPOPLASIA	0.01306555	0.4901691366862293
HALLERMANN-STREIFF SYNDROME	0.01306555	0.4901691366862293
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.012969374	0.4865609834213506
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.012956823000000001	0.48609011821976716
KBG SYNDROME	0.012956823000000001	0.48609011821976716
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.012956823000000001	0.48609011821976716
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.012859144	0.4824255781810872
ADNP SYNDROME	0.012814919	0.48076642643700085
SPINAL MUSCULAR ATROPHY-PROGRESSIVE MYOCLONIC EPILEPSY SYNDROME	0.01270754	0.4767379797410538
GAUCHER DISEASE TYPE 3	0.01270754	0.4767379797410538
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.01266635	0.47519268951292676
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.01266635	0.47519268951292676
CEREBROOCULONASAL SYNDROME	0.01265581	0.47479726928946325
11P15.4 MICRODUPLICATION SYNDROME	0.012636153	0.47405981432431904
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.012636152999999999	0.47405981432431893
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.012636152999999999	0.47405981432431893
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.012636152999999999	0.47405981432431893
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.012581272999999999	0.4720009279994922
HYPERPROLINEMIA, TYPE I	0.012581272999999999	0.4720009279994922
HYPERTELORISM, TEEBI TYPE; TBHS	0.012573689999999998	0.4717164430322699
17Q21.31 MICRODUPLICATION SYNDROME	0.012415404000000001	0.46577816167637476
HOLOPROSENCEPHALY 11	0.012415404000000001	0.46577816167637476
12Q14 MICRODELETION SYNDROME	0.012415404000000001	0.46577816167637476
ELSAHY-WATERS SYNDROME; ESWS	0.012415404000000001	0.46577816167637476
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.012415404000000001	0.46577816167637476
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.012411269	0.46562303239515823
WIEDEMANN-STEINER SYNDROME	0.012411269	0.46562303239515823
17Q24.2 MICRODELETION SYNDROME	0.012411269	0.46562303239515823
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.012411268999999999	0.46562303239515823
NON-DISTAL MONOSOMY 10Q	0.01224928	0.45954582873494754
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.012120859	0.45472796720578246
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.012112849	0.4544274628424104
HOLOPROSENCEPHALY 5; HPE5	0.012101374	0.4539969650184784
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.012094734	0.4537478577809265
20P13 MICRODELETION SYNDROME	0.012090598999999999	0.45359272849971
CORNELIA DE LANGE SYNDROME 1	0.012090598999999999	0.45359272849971
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.012039854	0.45168897145609965
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.012039854	0.45168897145609965
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.012039854	0.45168897145609965
PYRIDOXINE-DEPENDENT EPILEPSY	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.012039854	0.45168897145609965
RING CHROMOSOME 14 SYNDROME	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.012039854	0.45168897145609965
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.012039854	0.45168897145609965
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.012039854	0.45168897145609965
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.012039854	0.45168897145609965
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.012039854	0.45168897145609965
PERLMAN SYNDROME	0.012039854	0.45168897145609965
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.012039854	0.45168897145609965
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.012039854	0.45168897145609965
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.012039854	0.45168897145609965
PEHO-LIKE SYNDROME; PEHOL	0.012039854	0.45168897145609965
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.012039854	0.45168897145609965
BETA-UREIDOPROPIONASE DEFICIENCY	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.012039854	0.45168897145609965
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.012039854	0.45168897145609965
HYDROCEPHALUS, NORMAL-PRESSURE	0.011993834	0.44996247822234375
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.011993834	0.44996247822234375
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.011989699	0.4498073489411273
INCONTINENTIA PIGMENTI	0.011973313	0.4491926093033975
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.011869850000000001	0.4453110758517658
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.011869850000000001	0.4453110758517658
CEREBROFACIOTHORACIC DYSPLASIA	0.011869850000000001	0.4453110758517658
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.011869850000000001	0.4453110758517658
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.011869850000000001	0.4453110758517658
228560 FIBROMATOSIS, GINGIVAL, WITH DISTINCTIVE FACIES	0.011869850000000001	0.4453110758517658
NON-DISTAL TRISOMY 13Q	0.011869850000000001	0.4453110758517658
MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE; MCPH4	0.011869850000000001	0.4453110758517658
GINGIVAL FIBROMATOSIS-FACIAL DYSMORPHISM SYNDROME	0.011869850000000001	0.4453110758517658
MÜLLERIAN APLASIA AND HYPERANDROGENISM	0.011869850000000001	0.4453110758517658
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.011869850000000001	0.4453110758517658
PELGER-HUET ANOMALY; PHA	0.011861304	0.4449904628318684
DISTAL MONOSOMY 19P13.3	0.011853983	0.4447158070960073
MONOSOMY 22Q13.3	0.011853983	0.4447158070960073
OCULOCEREBRORENAL SYNDROME OF LOWE	0.011811008999999999	0.4431035880558632
MCDONOUGH SYNDROME	0.01177719	0.4418348293711089
OCHOA SYNDROME	0.01157143	0.4341155062990179
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.01157143	0.4341155062990179
PURE AUTONOMIC FAILURE	0.01157143	0.4341155062990179
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.011533312999999998	0.432685503200559
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 69; EIEE69	0.011494299999999999	0.4312218856314908
SEVERE NEURODEGENERATIVE SYNDROME WITH LIPODYSTROPHY	0.011494299999999999	0.4312218856314908
X-LINKED SPASTICITY-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.011494299999999999	0.4312218856314908
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH EPISODIC RHABDOMYOLYSIS; PEERB	0.011494299999999999	0.4312218856314908
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.011494299999999999	0.4312218856314908
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 1; IBGC1	0.01144828	0.4294953923977348
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.01144828	0.4294953923977348
ADULT POLYGLUCOSAN BODY DISEASE	0.01144828	0.4294953923977348
CEREBRAL ARTERIOPATHY, AUTOSOMAL RECESSIVE, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY; CARASIL	0.01144828	0.4294953923977348
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.01144828	0.4294953923977348
FRONTOTEMPORAL DEMENTIA, CHROMOSOME 3-LINKED; FTD3	0.01144828	0.4294953923977348
ALLAN-HERNDON-DUDLEY SYNDROME	0.01142466	0.42860926092921425
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.01142466	0.42860926092921425
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.011366674	0.42643384944176155
MUSCULAR PSEUDOHYPERTROPHY-HYPOTHYROIDISM SYNDROME	0.01129321	0.4236777629809913
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.01126959	0.42279163151247073
SPASTIC PARAPLEGIA 16, X-LINKED	0.01116456	0.4188513102534228
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.011151913	0.4183768435014168
SCHAAF-YANG SYNDROME; SHFYNG	0.011151913	0.4183768435014168
DOWN SYNDROME	0.011146439999999999	0.41817151761118765
EMANUEL SYNDROME	0.011059253	0.41490059702076
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.010991893999999999	0.4123735466571666
NETHERTON SYNDROME	0.010987963	0.41222607067059786
17Q11.2 MICRODUPLICATION SYNDROME	0.010987963	0.41222607067059786
OSTEOGENESIS IMPERFECTA	0.01088634	0.4084135669353961
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.010831242999999999	0.4063465396059686
RUBINSTEIN-TAYBI SYNDROME	0.010831242999999999	0.4063465396059686
CRANIOFACIOFRONTODIGITAL SYNDROME	0.01076701	0.4039367647280059
PROGEROID SYNDROME, PETTY TYPE	0.01076701	0.4039367647280059
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.01076701	0.4039367647280059
NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO; NTD	0.01075482	0.4034794428566568
COFFIN-SIRIS SYNDROME 4; CSS4	0.010745043	0.4031126474558217
COFFIN-SIRIS SYNDROME 2; CSS2	0.010745043	0.4031126474558217
COFFIN-SIRIS SYNDROME 3; CSS3	0.010745043	0.4031126474558217
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.010725689	0.4023865598841982
OROFACIODIGITAL SYNDROME TYPE 6	0.010708093	0.40172642570468553
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.010674349999999999	0.400460518247349
MELAS	0.01061368	0.3981844134126691
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.010610494	0.39806488695802433
COFFIN-SIRIS SYNDROME 7; CSS7	0.010610494	0.39806488695802433
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.010610494	0.39806488695802433
TEMPLE-BARAITSER SYNDROME	0.010606359	0.39790975767680786
TARP SYNDROME	0.010556673	0.39604573023629513
MYHRE SYNDROME	0.010556673	0.39604573023629513
COFFIN-SIRIS SYNDROME 5	0.010556673	0.39604573023629513
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.010556673	0.39604573023629513
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.01049053	0.3935642995113859
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.01049053	0.3935642995113859
HYDROCEPHALY-TALL STATURE-JOINT LAXITY SYNDROME	0.010476599999999999	0.3930416995386301
5Q14.3 MICRODELETION SYNDROME	0.010459589	0.3924035123070043
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.010454633	0.39221758226644593
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.010446544	0.3919141141272054
ROSSELLI-GULIENETTI SYNDROME	0.010446544	0.3919141141272054
CDAGS SYNDROME	0.010446544	0.3919141141272054
ROTHMUND-THOMSON SYNDROME	0.010446544	0.3919141141272054
NETHERTON SYNDROME; NETH	0.010446544	0.3919141141272054
NOONAN SYNDROME 9; NS9	0.010446544	0.3919141141272054
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.010446544	0.3919141141272054
CEREBELLOFACIODENTAL SYNDROME	0.010446544	0.3919141141272054
3MC SYNDROME	0.010446339999999998	0.39190646083255765
OHDO SYNDROME	0.010442409	0.3917589848459889
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.010442409	0.3917589848459889
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.010424372999999999	0.3910823435603734
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.010389413	0.3897707789482025
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.010346233	0.3881508315811103
ALEXANDER DISEASE	0.010315949	0.3870146924874322
TRISOMY 8P	0.010292329	0.38612856101891163
9Q33.3Q34.11 MICRODELETION SYNDROME	0.010285688999999999	0.3858794537813597
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.010236002999999999	0.3840154263408469
SHASHI-PENA SYNDROME; SHAPNS	0.010236002999999999	0.3840154263408469
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.010236002999999999	0.3840154263408469
WOLF-HIRSCHHORN SYNDROME	0.010236002999999999	0.3840154263408469
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.010236002999999999	0.3840154263408469
COHEN SYNDROME	0.010199488999999999	0.3826455616312127
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.010138919	0.3803732084115561
SMITH-MAGENIS SYNDROME; SMS	0.010034743	0.37646492594480774
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.010014633	0.37571047616360753
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00991817	0.3720915557636118
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00991817	0.3720915557636118
MUSCLE-EYE-BRAIN DISEASE	0.009909079	0.371750496441837
MARIE UNNA HEREDITARY HYPOTRICHOSIS 1	0.00990099	0.3714470283025964
SKIN FRAGILITY-WOOLLY HAIR SYNDROME; SFWHS	0.00990099	0.3714470283025964
ECTODERMAL DYSPLASIA 10B, HYPOHIDROTIC/HAIR/TOOTH TYPE, AUTOSOMAL RECESSIVE; ECTD10B	0.00990099	0.3714470283025964
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.00990099	0.3714470283025964
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, AUTOSOMAL DOMINANT; KFSD	0.00990099	0.3714470283025964
NEONATAL ICHTHYOSIS-SCLEROSING CHOLANGITIS SYNDROME	0.00990099	0.3714470283025964
KERATOSIS FOLLICULARIS SPINULOSA DECALVANS, X-LINKED; KFSDX	0.00990099	0.3714470283025964
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00990099	0.3714470283025964
ODONTO-ONYCHO DYSPLASIA-ALOPECIA SYNDROME	0.00990099	0.3714470283025964
HIDROTIC ECTODERMAL DYSPLASIA	0.00990099	0.3714470283025964
PALMOPLANTAR KERATODERMA AND WOOLLY HAIR; PPKWH	0.00990099	0.3714470283025964
HYPOHIDROTIC ECTODERMAL DYSPLASIA-HYPOTHYROIDISM-CILIARY DYSKINESIA SYNDROME	0.00990099	0.3714470283025964
HYPOTRICHOSIS SIMPLEX	0.00990099	0.3714470283025964
HYPOTRICHOSIS 7; HYPT7	0.00990099	0.3714470283025964
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND CILIARYDYSKINESIA	0.00990099	0.3714470283025964
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00990099	0.3714470283025964
NOONAN SYNDROME 4; NS4	0.00990099	0.3714470283025964
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00990099	0.3714470283025964
STORM SYNDROME	0.00990099	0.3714470283025964
ECTODERMAL DYSPLASIA 7, HAIR/NAIL TYPE; ECTD7	0.00990099	0.3714470283025964
HAIR DEFECT-PHOTOSENSITIVITY-INTELLECTUAL DISABILITY SYNDROME	0.00990099	0.3714470283025964
CARTILAGE-HAIR HYPOPLASIA; CHH	0.00990099	0.3714470283025964
BAZEX-DUPRÉ-CHRISTOL SYNDROME	0.00990099	0.3714470283025964
INTERSTITIAL LUNG DISEASE, NEPHROTIC SYNDROME, AND EPIDERMOLYSIS BULLOSA, CONGENITAL; ILNEB	0.00990099	0.3714470283025964
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.00990099	0.3714470283025964
ODONTOONYCHODERMAL DYSPLASIA; OODD	0.00990099	0.3714470283025964
HUTCHINSON-GILFORD PROGERIA SYNDROME	0.00990099	0.3714470283025964
HAIR DEFECT WITH PHOTOSENSITIVITY AND MENTAL RETARDATION	0.00990099	0.3714470283025964
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.00990099	0.3714470283025964
PACHYONYCHIA CONGENITA 2	0.00990099	0.3714470283025964
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.00990099	0.3714470283025964
HYPOTRICHOSIS 8; HYPT8	0.00990099	0.3714470283025964
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.00990099	0.3714470283025964
190360 TRICHODYSPLASIA-XERODERMA	0.00990099	0.3714470283025964
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00990099	0.3714470283025964
MARSHALL SYNDROME	0.00990099	0.3714470283025964
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.00990099	0.3714470283025964
NESTOR-GUILLERMO PROGERIA SYNDROME; NGPS	0.00990099	0.3714470283025964
NAXOS DISEASE; NXD	0.00990099	0.3714470283025964
ECTODERMAL DYSPLASIA WITH NATAL TEETH, TURNPENNY TYPE	0.00990099	0.3714470283025964
BARBER-SAY SYNDROME; BBRSAY	0.00990099	0.3714470283025964
TRICHODYSPLASIA-XERODERMA SYNDROME	0.00990099	0.3714470283025964
TRICHORHINOPHALANGEAL SYNDROME TYPE 1 AND 3	0.00990099	0.3714470283025964
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.00990099	0.3714470283025964
ICHTHYOSIS, CONGENITAL, AUTOSOMAL RECESSIVE 11; ARCI11	0.00990099	0.3714470283025964
NOONAN SYNDROME 10; NS10	0.00990099	0.3714470283025964
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00990099	0.3714470283025964
BOHRING-OPITZ SYNDROME	0.009887973	0.37095868057500403
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.009887973	0.37095868057500403
2Q23.1 MICRODUPLICATION SYNDROME	0.009882954	0.37077038701698095
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.009804814	0.36783887503771784
BIOTINIDASE DEFICIENCY	0.009804814	0.36783887503771784
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009804814	0.36783887503771784
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.009804814	0.36783887503771784
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.009804814	0.36783887503771784
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.009804814	0.36783887503771784
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.009804814	0.36783887503771784
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.009804814	0.36783887503771784
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.009804814	0.36783887503771784
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.009804814	0.36783887503771784
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.009800679	0.36768374575650137
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.009800679	0.36768374575650137
HURLER SYNDROME	0.009793884	0.3674288235156632
8Q12 MICRODUPLICATION SYNDROME	0.009694584	0.36370346979745444
CHROMOSOME 15Q14 DELETION SYNDROME	0.009694584	0.36370346979745444
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00964984	0.3620248471713967
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.0095975	0.3600612518681636
TRISOMY 18P	0.0095975	0.3600612518681636
PSEUDOAMINOPTERIN SYNDROME	0.009473214	0.355398519620215
JOUBERT SYNDROME 14	0.009473214	0.355398519620215
RAINE SYNDROME	0.009473214	0.355398519620215
CHROMOSOME 17P13.1 DELETION SYNDROME	0.009473214	0.355398519620215
WAARDENBURG SYNDROME TYPE 3	0.009469700000000001	0.35526668786829374
16P12.1P12.3 TRIPLICATION SYNDROME	0.009469700000000001	0.35526668786829374
2Q31.1 MICRODELETION SYNDROME	0.009439503	0.35413381267968597
AL KAISSI SYNDROME; ALKAS	0.009439503	0.35413381267968597
19P13.12 MICRODELETION SYNDROME	0.009439503	0.35413381267968597
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.009366039	0.35137772621891566
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.009346554	0.3506467240316116
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.009342419	0.3504915947503951
KLEEFSTRA SYNDROME	0.009342419	0.3504915947503951
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.009342419	0.3504915947503951
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.009342419	0.3504915947503951
MENTAL RETARDATION, X-LINKED 21	0.009342419	0.3504915947503951
JOUBERT SYNDROME 3; JBTS3	0.0093374	0.350303301192372
PAINE SYNDROME	0.00925926	0.3473717892131089
ADULT NEURONAL CEROID LIPOFUSCINOSIS	0.00925926	0.3473717892131089
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00925926	0.3473717892131089
SEIZURES-INTELLECTUAL DISABILITY DUE TO HYDROXYLYSINURIA SYNDROME	0.00925926	0.3473717892131089
MICROHYDRANENCEPHALY; MHAC	0.00925926	0.3473717892131089
GLYCINE ENCEPHALOPATHY	0.00925926	0.3473717892131089
MERRF	0.00925926	0.3473717892131089
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.00925926	0.3473717892131089
SPINAL MUSCULAR ATROPHY WITH PROGRESSIVE MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
CARNOSINASE DEFICIENCY	0.00925926	0.3473717892131089
HYDROXYLYSINURIA	0.00925926	0.3473717892131089
GAUCHER DISEASE TYPE 2	0.00925926	0.3473717892131089
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00925926	0.3473717892131089
310370 MYOCLONIC EPILEPSY, PROGRESSIVE	0.00925926	0.3473717892131089
MYOCLONIC EPILEPSY, HARTUNG TYPE	0.00925926	0.3473717892131089
XQ12-Q13.3 DUPLICATION SYNDROME	0.00925926	0.3473717892131089
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.00925926	0.3473717892131089
CARNOSINEMIA	0.00925926	0.3473717892131089
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00925926	0.3473717892131089
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.009248329999999999	0.34696173769105426
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.00915567	0.34348549121039745
PSEUDOTRISOMY 13 SYNDROME	0.00915567	0.34348549121039745
CATEL-MANZKE SYNDROME	0.009149029999999999	0.3432363839728455
3MC SYNDROME 1	0.009149029999999999	0.3432363839728455
17Q23.1Q23.2 MICRODELETION SYNDROME	0.009149029999999999	0.3432363839728455
SPINOCEREBELLAR ATAXIA TYPE 13	0.009086973	0.3409082442377913
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.009086973	0.3409082442377913
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.009086973	0.3409082442377913
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.009086973	0.3409082442377913
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.008931903	0.3350906148210478
FETAL TRIMETHADIONE SYNDROME	0.008898084	0.3338218561362935
17Q12 MICRODUPLICATION SYNDROME	0.008893949	0.33366672685507703
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.008801	0.3301796382070027
GASTROCUTANEOUS SYNDROME	0.008801	0.3301796382070027
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.008801	0.3301796382070027
IMMUNODEFICIENCY 49; IMD49	0.008785132999999999	0.32958436945124414
EDINBURGH MALFORMATION SYNDROME	0.008672579	0.3253617766778376
OKAMOTO SYNDROME	0.008545554	0.3205962876943989
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.008545554	0.3205962876943989
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.008545554	0.3205962876943989
CURRARINO SYNDROME	0.008545554	0.3205962876943989
COG5-CDG	0.008541419	0.3204411584131824
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.008541419	0.3204411584131824
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.008541419	0.3204411584131824
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.008541419	0.3204411584131824
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.008541419	0.3204411584131824
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.008541419	0.3204411584131824
CHILDHOOD DISINTEGRATIVE DISORDER	0.008541419	0.3204411584131824
HUNTINGTON DISEASE-LIKE 3	0.008541419	0.3204411584131824
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.008541419	0.3204411584131824
ENCEPHALITIS LETHARGICA	0.008541419	0.3204411584131824
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.008541419	0.3204411584131824
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.008541419	0.3204411584131824
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.008525033	0.3198264187754526
THYROID ECTOPIA	0.008390484	0.31477865827765533
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.008390484	0.31477865827765533
PERIPHERAL HYPOTHYROIDISM	0.008390484	0.31477865827765533
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.008390484	0.31477865827765533
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.008390484	0.31477865827765533
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.008390484	0.31477865827765533
PERMANENT CONGENITAL HYPOTHYROIDISM	0.008390484	0.31477865827765533
THYROID HEMIAGENESIS	0.008390484	0.31477865827765533
FAMILIAL THYROID DYSHORMONOGENESIS	0.008390484	0.31477865827765533
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.008390484	0.31477865827765533
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00835253	0.31335477031168457
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.008336663	0.312759501555926
SIMPSON-GOLABI-BEHMEL SYNDROME	0.008336663	0.312759501555926
COHEN-GIBSON SYNDROME; COGIS	0.008267334	0.31015854437637225
HEREDITARY HYPEREKPLEXIA	0.008263198999999999	0.3100034150951557
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.008243714	0.3092724129078517
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.008243714	0.3092724129078517
MONOSOMY 9Q22.3	0.008115292999999999	0.30445455137868666
TETRASOMY 9P	0.008115292999999999	0.30445455137868666
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.008106683	0.3041315373251743
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.008106683	0.3041315373251743
PITT-HOPKINS SYNDROME	0.008083063	0.3032454058566537
48,XXYY SYNDROME	0.008083063	0.3032454058566537
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.008083063	0.3032454058566537
49,XXXXY SYNDROME	0.008083063	0.3032454058566537
48,XXXY SYNDROME	0.008083063	0.3032454058566537
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.008	0.30012920186979
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 13	0.008	0.30012920186979
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 12	0.008	0.30012920186979
SPINOCEREBELLAR ATAXIA TYPE 19/22	0.008	0.30012920186979
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 8	0.008	0.30012920186979
SPINOCEREBELLAR ATAXIA TYPE 8	0.008	0.30012920186979
SPINOCEREBELLAR ATAXIA TYPE 42	0.008	0.30012920186979
%611945 SPASTIC PARAPLEGIA 37, AUTOSOMAL DOMINANT; SPG37	0.008	0.30012920186979
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.008	0.30012920186979
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.008	0.30012920186979
SPINOCEREBELLAR ATAXIA 42	0.008	0.30012920186979
207720 APNEA, CENTRAL SLEEP;;SLEEP APNEA, LETHAL CENTRAL	0.008	0.30012920186979
SANDHOFF DISEASE	0.008	0.30012920186979
SPASTIC PARAPLEGIA 76, AUTOSOMAL RECESSIVE	0.008	0.30012920186979
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.008	0.30012920186979
NEUROLEPTIC MALIGNANT SYNDROME	0.008	0.30012920186979
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.008	0.30012920186979
SPASTIC PARAPLEGIA 36, AUTOSOMAL DOMINANT; SPG36	0.008	0.30012920186979
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.008	0.30012920186979
METACHROMATIC LEUKODYSTROPHY, ADULT-ONSET, WITH NORMAL ARYLSULFATASEA	0.008	0.30012920186979
CHIARI MALFORMATION TYPE I	0.008	0.30012920186979
NORMAL PRESSURE HYDROCEPHALUS	0.008	0.30012920186979
MULTIPLE SYSTEM ATROPHY 1, SUSCEPTIBILITY TO; MSA1	0.008	0.30012920186979
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.008	0.30012920186979
SPASTIC PARAPLEGIA, ATAXIA, AND MENTAL RETARDATION	0.008	0.30012920186979
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.008	0.30012920186979
POSTERIOR COLUMN ATAXIA WITH RETINITIS PIGMENTOSA; AXPC1	0.008	0.30012920186979
SPASTIC PARAPLEGIA 19, AUTOSOMAL DOMINANT	0.008	0.30012920186979
FOWLER URETHRAL SPHINCTER DYSFUNCTION SYNDROME	0.008	0.30012920186979
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.008	0.30012920186979
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 46	0.008	0.30012920186979
POSTERIOR URETHRAL VALVE	0.008	0.30012920186979
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.008	0.30012920186979
SPASTIC PARAPLEGIA 13, AUTOSOMAL DOMINANT	0.008	0.30012920186979
ADULT-ONSET DISTAL MYOPATHY DUE TO VCP MUTATION	0.008	0.30012920186979
MULTIPLE SCLEROSIS, SUSCEPTIBILITY TO	0.008	0.30012920186979
SPASTIC PARAPLEGIA 12, AUTOSOMAL DOMINANT	0.008	0.30012920186979
CAMPTOBRACHYDACTYLY	0.008	0.30012920186979
ISOLATED EPISPADIAS	0.008	0.30012920186979
AMYOTROPHIC DYSTONIC PARAPLEGIA	0.008	0.30012920186979
SYRINGOMYELIA, ISOLATED	0.008	0.30012920186979
ARNOLD-CHIARI MALFORMATION TYPE I	0.008	0.30012920186979
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.008	0.30012920186979
PRIMARY PROGRESSIVE FREEZING GAIT	0.008	0.30012920186979
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.008	0.30012920186979
PEROXISOME BIOGENESIS DISORDER 14B	0.008	0.30012920186979
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.008	0.30012920186979
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.008	0.30012920186979
KUFOR-RAKEB SYNDROME	0.008	0.30012920186979
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IIB; HSAN2B	0.008	0.30012920186979
INDIFFERENCE TO PAIN, CONGENITAL, AUTOSOMAL RECESSIVE; CIP	0.008	0.30012920186979
SPINOCEREBELLAR ATAXIA 48; SCA48	0.008	0.30012920186979
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 73	0.008	0.30012920186979
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.007983614	0.2995144622320602
PYRUVATE DEHYDROGENASE DEFICIENCY	0.007959913	0.2986252919553707
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00784493	0.2943115724530464
HYPOTHYROIDISM DUE TO TSH RECEPTOR MUTATIONS	0.00784493	0.2943115724530464
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00784493	0.2943115724530464
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00784493	0.2943115724530464
ISOLATED THYROID-STIMULATING HORMONE DEFICIENCY	0.00784493	0.2943115724530464
PRADER-WILLI-LIKE SYNDROME	0.007822963	0.2934874551808622
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.007822963	0.2934874551808622
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.007795244	0.2924475450125336
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.007791108999999999	0.2922924157313171
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.007791108999999999	0.2922924157313171
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.007791108999999999	0.2922924157313171
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.007721779999999999	0.2896914585517633
BRITTLE CORNEA SYNDROME 2; BCS2	0.007721779999999999	0.2896914585517633
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.007699813	0.2888673412795791
HUNTER-MACDONALD SYNDROME	0.007698159999999999	0.28880532708324275
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.007698159999999999	0.28880532708324275
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.0076761929999999996	0.28798120981105857
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0076761929999999996	0.28798120981105857
611961 STEVENSON-CAREY SYNDROME	0.007634593	0.28642053796133565
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.007634593	0.28642053796133565
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007587804	0.28466519480804997
OROFACIODIGITAL SYNDROME TYPE 2	0.007587804	0.28466519480804997
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.007587804	0.28466519480804997
X SMALL RINGS	0.007587804	0.28466519480804997
SARCOSINEMIA	0.007587804	0.28466519480804997
W SYNDROME	0.007587804	0.28466519480804997
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.007587804	0.28466519480804997
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.007587804	0.28466519480804997
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.007587804	0.28466519480804997
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.007587804	0.28466519480804997
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.007587804	0.28466519480804997
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.0075836689999999995	0.2845100655268335
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.0075836689999999995	0.2845100655268335
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.007580483000000001	0.28439053907218886
RING CHROMOSOME 22 SYNDROME	0.007580483000000001	0.28439053907218886
11Q22.2Q22.3 MICRODELETION SYNDROME	0.007580483000000001	0.28439053907218886
WILSON-TURNER SYNDROME	0.007580483000000001	0.28439053907218886
PHELAN-MCDERMID SYNDROME	0.007580483000000001	0.28439053907218886
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.007580483000000001	0.28439053907218886
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.007580483000000001	0.28439053907218886
COFFIN-SIRIS SYNDROME	0.007580483000000001	0.28439053907218886
COHEN SYNDROME	0.007580483000000001	0.28439053907218886
KBG SYNDROME	0.007580483000000001	0.28439053907218886
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.007580483	0.28439053907218886
KLEEFSTRA SYNDROME 2; KLEFS2	0.007580483	0.28439053907218886
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.007580483	0.28439053907218886
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.0075738739999999995	0.28414259483529414
HURLER SYNDROME	0.0075738739999999995	0.28414259483529414
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.007569738999999999	0.2839874655540777
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.007569738999999999	0.2839874655540777
MUCOPOLYSACCHARIDOSIS, TYPE II	0.007569738999999999	0.2839874655540777
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.007569738999999999	0.2839874655540777
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.007565264	0.2838195807817818
LYNCH SYNDROME	0.007561129	0.28366445150056535
FAMILIAL COLORECTAL CANCER TYPE X	0.007561129	0.28366445150056535
PITT-HOPKINS SYNDROME	0.0075375089999999995	0.28277832003204484
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.0075375089999999995	0.28277832003204484
C SYNDROME	0.0075375089999999995	0.28277832003204484
DISTAL MONOSOMY 10Q	0.007487823	0.280914292591532
SMITH-LEMLI-OPITZ SYNDROME	0.007487823	0.280914292591532
CHROMOSOME 10Q26 DELETION SYNDROME	0.007487822999999999	0.280914292591532
KOOLEN-DE VRIES SYNDROME; KDVS	0.007487822999999999	0.280914292591532
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.007487822999999999	0.280914292591532
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.007487822999999999	0.280914292591532
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.007487822999999999	0.280914292591532
8P11.2 DELETION SYNDROME	0.007487822999999999	0.280914292591532
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.007487822999999999	0.280914292591532
BOHRING-OPITZ SYNDROME	0.007487822999999999	0.280914292591532
L1 SYNDROME	0.007290073	0.27349547388281314
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.007290073	0.27349547388281314
16P13.2 MICRODELETION SYNDROME	0.007290072999999999	0.27349547388281314
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.007281544	0.2731754986374697
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.007277409	0.2730203693562533
LOWE OCULOCEREBRORENAL SYNDROME	0.007277409	0.2730203693562533
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.007266453	0.2726093424142926
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.007266453	0.2726093424142926
MEND SYNDROME	0.007266452999999999	0.2726093424142925
HOLOPROSENCEPHALY 7	0.007266452999999999	0.2726093424142925
TETRASOMY 5P	0.007266452999999999	0.2726093424142925
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.007259813	0.2723602351767407
CHROMOSOME 2Q37 DELETION SYNDROME	0.007259813	0.2723602351767407
6Q TERMINAL DELETION SYNDROME	0.007259813	0.2723602351767407
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.007259813	0.2723602351767407
TEMTAMY SYNDROME; TEMTYS	0.007259813	0.2723602351767407
BARAITSER-WINTER SYNDROME 1; BRWS1	0.007259813	0.2723602351767407
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.007259813	0.2723602351767407
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.007259813	0.2723602351767407
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.007259813	0.2723602351767407
MACDERMOT-WINTER SYNDROME	0.0072598129999999995	0.27236023517674063
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0072598129999999995	0.27236023517674063
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0072598129999999995	0.27236023517674063
CLASSICAL EHLERS-DANLOS SYNDROME	0.00724969	0.2719804591879247
OMODYSPLASIA 1; OMOD1	0.00724969	0.2719804591879247
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE	0.00724969	0.2719804591879247
CHARGE SYNDROME	0.00724969	0.2719804591879247
FLOATING-HARBOR SYNDROME	0.00724969	0.2719804591879247
CADASIL	0.007154259	0.26840025545497015
KALLMANN SYNDROME	0.007154259	0.26840025545497015
PELIZAEUS-MERZBACHER DISEASE	0.007154259	0.26840025545497015
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.007154259	0.26840025545497015
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.007154259	0.26840025545497015
ZELLWEGER SYNDROME	0.007130638999999999	0.26751412398644964
COFFIN-SIRIS SYNDROME 6; CSS6	0.007093174000000001	0.2661085814179432
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.007093174000000001	0.2661085814179432
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.007089039	0.2659534521367267
KAPUR-TORIELLO SYNDROME	0.007089039	0.2659534521367267
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.00704225	0.26419810898344104
ALOPECIA-MENTAL RETARDATION SYNDROME WITH CONVULSIONS AND HYPERGONADOTROPICHYPOGONADISM	0.00704225	0.26419810898344104
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00704225	0.26419810898344104
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 29	0.00704225	0.26419810898344104
TUBULAR RENAL DISEASE-CARDIOMYOPATHY SYNDROME	0.00704225	0.26419810898344104
269720 SEIZURES, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;BFNS, AUTOSOMAL RECESSIVE;;CONVULSIONS, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE;;EPILEPSY, BENIGN FAMILIAL NEONATAL, AUTOSOMAL RECESSIVE	0.00704225	0.26419810898344104
TRAPPC11-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R18	0.00704225	0.26419810898344104
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.00704225	0.26419810898344104
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00704225	0.26419810898344104
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.00704225	0.26419810898344104
EPILEPSY, PROGRESSIVE MYOCLONIC, 8; EPM8	0.00704225	0.26419810898344104
608278 GROWTH FAILURE, MICROCEPHALY, MENTAL RETARDATION, CATARACTS, LARGEJOINT CONTRACTURES, OSTEOPOROSIS, CORTICAL DYSPLASIA, AND CEREBELLARATROPHY	0.00704225	0.26419810898344104
EPILEPSY, BENIGN NEONATAL, 3	0.00704225	0.26419810898344104
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 12	0.00704225	0.26419810898344104
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00704225	0.26419810898344104
SEIZURES, BENIGN FAMILIAL INFANTILE, 5	0.00704225	0.26419810898344104
PAROXYSMAL DYSTONIC CHOREATHETOSIS WITH EPISODIC ATAXIA AND SPASTICITY	0.00704225	0.26419810898344104
ENCEPHALOPATHY DUE TO PROSAPOSIN DEFICIENCY	0.00704225	0.26419810898344104
HEPATIC VENO-OCCLUSIVE DISEASE-IMMUNODEFICIENCY SYNDROME	0.00704225	0.26419810898344104
GLYCOGEN STORAGE DISEASE 0, MUSCLE; GSD0B	0.00704225	0.26419810898344104
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.00704225	0.26419810898344104
MYOCLONIC EPILEPSY, JUVENILE, 2	0.00704225	0.26419810898344104
AMISH LETHAL MICROCEPHALY	0.00704225	0.26419810898344104
CHOPS SYNDROME; CHOPS	0.007039064	0.2640785825287964
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.007039064	0.2640785825287964
HYPERTRICHOSIS CUBITI	0.007039064	0.2640785825287964
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.007039064	0.2640785825287964
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.007039064	0.2640785825287964
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.007039064	0.2640785825287964
TRISOMY 12P	0.007039064	0.2640785825287964
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.007039064	0.2640785825287964
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.0070349290000000005	0.26392345324757993
COFFIN-SIRIS SYNDROME 8; CSS8	0.0070349290000000005	0.26392345324757993
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.0070349290000000005	0.26392345324757993
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.0070349290000000005	0.26392345324757993
ZIMMERMANN-LABAND SYNDROME	0.0070349290000000005	0.26392345324757993
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.0070349290000000005	0.26392345324757993
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.007028319999999999	0.2636755090106852
FOCAL DERMAL HYPOPLASIA; FDH	0.007028319999999999	0.2636755090106852
CRANIOFACIAL DYSSYNOSTOSIS	0.007028319999999999	0.2636755090106852
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.007028319999999999	0.2636755090106852
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.007028319999999999	0.2636755090106852
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.007028319999999999	0.2636755090106852
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.007028319999999999	0.2636755090106852
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.007028319999999999	0.2636755090106852
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00701971	0.2633524949571729
NEUROFERRITINOPATHY	0.00701971	0.2633524949571729
RHEUMATIC FEVER	0.00701971	0.2633524949571729
POLYMYOSITIS	0.00701971	0.2633524949571729
CONGENITAL TOXOPLASMOSIS	0.007006353	0.26285139173850103
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.007006353	0.26285139173850103
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.007006353	0.26285139173850103
FRONTOOCULAR SYNDROME	0.006946404	0.26060233604813954
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.006946404	0.26060233604813954
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.006946404	0.26060233604813954
OROFACIODIGITAL SYNDROME XIV; OFD14	0.006946404	0.26060233604813954
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.006946404	0.26060233604813954
MOSAIC TRISOMY 9	0.006946404	0.26060233604813954
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.006942269	0.26044720676692307
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.006942269	0.26044720676692307
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.006942268999999999	0.26044720676692307
LERI PLEONOSTEOSIS	0.00687294	0.25784624958736924
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.006817983	0.2557844745189745
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.006817983	0.2557844745189745
FRIED SYNDROME	0.006748654	0.2531835173394207
MALT LYMPHOMA	0.00673599	0.25270841281286077
MATERNALLY-INHERITED DIABETES AND DEAFNESS	0.00673599	0.25270841281286077
3MC SYNDROME 2	0.006718394	0.2520482786333482
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.006718394	0.2520482786333482
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.006718394	0.2520482786333482
OCULOFACIOCARDIODENTAL SYNDROME	0.006718394	0.2520482786333482
JOUBERT SYNDROME 1	0.006718394	0.2520482786333482
JOUBERT SYNDROME 35; JBTS35	0.006718394	0.2520482786333482
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.006718394	0.2520482786333482
CHARGE SYNDROME	0.006718394	0.2520482786333482
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.006718394	0.2520482786333482
8P23.1 DUPLICATION SYNDROME	0.006718394	0.2520482786333482
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.006714259	0.25189314935213175
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.006714259	0.25189314935213175
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.006714259	0.25189314935213175
BARAITSER-WINTER SYNDROME 2; BRWS2	0.006714259	0.25189314935213175
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.006714259	0.25189314935213175
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.006714259	0.25189314935213175
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.006714259	0.25189314935213175
CONGENITAL RUBELLA SYNDROME	0.006682169	0.2506892560911315
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00661284	0.24808829891157774
ATAXIA-TAPETORETINAL DEGENERATION SYNDROME	0.00661284	0.24808829891157774
MANGANESE POISONING	0.00661284	0.24808829891157774
SPASTIC PARAPARESIS-DEAFNESS SYNDROME	0.00661284	0.24808829891157774
3-METHYLGLUTACONIC ACIDURIA TYPE 3	0.00661284	0.24808829891157774
CYSTINOSIS	0.00661284	0.24808829891157774
NEUROFIBROMATOSIS TYPE 2	0.00661284	0.24808829891157774
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00661284	0.24808829891157774
ATAXIA WITH VITAMIN E DEFICIENCY	0.00661284	0.24808829891157774
BETA-THALASSEMIA MAJOR	0.00658922	0.24720216744305717
TOWNES-BROCKS SYNDROME	0.0065476200000000005	0.24564149559333426
PRUNE BELLY SYNDROME	0.0065476200000000005	0.24564149559333426
HYPERTRICHOSIS LANUGINOSA CONGENITA	0.00649351	0.24361149670418747
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.00649351	0.24361149670418747
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.00649351	0.24361149670418747
%606242 MENTAL RETARDATION, MICROCEPHALY, GROWTH RETARDATION, JOINT CONTRACTURES,AND FACIAL DYSMORPHISM;;KONDOH SYNDROME	0.00649351	0.24361149670418747
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00649351	0.24361149670418747
TRISOMY 4P	0.00649351	0.24361149670418747
CATARACT-GROWTH HORMONE DEFICIENCY-SENSORY NEUROPATHY-SENSORINEURAL HEARING LOSS-SKELETAL DYSPLASIA SYNDROME	0.00649351	0.24361149670418747
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00649351	0.24361149670418747
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00649351	0.24361149670418747
3M SYNDROME	0.00649351	0.24361149670418747
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00649351	0.24361149670418747
DEAFNESS, X-LINKED 7; DFNX7	0.00649351	0.24361149670418747
CARPENTER-WAZIRI SYNDROME	0.00649351	0.24361149670418747
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00649351	0.24361149670418747
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.00649351	0.24361149670418747
CRANIOTELENCEPHALIC DYSPLASIA	0.006464934	0.2425394351951086
JOUBERT SYNDROME 2	0.0064649339999999994	0.24253943519510854
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.006463313	0.24247862151557972
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.006463313	0.24247862151557972
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.006463313	0.24247862151557972
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.006463313	0.24247862151557972
NEUROFIBROMATOSIS TYPE 1	0.006460799	0.2423843059138921
PAPILLOMA OF CHOROID PLEXUS	0.006460799	0.2423843059138921
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.006460799	0.2423843059138921
RAMOS-ARROYO SYNDROME	0.00640085	0.2401352502235306
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.00640085	0.2401352502235306
BRAIN MALFORMATION-CONGENITAL HEART DISEASE-POSTAXIAL POLYDACTYLY SYNDROME	0.00640085	0.2401352502235306
ALAGILLE SYNDROME 1; ALGS1	0.00640085	0.2401352502235306
SIFRIM-HITZ-WEISS SYNDROME	0.00640085	0.2401352502235306
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00640085	0.2401352502235306
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.00632625	0.23733654541609486
RITSCHER-SCHINZEL SYNDROME 1	0.006276564	0.23547251797558202
3C SYNDROME	0.006276564	0.23547251797558202
CUTIS LAXA	0.006276564	0.23547251797558202
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.006276564	0.23547251797558202
COSTELLO SYNDROME; CSTLO	0.006276564	0.23547251797558202
THANATOPHORIC DYSPLASIA	0.0062724289999999995	0.23531738869436558
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.0062724289999999995	0.23531738869436558
THANATOPHORIC DYSPLASIA TYPE 2	0.0062724289999999995	0.23531738869436558
THANATOPHORIC DYSPLASIA TYPE 1	0.0062724289999999995	0.23531738869436558
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.0062724289999999995	0.23531738869436558
VON HIPPEL-LINDAU DISEASE	0.0062031	0.23271643151481172
ISOTRETINOIN-LIKE SYNDROME	0.006179479999999999	0.23183030004629118
CZEIZEL-LOSONCI SYNDROME	0.006179479999999999	0.23183030004629118
ARTHROGRYPOSIS, DISTAL, TYPE 5D; DA5D	0.00617284	0.23158119280873926
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.00617284	0.23158119280873926
TEEBI-SHALTOUT SYNDROME; TBSH	0.00617284	0.23158119280873926
RING CHROMOSOME 7 SYNDROME	0.00617284	0.23158119280873926
3MC SYNDROME 3	0.00617284	0.23158119280873926
9Q31.1Q31.3 MICRODELETION SYNDROME	0.00617284	0.23158119280873926
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.00617284	0.23158119280873926
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00617284	0.23158119280873926
INTELLECTUAL DISABILITY-MUSCLE WEAKNESS-SHORT STATURE-FACIAL DYSMORPHISM SYNDROME	0.00617284	0.23158119280873926
JUBERG-HAYWARD SYNDROME	0.00617284	0.23158119280873926
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.00617284	0.23158119280873926
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3B	0.00617284	0.23158119280873926
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.0059218940000000005	0.22216666497218723
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.0059218940000000005	0.22216666497218723
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.0059218940000000005	0.22216666497218723
DESBUQUOIS DYSPLASIA 2; DBQD2	0.0059218940000000005	0.22216666497218723
BARATELA-SCOTT SYNDROME	0.0059218940000000005	0.22216666497218723
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.0059218940000000005	0.22216666497218723
GERMAN SYNDROME	0.0059218940000000005	0.22216666497218723
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.0059218940000000005	0.22216666497218723
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.0059218940000000005	0.22216666497218723
AUTOSOMAL RECESSIVE MALIGNANT OSTEOPETROSIS	0.00591938	0.22207234937049966
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00591938	0.22207234937049966
APERT SYNDROME	0.00591938	0.22207234937049966
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00591938	0.22207234937049966
MUCOPOLYSACCHARIDOSIS TYPE 1	0.00591938	0.22207234937049966
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.005917759	0.2220115356909708
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.005917759	0.2220115356909708
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.005917759	0.2220115356909708
DUPLICATION/INVERSION 15Q11	0.005917759	0.2220115356909708
8P INVERTED DUPLICATION/DELETION SYNDROME	0.005917759	0.2220115356909708
4Q21 MICRODELETION SYNDROME	0.005917759	0.2220115356909708
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.005917759	0.2220115356909708
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.005917759	0.2220115356909708
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.005917759	0.2220115356909708
EPILEPSY-TELANGIECTASIA	0.005917759	0.2220115356909708
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.005917759	0.2220115356909708
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.005917759	0.2220115356909708
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00573101	0.2150054321509731
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.00573101	0.2150054321509731
ROBERTS SYNDROME; RBS	0.00573101	0.2150054321509731
MECKEL SYNDROME, TYPE 4; MKS4	0.00573101	0.2150054321509731
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00573101	0.2150054321509731
JACOBSEN SYNDROME	0.00573101	0.2150054321509731
PENTALOGY OF CANTRELL	0.00573101	0.2150054321509731
ISOLATED TRIGONOCEPHALY	0.00537634	0.2016995791475783
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00537634	0.2016995791475783
ACROMEGALY	0.00537634	0.2016995791475783
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00537634	0.2016995791475783
WAARDENBURG SYNDROME	0.00537634	0.2016995791475783
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00537634	0.2016995791475783
MCDONOUGH SYNDROME	0.00537634	0.2016995791475783
TRANSALDOLASE DEFICIENCY	0.00537634	0.2016995791475783
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.2016995791475783
MONOSOMY 22	0.00537634	0.2016995791475783
SOMATOMAMMOTROPINOMA	0.00537634	0.2016995791475783
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.00537634	0.2016995791475783
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00537634	0.2016995791475783
HYPOSPADIAS-INTELLECTUAL DISABILITY, GOLDBLATT TYPE SYNDROME	0.00537634	0.2016995791475783
9Q SUBTELOMERIC DELETION SYNDROME	0.00537634	0.2016995791475783
DISORDER OF SEX DEVELOPMENT-INTELLECTUAL DISABILITY SYNDROME	0.00537634	0.2016995791475783
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.00537634	0.2016995791475783
LICHTENSTEIN SYNDROME	0.00537634	0.2016995791475783
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.00537634	0.2016995791475783
PRIMROSE SYNDROME; PRIMS	0.00537634	0.2016995791475783
MENTAL RETARDATION, X-LINKED 73	0.00537634	0.2016995791475783
XYLT1-CDG	0.00537634	0.2016995791475783
MENTAL RETARDATION, X-LINKED 97; MRX97	0.00537634	0.2016995791475783
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00537634	0.2016995791475783
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00537634	0.2016995791475783
DIGEORGE SYNDROME; DGS	0.005360472999999999	0.2011043103918198
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.005360472999999999	0.2011043103918198
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.005360472999999999	0.2011043103918198
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.005360472999999999	0.2011043103918198
CATEL-MANZKE SYNDROME; CATMANS	0.005360472999999999	0.2011043103918198
HYPEREKPLEXIA 4; HKPX4	0.005360472999999999	0.2011043103918198
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.005360472999999999	0.2011043103918198
DONNAI-BARROW SYNDROME	0.005360472999999999	0.2011043103918198
MUCOPOLYSACCHARIDOSIS TYPE 2	0.005360472999999999	0.2011043103918198
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.005360472999999999	0.2011043103918198
SIALIDOSIS TYPE 2	0.005360472999999999	0.2011043103918198
WEAVER SYNDROME	0.005360472999999999	0.2011043103918198
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.005360472999999999	0.2011043103918198
DE BARSY SYNDROME	0.004819054	0.18079235384842735
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.004819054	0.18079235384842735
TOWNES-BROCKS SYNDROME 1; TBS1	0.004819054	0.18079235384842735
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.004819054	0.18079235384842735
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.004819054	0.18079235384842735
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.004819054	0.18079235384842735
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.004819054	0.18079235384842735
PRIMARY CONGENITAL HYPOTHYROIDISM	0.004819054	0.18079235384842735
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.004819054	0.18079235384842735
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.004819054	0.18079235384842735
ICF SYNDROME	0.004819054	0.18079235384842735
CRANIOFRONTONASAL SYNDROME; CFNS	0.004819054	0.18079235384842735
LATERAL MENINGOCELE SYNDROME	0.004819054	0.18079235384842735
AARSKOG-SCOTT SYNDROME	0.004819054	0.18079235384842735
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.004814918999999999	0.18063722456721087
MUCOPOLYSACCHARIDOSIS TYPE 3	0.004814918999999999	0.18063722456721087
DISTAL MONOSOMY 3P	0.004814918999999999	0.18063722456721087
XP22.13P22.2 DUPLICATION SYNDROME	0.004814918999999999	0.18063722456721087
MENKES DISEASE	0.004814918999999999	0.18063722456721087
SMITH-KINGSMORE SYNDROME; SKS	0.004814918999999999	0.18063722456721087
ACROCALLOSAL SYNDROME; ACLS	0.004814918999999999	0.18063722456721087
ASPARTYLGLUCOSAMINURIA	0.004814918999999999	0.18063722456721087
ADAMS-OLIVER SYNDROME 5; AOS5	0.004814918999999999	0.18063722456721087
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.004658403	0.1747653467972294
NEPHROGENIC DIABETES INSIPIDUS	0.004658403	0.1747653467972294
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.004658403	0.1747653467972294
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.004658403	0.1747653467972294
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004658403	0.1747653467972294
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.004658403	0.1747653467972294
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.004658403	0.1747653467972294
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.004658403	0.1747653467972294
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.004658403	0.1747653467972294
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.004658403	0.1747653467972294
XQ28 (MECP2) DUPLICATION	0.004658403	0.1747653467972294
PROPIONIC ACIDEMIA	0.004658403	0.1747653467972294
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.004658403	0.1747653467972294
ANGELMAN SYNDROME	0.004658403	0.1747653467972294
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.004658403	0.1747653467972294
HOLOPROSENCEPHALY 2; HPE2	0.004658403	0.1747653467972294
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.004658403	0.1747653467972294
CHROMOSOME 19P13.13 DELETION SYNDROME	0.004658403	0.1747653467972294
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.004658403	0.1747653467972294
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.004658403	0.1747653467972294
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.004658403	0.1747653467972294
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.004658403	0.1747653467972294
KAGAMI-OGATA SYNDROME	0.004658403	0.1747653467972294
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.004658403	0.1747653467972294
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.004535253	0.17014523289594632
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.004535253	0.17014523289594632
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.004535253	0.17014523289594632
NIEMANN-PICK DISEASE TYPE C	0.004535253	0.17014523289594632
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.004535253	0.17014523289594632
FOIX-CHAVANY-MARIE SYNDROME	0.004535253	0.17014523289594632
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.004535253	0.17014523289594632
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.004535253	0.17014523289594632
FREE SIALIC ACID STORAGE DISEASE	0.0045352529999999995	0.1701452328959463
HSD10 DISEASE	0.0045352529999999995	0.1701452328959463
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.0045352529999999995	0.1701452328959463
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.0045352529999999995	0.1701452328959463
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0045352529999999995	0.1701452328959463
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0045352529999999995	0.1701452328959463
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.0045352529999999995	0.1701452328959463
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.0045352529999999995	0.1701452328959463
KOOLEN-DE VRIES SYNDROME	0.004511633	0.16925910142742576
CK SYNDROME	0.004511633	0.16925910142742576
10Q22.3Q23.3 MICRODELETION SYNDROME	0.004511633	0.16925910142742576
PMM2-CDG	0.004511633	0.16925910142742576
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.004511633	0.16925910142742576
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.004511633	0.16925910142742576
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.004511633	0.16925910142742576
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.004511633	0.16925910142742576
PRADER-WILLI SYNDROME; PWS	0.004511633	0.16925910142742576
DISTAL MONOSOMY 15Q	0.004511633	0.16925910142742576
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.004511633	0.16925910142742576
MENTAL RETARDATION, X-LINKED 90	0.004511633	0.16925910142742576
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.004511632999999999	0.1692591014274257
TRISOMY X	0.004511632999999999	0.1692591014274257
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.004511632999999999	0.1692591014274257
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.004511632999999999	0.1692591014274257
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.004511632999999999	0.1692591014274257
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.004511632999999999	0.1692591014274257
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.004511632999999999	0.1692591014274257
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.004511632999999999	0.1692591014274257
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.004511632999999999	0.1692591014274257
WIEACKER-WOLFF SYNDROME	0.004511632999999999	0.1692591014274257
6Q25 MICRODELETION SYNDROME	0.004511632999999999	0.1692591014274257
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.004511632999999999	0.1692591014274257
C SYNDROME	0.004511632999999999	0.1692591014274257
8P23.1 MICRODELETION SYNDROME	0.004511632999999999	0.1692591014274257
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.004511632999999999	0.1692591014274257
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.004511632999999999	0.1692591014274257
FRASER SYNDROME	0.0042734999999999995	0.1603252680238184
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.0042734999999999995	0.1603252680238184
CATARACT-ABERRANT ORAL FRENULA-GROWTH DELAY SYNDROME	0.0042734999999999995	0.1603252680238184
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.0042734999999999995	0.1603252680238184
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.0042734999999999995	0.1603252680238184
AUTOSOMAL DOMINANT CUTIS LAXA	0.0042734999999999995	0.1603252680238184
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.0042734999999999995	0.1603252680238184
BECKWITH-WIEDEMANN SYNDROME	0.0042734999999999995	0.1603252680238184
FETAL MINOXIDIL SYNDROME	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, PERIODONTAL TYPE, 2; EDSPD2	0.0042734999999999995	0.1603252680238184
XY TYPE GONADAL DYSGENESIS-ASSOCIATED ANOMALIES SYNDROME	0.0042734999999999995	0.1603252680238184
FAMILIAL VISCERAL MYOPATHY	0.0042734999999999995	0.1603252680238184
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0042734999999999995	0.1603252680238184
MUCOPOLYSACCHARIDOSIS TYPE 7	0.0042734999999999995	0.1603252680238184
CARPENTER SYNDROME	0.0042734999999999995	0.1603252680238184
BLADDER EXSTROPHY	0.0042734999999999995	0.1603252680238184
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.0042734999999999995	0.1603252680238184
MUSCULAR HYPERTONIA, LETHAL	0.0042734999999999995	0.1603252680238184
ARTERIAL TORTUOSITY SYNDROME	0.0042734999999999995	0.1603252680238184
GORLIN-CHAUDHRY-MOSS SYNDROME	0.0042734999999999995	0.1603252680238184
LEPRECHAUNISM	0.0042734999999999995	0.1603252680238184
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.0042734999999999995	0.1603252680238184
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.0042734999999999995	0.1603252680238184
HURLER-SCHEIE SYNDROME	0.0042734999999999995	0.1603252680238184
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.0042734999999999995	0.1603252680238184
LOEYS-DIETZ SYNDROME 3; LDS3	0.0042734999999999995	0.1603252680238184
VASCULAR MALFORMATION, PRIMARY INTRAOSSEOUS	0.0042734999999999995	0.1603252680238184
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.0042734999999999995	0.1603252680238184
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.0042734999999999995	0.1603252680238184
LATERAL MENINGOCELE SYNDROME	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, TYPE I	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS	0.0042734999999999995	0.1603252680238184
ANEURYSM-OSTEOARTHRITIS SYNDROME	0.0042734999999999995	0.1603252680238184
FOCAL DERMAL HYPOPLASIA	0.0042734999999999995	0.1603252680238184
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.0042734999999999995	0.1603252680238184
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS TYPE 1B	0.0042734999999999995	0.1603252680238184
VELOCARDIOFACIAL SYNDROME	0.0042734999999999995	0.1603252680238184
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0042734999999999995	0.1603252680238184
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS TYPE 1A	0.0042734999999999995	0.1603252680238184
SCARF SYNDROME	0.0042734999999999995	0.1603252680238184
ACHONDROGENESIS TYPE 2	0.0042734999999999995	0.1603252680238184
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.0042734999999999995	0.1603252680238184
SCARF SYNDROME	0.0042734999999999995	0.1603252680238184
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 2	0.0042734999999999995	0.1603252680238184
SHPRINTZEN-GOLDBERG SYNDROME	0.0042734999999999995	0.1603252680238184
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.0042734999999999995	0.1603252680238184
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.0042734999999999995	0.1603252680238184
COOPER-JABS SYNDROME	0.0042734999999999995	0.1603252680238184
MEIER-GORLIN SYNDROME 6; MGORS6	0.0042734999999999995	0.1603252680238184
RIN2 SYNDROME	0.0042734999999999995	0.1603252680238184
ISOLATED CLEFT LIP	0.0042734999999999995	0.1603252680238184
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.0042734999999999995	0.1603252680238184
X-LINKED EHLERS-DANLOS SYNDROME	0.0042734999999999995	0.1603252680238184
FRANK-TER HAAR SYNDROME	0.0042734999999999995	0.1603252680238184
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.004251533	0.1595011507516342
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.004251533	0.1595011507516342
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.004251533	0.1595011507516342
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.004251533	0.1595011507516342
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.004251533	0.1595011507516342
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.004251533	0.1595011507516342
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.004251533	0.1595011507516342
GALACTOSEMIA	0.004251533	0.1595011507516342
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004251533	0.1595011507516342
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.004251533	0.1595011507516342
HEART AND BRAIN MALFORMATION SYNDROME	0.004251533	0.1595011507516342
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.004251533	0.1595011507516342
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.004251533	0.1595011507516342
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.004251533	0.1595011507516342
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.004251533	0.1595011507516342
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.004251533	0.1595011507516342
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.004251533	0.1595011507516342
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.004251533	0.1595011507516342
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.004251533	0.1595011507516342
HELSMOORTEL-VAN DER AA SYNDROME	0.004251533	0.1595011507516342
RFT1-CDG	0.004251533	0.1595011507516342
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.004251533	0.1595011507516342
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.004251533	0.1595011507516342
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.004251533	0.1595011507516342
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.004251533	0.1595011507516342
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.004251533	0.1595011507516342
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.004116984	0.1544533902538369
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.004116984	0.1544533902538369
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.004116984	0.1544533902538369
FLOATING-HARBOR SYNDROME	0.004116984	0.1544533902538369
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.004116984	0.1544533902538369
PROPIONIC ACIDEMIA	0.004116984	0.1544533902538369
300270 ADRENOMYODYSTROPHY	0.004116984	0.1544533902538369
NIEMANN-PICK DISEASE, TYPE A	0.004116984	0.1544533902538369
ATHYREOSIS	0.004116984	0.1544533902538369
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.004116984	0.1544533902538369
THYROID HYPOPLASIA	0.004116984	0.1544533902538369
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.004116984	0.1544533902538369
INFANTILE DYSTONIA-PARKINSONISM	0.004116984	0.1544533902538369
HYPOPHOSPHATASIA, INFANTILE	0.004112849	0.15429826097262048
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.004112849	0.15429826097262048
PORPHYRIA	0.004112849	0.15429826097262048
GITELMAN SYNDROME	0.004112849	0.15429826097262048
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.004112849	0.15429826097262048
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.004112849	0.15429826097262048
PAROXYSMAL EXTREME PAIN DISORDER	0.004112849	0.15429826097262048
RETT SYNDROME; RTT	0.004112849	0.15429826097262048
ACUTE ADRENAL INSUFFICIENCY	0.004112849	0.15429826097262048
HEREDITARY FRUCTOSE INTOLERANCE	0.004112849	0.15429826097262048
WOLFRAM SYNDROME	0.004112849	0.15429826097262048
PORPHYRIA VARIEGATA	0.004112849	0.15429826097262048
ACUTE INTERMITTENT PORPHYRIA	0.004112849	0.15429826097262048
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.004112849	0.15429826097262048
HEREDITARY COPROPORPHYRIA	0.004112849	0.15429826097262048
DDOST-CDG	0.004112849	0.15429826097262048
AUTISM, SUSCEPTIBILITY TO, 18	0.004112849	0.15429826097262048
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.004112849	0.15429826097262048
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.004112849	0.15429826097262048
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.004112849	0.15429826097262048
RETT SYNDROME, CONGENITAL VARIANT	0.004112849	0.15429826097262048
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.004112849	0.15429826097262048
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.004112849	0.15429826097262048
ADIPOSIS DOLOROSA	0.004112849	0.15429826097262048
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.004112849	0.15429826097262048
FAMILIAL MEDITERRANEAN FEVER	0.004112849	0.15429826097262048
ADDISON DISEASE	0.004112849	0.15429826097262048
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.004112849	0.15429826097262048
KAGAMI-OGATA SYNDROME	0.004063163	0.15243423353210767
CHÉDIAK-HIGASHI SYNDROME	0.004063163	0.15243423353210767
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.004063163	0.15243423353210767
RECOMBINANT CHROMOSOME 8 SYNDROME	0.004063163	0.15243423353210767
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.004063163	0.15243423353210767
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.004063163	0.15243423353210767
OCULOECTODERMAL SYNDROME; OES	0.004063163	0.15243423353210767
15Q14 MICRODELETION SYNDROME	0.004063163	0.15243423353210767
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.004063163	0.15243423353210767
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.004063163	0.15243423353210767
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.004063163	0.15243423353210767
GENITOPATELLAR SYNDROME	0.004063163	0.15243423353210767
RECOMBINANT 8 SYNDROME	0.004063163	0.15243423353210767
CODAS SYNDROME	0.004063163	0.15243423353210767
ADAMS-OLIVER SYNDROME 1; AOS1	0.004063163	0.15243423353210767
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.004063163	0.15243423353210767
20P12.3 MICRODELETION SYNDROME	0.004063163	0.15243423353210767
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.004063163	0.15243423353210767
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.004063163	0.15243423353210767
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.004063163	0.15243423353210767
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.004063163	0.15243423353210767
HYPERMANGANESEMIA WITH DYSTONIA 2	0.003993834	0.14983327635255383
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.003993834	0.14983327635255383
SHWACHMAN-DIAMOND SYNDROME	0.003993834	0.14983327635255383
JOUBERT SYNDROME 24	0.003993834	0.14983327635255383
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.003993834	0.14983327635255383
3Q29 MICRODELETION SYNDROME	0.003993834	0.14983327635255383
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003993834	0.14983327635255383
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.003993834	0.14983327635255383
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003993834	0.14983327635255383
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.003993834	0.14983327635255383
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.003993834	0.14983327635255383
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.003993834	0.14983327635255383
PARTINGTON SYNDROME	0.003989699	0.1496781470713374
CHOREOACANTHOCYTOSIS	0.003989699	0.1496781470713374
CHOREOATHETOSIS, FAMILIAL INVERTED	0.003989699	0.1496781470713374
WOLCOTT-RALLISON SYNDROME	0.003989699	0.1496781470713374
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.003989699	0.1496781470713374
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.003989699	0.1496781470713374
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.003989699	0.1496781470713374
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.003989699	0.1496781470713374
EPENDYMOMA	0.003989699	0.1496781470713374
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.003989699	0.1496781470713374
DYSEQUILIBRIUM SYNDROME	0.003989699	0.1496781470713374
FAMILIAL DYSAUTONOMIA	0.003989699	0.1496781470713374
SUBEPENDYMOMA	0.003989699	0.1496781470713374
ALZHEIMER DISEASE 3; AD	0.003989699	0.1496781470713374
KUFOR-RAKEB SYNDROME	0.003989699	0.1496781470713374
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.003989699	0.1496781470713374
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.003989699	0.1496781470713374
METACHROMATIC LEUKODYSTROPHY	0.003989699	0.1496781470713374
CENTRONUCLEAR MYOPATHY	0.003989699	0.1496781470713374
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.003989699	0.1496781470713374
SPONTANEOUS PERIODIC HYPOTHERMIA	0.003989699	0.1496781470713374
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.003989699	0.1496781470713374
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.003989699	0.1496781470713374
ATAXIA-TELANGIECTASIA	0.003989699	0.1496781470713374
COCKAYNE SYNDROME A; CSA	0.003989699	0.1496781470713374
BEHÇET DISEASE	0.003989699	0.1496781470713374
X-LINKED CENTRONUCLEAR MYOPATHY	0.003989699	0.1496781470713374
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.003989699	0.1496781470713374
TETRASOMY 18P	0.003989699	0.1496781470713374
COFFIN-LOWRY SYNDROME	0.003989699	0.1496781470713374
SIALIDOSIS TYPE 1	0.003989699	0.1496781470713374
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.003989699	0.1496781470713374
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.003989699	0.1496781470713374
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.003989699	0.1496781470713374
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.003970214	0.14894714488403327
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.003970214	0.14894714488403327
TRISOMY 8Q	0.003970214	0.14894714488403327
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.003970214	0.14894714488403327
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.003970214	0.14894714488403327
OROFACIODIGITAL SYNDROME TYPE 14	0.003970214	0.14894714488403327
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.003970214	0.14894714488403327
DISTAL MONOSOMY 9P	0.003970214	0.14894714488403327
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.003970214	0.14894714488403327
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.003970214	0.14894714488403327
MENTAL RETARDATION, X-LINKED 107; MRX107	0.003970214	0.14894714488403327
PENTASOMY X	0.003970214	0.14894714488403327
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.003970214	0.14894714488403327
LIG4 SYNDROME	0.003970214	0.14894714488403327
XIA-GIBBS SYNDROME	0.003970214	0.14894714488403327
CHROMOSOME 16Q22 DELETION SYNDROME	0.003970214	0.14894714488403327
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.003970214	0.14894714488403327
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.003970214	0.14894714488403327
TETRASOMY X	0.003970214	0.14894714488403327
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.003970214	0.14894714488403327
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.003970214	0.14894714488403327
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.003970214	0.14894714488403327
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.003970214	0.14894714488403327
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.003970214	0.14894714488403327
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.003970214	0.14894714488403327
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.003970214	0.14894714488403327
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.003970214	0.14894714488403327
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.003970214	0.14894714488403327
1P21.3 MICRODELETION SYNDROME	0.003970214	0.14894714488403327
INTELLECTUAL DISABILITY, WOLFF TYPE	0.003966079	0.14879201560281682
HENNEKAM-BEEMER SYNDROME	0.003966079	0.14879201560281682
CHIME SYNDROME	0.003966079	0.14879201560281682
BRANCHIOOCULOFACIAL SYNDROME	0.003966079	0.14879201560281682
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.003966079	0.14879201560281682
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.003966079	0.14879201560281682
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.003966079	0.14879201560281682
1Q41Q42 MICRODELETION SYNDROME	0.003966079	0.14879201560281682
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.003966079	0.14879201560281682
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.003966079	0.14879201560281682
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.003966079	0.14879201560281682
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.003966079	0.14879201560281682
DISTAL MONOSOMY 7Q36	0.003966079	0.14879201560281682
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.003966079	0.14879201560281682
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.003966079	0.14879201560281682
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.003966079	0.14879201560281682
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.003966079	0.14879201560281682
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.003966079	0.14879201560281682
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.003841793	0.14412928335486824
WALKER-WARBURG SYNDROME	0.003841793	0.14412928335486824
MONOSOMY 18Q	0.003841793	0.14412928335486824
CRANIOPHARYNGIOMA	0.003841793	0.14412928335486824
OPTIC PATHWAY GLIOMA	0.003841793	0.14412928335486824
MIRAGE SYNDROME; MIRAGE	0.003841793	0.14412928335486824
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.003841793	0.14412928335486824
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.003841793	0.14412928335486824
BAND HETEROTOPIA; BH	0.003841793	0.14412928335486824
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.003841793	0.14412928335486824
PFEIFFER SYNDROME TYPE 2	0.003841793	0.14412928335486824
PETTIGREW SYNDROME	0.003841793	0.14412928335486824
1Q21.1 MICRODUPLICATION SYNDROME	0.003841793	0.14412928335486824
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.003841793	0.14412928335486824
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.003841793	0.14412928335486824
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.003841793	0.14412928335486824
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.003841793	0.14412928335486824
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.003841793	0.14412928335486824
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.003841793	0.14412928335486824
MUENKE SYNDROME	0.003841793	0.14412928335486824
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.003841793	0.14412928335486824
GRACILE BONE DYSPLASIA; GCLEB	0.003841793	0.14412928335486824
INFANTILE SIALIC ACID STORAGE DISEASE	0.003841793	0.14412928335486824
MEND SYNDROME; MEND	0.003841793	0.14412928335486824
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.003841793	0.14412928335486824
1Q21.1 MICRODELETION SYNDROME	0.003841793	0.14412928335486824
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.003841793	0.14412928335486824
MELANOSIS, NEUROCUTANEOUS; NCMS	0.003841793	0.14412928335486824
EPIDERMAL NEVUS SYNDROME	0.0037101139999999996	0.13918919420824172
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.0037101139999999996	0.13918919420824172
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.0037101139999999996	0.13918919420824172
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.0037101139999999996	0.13918919420824172
N SYNDROME	0.0037101139999999996	0.13918919420824172
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.0037101139999999996	0.13918919420824172
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.0037101139999999996	0.13918919420824172
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.0037101139999999996	0.13918919420824172
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0037101139999999996	0.13918919420824172
TREACHER-COLLINS SYNDROME	0.0037101139999999996	0.13918919420824172
HYPERTRYPTOPHANEMIA; HYPTRP	0.0037101139999999996	0.13918919420824172
BAKER-GORDON SYNDROME; BAGOS	0.0037101139999999996	0.13918919420824172
PEROXISOME BIOGENESIS DISORDER 5B	0.0037101139999999996	0.13918919420824172
MUCOLIPIDOSIS IV; ML4	0.0037101139999999996	0.13918919420824172
CROUZON SYNDROME	0.003705979	0.13903406492702527
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.003705979	0.13903406492702527
COFS SYNDROME	0.003705979	0.13903406492702527
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.003705979	0.13903406492702527
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.003705979	0.13903406492702527
MICROPHTHALMIA, LENZ TYPE	0.003705979	0.13903406492702527
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.003705979	0.13903406492702527
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.003705979	0.13903406492702527
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.003705979	0.13903406492702527
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.003705979	0.13903406492702527
TRIPLE A SYNDROME	0.003705979	0.13903406492702527
FILIPPI SYNDROME; FLPIS	0.003705979	0.13903406492702527
GRANULOMATOSIS WITH POLYANGIITIS	0.003705979	0.13903406492702527
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.003705979	0.13903406492702527
NEONATAL ADRENOLEUKODYSTROPHY	0.003705979	0.13903406492702527
FLYNN-AIRD SYNDROME	0.003705979	0.13903406492702527
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.003705979	0.13903406492702527
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.003705979	0.13903406492702527
INFANTILE NEUROAXONAL DYSTROPHY	0.003705979	0.13903406492702527
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.003705979	0.13903406492702527
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00357143	0.133986304429228
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00357143	0.133986304429228
PRIMARY PERITONEAL CARCINOMA	0.00357143	0.133986304429228
UROFACIAL SYNDROME	0.00357143	0.133986304429228
WOUND BOTULISM	0.00357143	0.133986304429228
INFANT BOTULISM	0.00357143	0.133986304429228
NK-CELL ENTEROPATHY	0.00357143	0.133986304429228
GASTROINTESTINAL STROMAL TUMOR	0.00357143	0.133986304429228
13Q12.3 MICRODELETION SYNDROME	0.00357143	0.133986304429228
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00357143	0.133986304429228
UROFACIAL SYNDROME 2	0.00357143	0.133986304429228
SECONDARY SHORT BOWEL SYNDROME	0.00357143	0.133986304429228
PERITONEAL CYSTIC MESOTHELIOMA	0.00357143	0.133986304429228
GRFOMA	0.00357143	0.133986304429228
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00357143	0.133986304429228
HIRSCHSPRUNG DISEASE	0.00357143	0.133986304429228
THYROTOXIC PERIODIC PARALYSIS	0.00357143	0.133986304429228
KAPUR-TORIELLO SYNDROME	0.00357143	0.133986304429228
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00357143	0.133986304429228
TURCOT SYNDROME WITH POLYPOSIS	0.00357143	0.133986304429228
ATTRV30M AMYLOIDOSIS	0.00357143	0.133986304429228
FG SYNDROME 2; FGS2	0.00357143	0.133986304429228
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00357143	0.133986304429228
TYPHOID	0.00357143	0.133986304429228
SILVER-RUSSELL SYNDROME	0.00357143	0.133986304429228
ADIPOSIS DOLOROSA	0.00357143	0.133986304429228
LIDDLE SYNDROME	0.00357143	0.133986304429228
PSEUDOMYXOMA PERITONEI	0.00357143	0.133986304429228
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00357143	0.133986304429228
JUVENILE DERMATOMYOSITIS	0.00357143	0.133986304429228
ANAL SPHINCTER DYSPLASIA; ASDP	0.00357143	0.133986304429228
PRIMARY PARATHYROID HYPERPLASIA	0.00357143	0.133986304429228
PPOMA	0.00357143	0.133986304429228
YOUNG-ONSET PARKINSON DISEASE	0.00357143	0.133986304429228
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00357143	0.133986304429228
GLUCAGONOMA	0.00357143	0.133986304429228
PUDENDAL NEURALGIA	0.00357143	0.133986304429228
TUMOR NECROSIS FACTOR RECEPTOR 1 ASSOCIATED PERIODIC SYNDROME	0.00357143	0.133986304429228
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00357143	0.133986304429228
PARATHYROID CARCINOMA	0.00357143	0.133986304429228
CAP POLYPOSIS	0.00357143	0.133986304429228
HINMAN SYNDROME	0.00357143	0.133986304429228
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00357143	0.133986304429228
LAMBERT-EATON MYASTHENIC SYNDROME	0.00357143	0.133986304429228
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.00357143	0.133986304429228
PARKINSON DISEASE, LATE-ONSET; PD	0.00357143	0.133986304429228
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00357143	0.133986304429228
IATROGENIC BOTULISM	0.00357143	0.133986304429228
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00357143	0.133986304429228
INHALATIONAL BOTULISM	0.00357143	0.133986304429228
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.00357143	0.133986304429228
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00357143	0.133986304429228
IGG4-RELATED RETROPERITONEAL FIBROSIS	0.00357143	0.133986304429228
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00357143	0.133986304429228
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00357143	0.133986304429228
SHEEHAN SYNDROME	0.00357143	0.133986304429228
SOLITARY FIBROUS TUMOUR/HEMANGIOPERICYTOMA	0.00357143	0.133986304429228
EPIDERMOLYSIS BULLOSA SIMPLEX, GENERALIZED SEVERE	0.00357143	0.133986304429228
MULTIPLE SYSTEM ATROPHY, CEREBELLAR TYPE	0.00357143	0.133986304429228
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.00357143	0.133986304429228
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.00357143	0.133986304429228
MYXEDEMA	0.00357143	0.133986304429228
MULTIPLE ENDOCRINE NEOPLASIA TYPE 2	0.00357143	0.133986304429228
SOMATOSTATINOMA	0.00357143	0.133986304429228
VISCERAL MYOPATHY; VSCM	0.00357143	0.133986304429228
PORPHYRIA VARIEGATA	0.00357143	0.133986304429228
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00357143	0.133986304429228
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00357143	0.133986304429228
MULTIPLE SYSTEM ATROPHY, PARKINSONIAN TYPE	0.00357143	0.133986304429228
BOTULISM	0.00357143	0.133986304429228
PANHYPOPITUITARISM	0.00357143	0.133986304429228
NEUROENDOCRINE NEOPLASM OF APPENDIX	0.00357143	0.133986304429228
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00357143	0.133986304429228
NEUROENDOCRINE TUMOR OF THE RECTUM	0.00357143	0.133986304429228
MULTIPLE SYSTEM ATROPHY	0.00357143	0.133986304429228
NEUROENDOCRINE TUMOR OF ANAL CANAL	0.00357143	0.133986304429228
FOODBORNE BOTULISM	0.00357143	0.133986304429228
TURNPENNY-FRY SYNDROME; TPFS	0.0035217440000000003	0.1321222769887152
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0035217440000000003	0.1321222769887152
NOONAN SYNDROME 3; NS3	0.0035217440000000003	0.1321222769887152
TRANSALDOLASE DEFICIENCY	0.0035217440000000003	0.1321222769887152
OROTIC ACIDURIA	0.0035217440000000003	0.1321222769887152
RABSON-MENDENHALL SYNDROME	0.0035217440000000003	0.1321222769887152
MCKUSICK-KAUFMAN SYNDROME	0.0035217440000000003	0.1321222769887152
SYNDROMIC DIARRHEA	0.0035217440000000003	0.1321222769887152
GENITOPATELLAR SYNDROME; GTPTS	0.0035217440000000003	0.1321222769887152
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.0035217440000000003	0.1321222769887152
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.0035217440000000003	0.1321222769887152
ZECHI-CEIDE SYNDROME	0.0035217440000000003	0.1321222769887152
DISTAL MONOSOMY 6P	0.0035217440000000003	0.1321222769887152
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.0035217440000000003	0.1321222769887152
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0035217440000000003	0.1321222769887152
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.0035217440000000003	0.1321222769887152
NOONAN SYNDROME 11; NS11	0.0035217440000000003	0.1321222769887152
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.0035217440000000003	0.1321222769887152
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.0035217440000000003	0.1321222769887152
HADZISELIMOVIC SYNDROME	0.0035217440000000003	0.1321222769887152
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.0035217440000000003	0.1321222769887152
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0035217440000000003	0.1321222769887152
SECKEL SYNDROME 9; SCKL9	0.0035217440000000003	0.1321222769887152
BARDET-BIEDL SYNDROME 2	0.0035217440000000003	0.1321222769887152
16P13.11 MICRODUPLICATION SYNDROME	0.0035217440000000003	0.1321222769887152
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0035217440000000003	0.1321222769887152
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.0035217440000000003	0.1321222769887152
LYMPHEDEMA, HEREDITARY, III	0.0035217440000000003	0.1321222769887152
NOONAN SYNDROME 5; NS5	0.0035217440000000003	0.1321222769887152
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0035217440000000003	0.1321222769887152
%300712 CRANIOFACIOSKELETAL SYNDROME	0.0035217440000000003	0.1321222769887152
FETAL ALCOHOL SYNDROME	0.0035217440000000003	0.1321222769887152
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.0035217440000000003	0.1321222769887152
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.0035217440000000003	0.1321222769887152
TRISOMY 18	0.0035217440000000003	0.1321222769887152
TYSHCHENKO SYNDROME	0.0035217440000000003	0.1321222769887152
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.0035217440000000003	0.1321222769887152
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.003517609	0.13196714770749876
21Q22.11Q22.12 MICRODELETION SYNDROME	0.003517609	0.13196714770749876
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.003517609	0.13196714770749876
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.003517609	0.13196714770749876
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.003517609	0.13196714770749876
TRISOMY 13	0.003517609	0.13196714770749876
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.003517609	0.13196714770749876
FRYNS SYNDROME; FRNS	0.003517609	0.13196714770749876
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.003517609	0.13196714770749876
ACROCARDIOFACIAL SYNDROME	0.003517609	0.13196714770749876
NOONAN SYNDROME 7; NS7	0.003517609	0.13196714770749876
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.003517609	0.13196714770749876
BENIGN HEREDITARY CHOREA	0.00344828	0.1293661905279449
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2K	0.00344828	0.1293661905279449
MAST SYNDROME	0.00344828	0.1293661905279449
HUNTINGTON DISEASE-LIKE 2	0.00344828	0.1293661905279449
RICHARDS-RUNDLE SYNDROME	0.00344828	0.1293661905279449
PARALYSIS AGITANS, JUVENILE, OF HUNT	0.00344828	0.1293661905279449
SPINOCEREBELLAR ATAXIA TYPE 5	0.00344828	0.1293661905279449
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00344828	0.1293661905279449
BEHR SYNDROME	0.00344828	0.1293661905279449
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.00344828	0.1293661905279449
AUTOSOMAL RECESSIVE CEREBELLOPARENCHYMAL DISORDER TYPE 3	0.00344828	0.1293661905279449
PRIMARY DYSTONIA, DYT4 TYPE	0.00344828	0.1293661905279449
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 26	0.00344828	0.1293661905279449
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 1	0.00344828	0.1293661905279449
PROGRESSIVE PSEUDORHEUMATOID ARTHROPATHY OF CHILDHOOD	0.00344828	0.1293661905279449
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 3	0.00344828	0.1293661905279449
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 4	0.00344828	0.1293661905279449
KENNEDY DISEASE	0.00344828	0.1293661905279449
LATE-ONSET DISTAL MYOPATHY, MARKESBERY-GRIGGS TYPE	0.00344828	0.1293661905279449
KUSKOKWIM SYNDROME	0.00344828	0.1293661905279449
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA	0.00344828	0.1293661905279449
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 5	0.00344828	0.1293661905279449
INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 1	0.00344828	0.1293661905279449
MUTILATING HEREDITARY SENSORY NEUROPATHY WITH SPASTIC PARAPLEGIA	0.00344828	0.1293661905279449
SPINOCEREBELLAR ATAXIA TYPE 4	0.00344828	0.1293661905279449
CORTICOBASAL SYNDROME	0.00344828	0.1293661905279449
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2EE; CMT2EE	0.00344828	0.1293661905279449
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00344828	0.1293661905279449
SPASTIC PARAPLEGIA 80, AUTOSOMAL DOMINANT; SPG80	0.00344828	0.1293661905279449
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00344828	0.1293661905279449
CLASSIC GALACTOSEMIA	0.00344828	0.1293661905279449
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00344828	0.1293661905279449
MYOTONIA PERMANENS	0.00344828	0.1293661905279449
224550 DYSTONIA WITH RINGBINDEN	0.00344828	0.1293661905279449
MYOTONIA FLUCTUANS	0.00344828	0.1293661905279449
MULTIPLE EPIPHYSEAL DYSPLASIA DUE TO COLLAGEN 9 ANOMALY	0.00344828	0.1293661905279449
CHARCOT-MARIE-TOOTH DISEASE/HEREDITARY MOTOR AND SENSORY NEUROPATHY	0.00344828	0.1293661905279449
MOEBIUS SYNDROME; MBS	0.00344828	0.1293661905279449
MYOPATHY, DISTAL, 1; MPD1	0.00344828	0.1293661905279449
SPINOCEREBELLAR ATAXIA TYPE 17	0.00344828	0.1293661905279449
SPONDYLOMETAPHYSEAL DYSPLASIA	0.00344828	0.1293661905279449
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00344828	0.1293661905279449
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00344828	0.1293661905279449
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00344828	0.1293661905279449
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.00344828	0.1293661905279449
EMERY-DREIFUSS MUSCULAR DYSTROPHY 3, AUTOSOMAL RECESSIVE; EDMD3	0.00344828	0.1293661905279449
GLYCOGEN STORAGE DISEASE DUE TO LAMP-2 DEFICIENCY	0.00344828	0.1293661905279449
HYPOCALCEMIC VITAMIN D-RESISTANT RICKETS	0.00344828	0.1293661905279449
POTASSIUM-AGGRAVATED MYOTONIA	0.00344828	0.1293661905279449
PSEUDOACHONDROPLASIA	0.00344828	0.1293661905279449
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00344828	0.1293661905279449
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 1	0.00344828	0.1293661905279449
MELNICK-NEEDLES SYNDROME	0.00344828	0.1293661905279449
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, IRAPA TYPE	0.00344828	0.1293661905279449
SPASTIC PARAPLEGIA-NEPHRITIS-DEAFNESS SYNDROME	0.00344828	0.1293661905279449
MYASTHENIC SYNDROME, CONGENITAL, 16; CMS16	0.00344828	0.1293661905279449
SPINOCEREBELLAR ATAXIA TYPE 34	0.00344828	0.1293661905279449
OSTEOCHONDRITIS DISSECANS	0.00344828	0.1293661905279449
IDIOPATHIC JUVENILE OSTEOPOROSIS	0.00344828	0.1293661905279449
BARTH SYNDROME; BTHS	0.00344828	0.1293661905279449
MULTIPLE SYMMETRIC LIPOMATOSIS	0.00344828	0.1293661905279449
AMYOTROPHIC LATERAL SCLEROSIS TYPE 4	0.00344828	0.1293661905279449
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SHOHAT TYPE	0.00344828	0.1293661905279449
SPONASTRIME DYSPLASIA	0.00344828	0.1293661905279449
SPASTIC PARAPLEGIA-FACIAL-CUTANEOUS LESIONS SYNDROME	0.00344828	0.1293661905279449
HEREDITARY SPASTIC PARAPLEGIA	0.00344828	0.1293661905279449
MULTIPLE METAPHYSEAL DYSPLASIA	0.00344828	0.1293661905279449
ATP13A2-RELATED JUVENILE NEURONAL CEROID LIPOFUSCINOSIS	0.00344828	0.1293661905279449
ICHTHYOSIS-HEPATOSPLENOMEGALY-CEREBELLAR DEGENERATION SYNDROME	0.00344828	0.1293661905279449
DYSTONIA 16; DYT16	0.00344828	0.1293661905279449
TREMOR, HEREDITARY ESSENTIAL, AND IDIOPATHIC NORMAL PRESSURE HYDROCEPHALUS	0.00344828	0.1293661905279449
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4J	0.00344828	0.1293661905279449
JUVENILE AMYOTROPHIC LATERAL SCLEROSIS	0.00344828	0.1293661905279449
NEMALINE MYOPATHY 7; NEM7	0.00344828	0.1293661905279449
NEMALINE MYOPATHY 6	0.00344828	0.1293661905279449
POLYNEUROPATHY-INTELLECTUAL DISABILITY-ACROMICRIA-PREMATURE MENOPAUSE SYNDROME	0.00344828	0.1293661905279449
ROUSSY-LÉVY SYNDROME	0.00344828	0.1293661905279449
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00344828	0.1293661905279449
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00344828	0.1293661905279449
BRITTLE CORNEA SYNDROME	0.00344828	0.1293661905279449
PALMOPLANTAR KERATODERMA-SPASTIC PARALYSIS SYNDROME	0.00344828	0.1293661905279449
MULTIPLE SCLEROSIS-ICHTHYOSIS-FACTOR VIII DEFICIENCY SYNDROME	0.00344828	0.1293661905279449
PELVIC DYSPLASIA-ARTHROGRYPOSIS OF LOWER LIMBS SYNDROME	0.00344828	0.1293661905279449
NONAKA MYOPATHY	0.00344828	0.1293661905279449
HYPERKALEMIC PERIODIC PARALYSIS	0.00344828	0.1293661905279449
SPASTIC PARAPLEGIA 78, AUTOSOMAL RECESSIVE	0.00344828	0.1293661905279449
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, OKINAWA TYPE; HMSNO	0.00344828	0.1293661905279449
ABETA AMYLOIDOSIS, IOWA TYPE	0.00344828	0.1293661905279449
MENTAL RETARDATION, X-LINKED 12; MRX12	0.00344828	0.1293661905279449
MULTIPLE EPIPHYSEAL DYSPLASIA TYPE 5	0.00344828	0.1293661905279449
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00344828	0.1293661905279449
THORACOMELIC DYSPLASIA	0.00344828	0.1293661905279449
DOPA-RESPONSIVE DYSTONIA	0.00344828	0.1293661905279449
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.00344828	0.1293661905279449
TRYPTOPHANURIA WITH DWARFISM	0.00344828	0.1293661905279449
SPASTIC PARAPLEGIA 43, AUTOSOMAL RECESSIVE; SPG43	0.00344828	0.1293661905279449
MUCOPOLYSACCHARIDOSIS TYPE 4	0.00344828	0.1293661905279449
EARLY-ONSET GENERALIZED LIMB-ONSET DYSTONIA	0.00344828	0.1293661905279449
DUCHENNE AND BECKER MUSCULAR DYSTROPHY	0.00344828	0.1293661905279449
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00344828	0.1293661905279449
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 5	0.00344828	0.1293661905279449
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00344828	0.1293661905279449
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00344828	0.1293661905279449
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00344828	0.1293661905279449
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.00344828	0.1293661905279449
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.00344828	0.1293661905279449
PSYCHOGENIC MOVEMENT DISORDERS	0.00344828	0.1293661905279449
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL DOMINANT 4; LGMDD4	0.00344828	0.1293661905279449
X-LINKED ADRENOLEUKODYSTROPHY	0.00344828	0.1293661905279449
CONGENITAL MYOPATHY WITH MYASTHENIC-LIKE ONSET	0.00344828	0.1293661905279449
MUCOLIPIDOSIS TYPE IV	0.00344828	0.1293661905279449
LAING EARLY-ONSET DISTAL MYOPATHY	0.00344828	0.1293661905279449
MASA SYNDROME	0.00344828	0.1293661905279449
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00344828	0.1293661905279449
TRISOMY XQ28	0.00344828	0.1293661905279449
DYSTONIA 23; DYT23	0.00344828	0.1293661905279449
%300158 ARTHROGRYPOSIS, CONGENITAL, LOWER LIMB, X-LINKED; ACLLX;;ARTHROGRYPOSIS, X-LINKED, TYPE V, FORMERLY; AMCX5, FORMERLY	0.00344828	0.1293661905279449
BENCZE SYNDROME	0.00342466	0.12848005905942433
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.00342466	0.12848005905942433
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00342466	0.12848005905942433
NIJMEGEN BREAKAGE SYNDROME	0.00342466	0.12848005905942433
DEAFNESS-CRANIOFACIAL SYNDROME	0.00342466	0.12848005905942433
260150 PALANT CLEFT PALATE SYNDROME	0.00342466	0.12848005905942433
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.00342466	0.12848005905942433
BRANCHIO-OCULO-FACIAL SYNDROME	0.00342466	0.12848005905942433
FEINGOLD SYNDROME 1; FGLDS1	0.00342466	0.12848005905942433
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	0.00342466	0.12848005905942433
NIJMEGEN BREAKAGE SYNDROME	0.00342466	0.12848005905942433
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.00342466	0.12848005905942433
CHROMOSOME 8Q22.1 DUPLICATION SYNDROME	0.00342466	0.12848005905942433
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.00342466	0.12848005905942433
GROWTH DELAY-HYDROCEPHALY-LUNG HYPOPLASIA SYNDROME	0.00342466	0.12848005905942433
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00342466	0.12848005905942433
DISTAL MONOSOMY 17Q	0.00342466	0.12848005905942433
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00342466	0.12848005905942433
DELAYED MEMBRANOUS CRANIAL OSSIFICATION	0.00342466	0.12848005905942433
MICROCEPHALY, AUTOSOMAL DOMINANT	0.00342466	0.12848005905942433
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.00342466	0.12848005905942433
THAKKER-DONNAI SYNDROME	0.00342466	0.12848005905942433
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.00342466	0.12848005905942433
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.00342466	0.12848005905942433
CROSSED POLYSYNDACTYLY	0.00342466	0.12848005905942433
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.00342466	0.12848005905942433
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.00342466	0.12848005905942433
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00342466	0.12848005905942433
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00342466	0.12848005905942433
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00342466	0.12848005905942433
SCHOLTE SYNDROME; SHLTS	0.00342466	0.12848005905942433
VERVERI-BRADY SYNDROME; VERBRAS	0.00342466	0.12848005905942433
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.00342466	0.12848005905942433
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00342466	0.12848005905942433
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00342466	0.12848005905942433
FEMORAL-FACIAL SYNDROME	0.00342466	0.12848005905942433
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.00342466	0.12848005905942433
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00342466	0.12848005905942433
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.00342466	0.12848005905942433
CLEFT LIP/PALATE-INTESTINAL MALROTATION-CARDIOPATHY SYNDROME	0.00342466	0.12848005905942433
OTOONYCHOPERONEAL SYNDROME	0.00342466	0.12848005905942433
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.00342466	0.12848005905942433
FAMILIAL SCAPHOCEPHALY SYNDROME, MCGILLIVRAY TYPE	0.00342466	0.12848005905942433
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00342466	0.12848005905942433
URBAN-ROGERS-MEYER SYNDROME	0.00342466	0.12848005905942433
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.003300374	0.12381732681147575
LIGNEOUS CONJUNCTIVITIS	0.003300374	0.12381732681147575
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.003300374	0.12381732681147575
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.003300374	0.12381732681147575
MARDEN-WALKER SYNDROME	0.003300374	0.12381732681147575
POPOV-CHANG SYNDROME; POPCHAS	0.003300374	0.12381732681147575
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.003300374	0.12381732681147575
DEXTROCARDIA	0.003300374	0.12381732681147575
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.003300374	0.12381732681147575
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.003300374	0.12381732681147575
THANATOPHORIC DYSPLASIA, TYPE I	0.003300374	0.12381732681147575
BRESEK SYNDROME	0.003300374	0.12381732681147575
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.003300374	0.12381732681147575
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.003300374	0.12381732681147575
OTOPALATODIGITAL SYNDROME TYPE 2	0.003300374	0.12381732681147575
MEDULLOBLASTOMA	0.003300374	0.12381732681147575
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.003300374	0.12381732681147575
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.003300374	0.12381732681147575
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.003300374	0.12381732681147575
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.003300374	0.12381732681147575
OXOGLUTARIC ACIDURIA	0.003300374	0.12381732681147575
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.003296239	0.12366219753025931
HISTIOCYTOID CARDIOMYOPATHY	0.003296239	0.12366219753025931
LOWRY-MACLEAN SYNDROME	0.003296239	0.12366219753025931
CRYPTOCOCCOSIS	0.003296239	0.12366219753025931
LYMPHANGIOLEIOMYOMATOSIS	0.003296239	0.12366219753025931
NEUROFIBROMATOSIS, TYPE I	0.003296239	0.12366219753025931
NASU-HAKOLA DISEASE	0.003296239	0.12366219753025931
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.003296239	0.12366219753025931
ATYPICAL TERATOID RHABDOID TUMOR	0.003296239	0.12366219753025931
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.003296239	0.12366219753025931
PAPILLOMA OF CHOROID PLEXUS	0.003296239	0.12366219753025931
GAUCHER DISEASE, TYPE IIIC	0.003296239	0.12366219753025931
FRONTAL ENCEPHALOCELE	0.003296239	0.12366219753025931
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.003296239	0.12366219753025931
OCULOCEREBROCUTANEOUS SYNDROME	0.003296239	0.12366219753025931
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.003296239	0.12366219753025931
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.003296239	0.12366219753025931
ADAMS-OLIVER SYNDROME	0.003296239	0.12366219753025931
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.003296239	0.12366219753025931
OROFACIODIGITAL SYNDROME I; OFD1	0.003296239	0.12366219753025931
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.003296239	0.12366219753025931
WHIPPLE DISEASE	0.003296239	0.12366219753025931
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.003296239	0.12366219753025931
LARGE CONGENITAL MELANOCYTIC NEVUS	0.003296239	0.12366219753025931
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.003296239	0.12366219753025931
ISOLATED SPINA BIFIDA	0.003296239	0.12366219753025931
KRABBE DISEASE	0.003296239	0.12366219753025931
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.003296239	0.12366219753025931
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.003296239	0.12366219753025931
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.003296239	0.12366219753025931
LHERMITTE-DUCLOS DISEASE	0.003296239	0.12366219753025931
CONGENITAL HYDROCEPHALUS	0.003296239	0.12366219753025931
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.003296239	0.12366219753025931
STURGE-WEBER SYNDROME	0.003296239	0.12366219753025931
47,XYY SYNDROME	0.003296239	0.12366219753025931
ALEXANDER DISEASE	0.003296239	0.12366219753025931
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.003296239	0.12366219753025931
LOWRY-WOOD SYNDROME	0.00316456	0.11872210838363281
45,X/46,XY MIXED GONADAL DYSGENESIS	0.00316456	0.11872210838363281
GOLDENHAR SYNDROME	0.00316456	0.11872210838363281
CORNEAL DYSTROPHY-PERCEPTIVE DEAFNESS SYNDROME	0.00316456	0.11872210838363281
MICROCORNEA-GLAUCOMA-ABSENT FRONTAL SINUSES SYNDROME	0.00316456	0.11872210838363281
JALILI SYNDROME	0.00316456	0.11872210838363281
CONE ROD DYSTROPHY	0.00316456	0.11872210838363281
CHYLOMICRON RETENTION DISEASE	0.00316456	0.11872210838363281
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00316456	0.11872210838363281
PSEUDOHYPOPARATHYROIDISM WITH ALBRIGHT HEREDITARY OSTEODYSTROPHY	0.00316456	0.11872210838363281
RENAL COLOBOMA SYNDROME	0.00316456	0.11872210838363281
PROGRESSIVE CONE DYSTROPHY	0.00316456	0.11872210838363281
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00316456	0.11872210838363281
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.00316456	0.11872210838363281
X-LINKED RETINAL DYSPLASIA	0.00316456	0.11872210838363281
MOEBIUS SYNDROME	0.00316456	0.11872210838363281
FETAL METHYLMERCURY SYNDROME	0.00316456	0.11872210838363281
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00316456	0.11872210838363281
MUCOPOLYSACCHARIDOSIS TYPE 6	0.00316456	0.11872210838363281
BLUE CONE MONOCHROMATISM	0.00316456	0.11872210838363281
STEVENS-JOHNSON SYNDROME	0.00316456	0.11872210838363281
INTERMEDIATE OSTEOPETROSIS	0.00316456	0.11872210838363281
CEREBELLAR HYPOPLASIA-TAPETORETINAL DEGENERATION SYNDROME	0.00316456	0.11872210838363281
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.00316456	0.11872210838363281
PSEUDOXANTHOMA ELASTICUM	0.00316456	0.11872210838363281
BRADYOPSIA	0.00316456	0.11872210838363281
OCULAR ALBINISM	0.00316456	0.11872210838363281
SPINOCEREBELLAR DEGENERATION-CORNEAL DYSTROPHY SYNDROME	0.00316456	0.11872210838363281
DUANE ANOMALY-MYOPATHY-SCOLIOSIS SYNDROME	0.00316456	0.11872210838363281
ABSENCE DEFORMITY OF LEG-CATARACT SYNDROME	0.00316456	0.11872210838363281
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00316456	0.11872210838363281
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.00316456	0.11872210838363281
MMEP SYNDROME	0.00316456	0.11872210838363281
OCULOCUTANEOUS ALBINISM	0.00316456	0.11872210838363281
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00316456	0.11872210838363281
AUTOIMMUNE POLYENDOCRINOPATHY TYPE 1	0.00316456	0.11872210838363281
SPORADIC CREUTZFELDT-JAKOB DISEASE	0.00316456	0.11872210838363281
CLEFT LIP-RETINOPATHY SYNDROME	0.00316456	0.11872210838363281
CRANIOMETAPHYSEAL DYSPLASIA	0.00316456	0.11872210838363281
ERDHEIM-CHESTER DISEASE	0.00316456	0.11872210838363281
PROLIDASE DEFICIENCY	0.00316456	0.11872210838363281
INTESTINAL LYMPHANGIECTASIA	0.00316456	0.11872210838363281
MARFAN SYNDROME	0.00316456	0.11872210838363281
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00316456	0.11872210838363281
MUCOLIPIDOSIS TYPE III	0.00316456	0.11872210838363281
X-LINKED RECESSIVE OCULAR ALBINISM	0.00316456	0.11872210838363281
PANCREATITIS, SCLEROSING CHOLANGITIS, AND SICCA COMPLEX	0.00316456	0.11872210838363281
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00316456	0.11872210838363281
BLUE CONE MONOCHROMACY; BCM	0.00316456	0.11872210838363281
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00316456	0.11872210838363281
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00316456	0.11872210838363281
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.00316456	0.11872210838363281
MACULAR DYSTROPHY, VITELLIFORM, 2; VMD2	0.00316456	0.11872210838363281
N SYNDROME	0.00316456	0.11872210838363281
ARTHROGRYPOSIS-OCULOMOTOR LIMITATION-ELECTRORETINAL ANOMALIES SYNDROME	0.00316456	0.11872210838363281
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00316456	0.11872210838363281
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00316456	0.11872210838363281
OCULOCUTANEOUS ALBINISM TYPE 2	0.00316456	0.11872210838363281
FOVEAL HYPOPLASIA AND PRESENILE CATARACT SYNDROMEFOVEAL HYPOPLASIA, ISOLATED, INCLUDED	0.00316456	0.11872210838363281
DYSKERATOSIS, HEREDITARY BENIGN INTRAEPITHELIAL; HBID	0.00316456	0.11872210838363281
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00316456	0.11872210838363281
CONE-ROD DYSTROPHY 17; CORD17	0.00316456	0.11872210838363281
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.00316456	0.11872210838363281
DOYNE HONEYCOMB RETINAL DYSTROPHY	0.00316456	0.11872210838363281
ASCHER SYNDROME	0.00316456	0.11872210838363281
CONE DYSTROPHY 4	0.00316456	0.11872210838363281
HERMANSKY-PUDLAK SYNDROME 3; HPS3	0.00316456	0.11872210838363281
OCULOCUTANEOUS ALBINISM TYPE 1A	0.00316456	0.11872210838363281
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.11872210838363281
LEBER CONGENITAL AMAUROSIS 8; LCA8	0.00316456	0.11872210838363281
GILLESPIE SYNDROME; GLSP	0.00316456	0.11872210838363281
TANGIER DISEASE; TGD	0.00316456	0.11872210838363281
ALBINISM, OCULAR, TYPE I	0.00316456	0.11872210838363281
CHROMOSOME XP11.3 DELETION SYNDROME	0.00316456	0.11872210838363281
RETINITIS PIGMENTOSA 20	0.00316456	0.11872210838363281
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00316456	0.11872210838363281
RETINITIS PIGMENTOSA 27; RP27	0.00316456	0.11872210838363281
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00316456	0.11872210838363281
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.00316456	0.11872210838363281
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 6	0.00316456	0.11872210838363281
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00316456	0.11872210838363281
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.00316456	0.11872210838363281
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIC, WITH OPTIC ATROPHY; HMSN6C	0.00316456	0.11872210838363281
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00316456	0.11872210838363281
LEBER CONGENITAL AMAUROSIS 19; LCA19	0.00316456	0.11872210838363281
BONNEMANN-MEINECKE-REICH SYNDROME	0.00316456	0.11872210838363281
LEBER CONGENITAL AMAUROSIS 11; LCA11	0.00316456	0.11872210838363281
CREUTZFELDT-JAKOB DISEASE; CJD	0.00316456	0.11872210838363281
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00316456	0.11872210838363281
OSTEOPETROSIS,  AUTOSOMAL RECESSIVE 4; OPTB4	0.00316456	0.11872210838363281
LEBER CONGENITAL AMAUROSIS 5; LCA5	0.00316456	0.11872210838363281
BUSCHKE-OLLENDORFF SYNDROME	0.00316456	0.11872210838363281
XFE PROGEROID SYNDROME; XFEPS	0.00316456	0.11872210838363281
BIRDSHOT CHORIORETINOPATHY	0.00316456	0.11872210838363281
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.00316456	0.11872210838363281
ACRO-RENAL-OCULAR SYNDROME	0.00316456	0.11872210838363281
RETINAL CONE DYSTROPHY 4	0.00316456	0.11872210838363281
ABETALIPOPROTEINEMIA	0.00316456	0.11872210838363281
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00316456	0.11872210838363281
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.00316456	0.11872210838363281
BROOKE-SPIEGLER SYNDROME	0.00316456	0.11872210838363281
LEG, ABSENCE DEFORMITY OF, WITH CONGENITAL CATARACT	0.00316456	0.11872210838363281
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00316456	0.11872210838363281
CHOROIDAL ATROPHY-ALOPECIA SYNDROME	0.00316456	0.11872210838363281
WAGR SYNDROME	0.00316456	0.11872210838363281
FISH-EYE DISEASE	0.00316456	0.11872210838363281
CORNEA GUTTATA WITH ANTERIOR POLAR CATARACTS	0.00316456	0.11872210838363281
EPITHELIAL RECURRENT EROSION DYSTROPHY	0.00316456	0.11872210838363281
CATARACT-ATAXIA-DEAFNESS SYNDROME	0.00316456	0.11872210838363281
AUTOSOMAL RECESSIVE PALMOPLANTAR KERATODERMA AND CONGENITAL ALOPECIA	0.00316456	0.11872210838363281
OCULOCUTANEOUS ALBINISM TYPE 4	0.00316456	0.11872210838363281
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 3; OPTB3	0.00316456	0.11872210838363281
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.00316456	0.11872210838363281
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.00316456	0.11872210838363281
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 2; CFEOM2	0.00316456	0.11872210838363281
AGEL AMYLOIDOSIS	0.00316456	0.11872210838363281
%258500 OPTIC ATROPHY 6; OPA6;;OPTIC ATROPHY, CONGENITAL OR EARLY INFANTILE, AUTOSOMAL RECESSIVE	0.00316456	0.11872210838363281
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.00297619	0.11165519116410627
EBSTEIN MALFORMATION	0.00297619	0.11165519116410627
MESOAXIAL HEXADACTYLY AND CARDIAC MALFORMATION	0.00297619	0.11165519116410627
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.00297619	0.11165519116410627
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.00297619	0.11165519116410627
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.00297619	0.11165519116410627
JUVENILE POLYPOSIS OF INFANCY	0.00297619	0.11165519116410627
614262 ARTHROGRYPOSIS, PERTHES DISEASE, AND UPWARD GAZE PALSY; APUG	0.00297619	0.11165519116410627
WHITE FORELOCK WITH MALFORMATIONS	0.00297619	0.11165519116410627
BONE DYSPLASIA, LETHAL HOLMGREN TYPE	0.00297619	0.11165519116410627
INDOMETHACIN EMBRYOFETOPATHY	0.00297619	0.11165519116410627
HOLT-ORAM SYNDROME	0.00297619	0.11165519116410627
SCIMITAR SYNDROME	0.00297619	0.11165519116410627
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00297619	0.11165519116410627
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00297619	0.11165519116410627
ALVEOLAR CAPILLARY DYSPLASIA WITH MISALIGNMENT OF PULMONARY VEINS; ACDMPV	0.00297619	0.11165519116410627
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 5; CHTD5	0.00297619	0.11165519116410627
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.00297619	0.11165519116410627
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.00297619	0.11165519116410627
MEGALENCEPHALY	0.00297619	0.11165519116410627
DUANE-RADIAL RAY SYNDROME; DRRS	0.00297619	0.11165519116410627
CONGENITALLY CORRECTED TRANSPOSITION OF THE GREAT ARTERIES	0.00297619	0.11165519116410627
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00297619	0.11165519116410627
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00297619	0.11165519116410627
SPONDYLOOCULAR SYNDROME; SOS	0.00297619	0.11165519116410627
HYPOPLASTIC LEFT HEART SYNDROME	0.00297619	0.11165519116410627
CONGENITAL PULMONARY VALVE STENOSIS	0.00297619	0.11165519116410627
ALAGILLE SYNDROME 2	0.00297619	0.11165519116410627
WHITE FORELOCK WITH MALFORMATIONS	0.00297619	0.11165519116410627
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00297619	0.11165519116410627
KLIPPEL-TRÉNAUNAY SYNDROME	0.00297619	0.11165519116410627
DIPHALLIA	0.00297619	0.11165519116410627
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.00297619	0.11165519116410627
%608572 BURN-MCKEOWN SYNDROME	0.00297619	0.11165519116410627
HETEROTAXY, VISCERAL, 7, AUTOSOMAL; HTX7	0.00297619	0.11165519116410627
PORENCEPHALY, CEREBELLAR HYPOPLASIA, AND INTERNAL MALFORMATIONS	0.00297619	0.11165519116410627
LYMPHATIC MALFORMATION 7; LMPHM7	0.00297619	0.11165519116410627
ABRUZZO-ERICKSON SYNDROME	0.00297619	0.11165519116410627
DIAMOND-BLACKFAN ANEMIA 4	0.00297619	0.11165519116410627
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.00297619	0.11165519116410627
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.00297619	0.11165519116410627
CONGENITAL ALVEOLAR CAPILLARY DYSPLASIA	0.00297619	0.11165519116410627
POLAND SYNDROME	0.00297619	0.11165519116410627
XK APROSENCEPHALY SYNDROME	0.00297619	0.11165519116410627
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00297619	0.11165519116410627
DIAMOND-BLACKFAN ANEMIA 16	0.00297619	0.11165519116410627
ATRIAL SEPTAL DEFECT 5	0.00297619	0.11165519116410627
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00297619	0.11165519116410627
%241310 HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00297619	0.11165519116410627
ELLIS VAN CREVELD SYNDROME	0.00297619	0.11165519116410627
TURNER SYNDROME	0.00297619	0.11165519116410627
PERICARDIAL AND DIAPHRAGMATIC DEFECT	0.00297619	0.11165519116410627
JOHANSON-BLIZZARD SYNDROME; JBS	0.00297619	0.11165519116410627
MEACHAM SYNDROME	0.00297619	0.11165519116410627
PENILE AGENESIS	0.00297619	0.11165519116410627
EISENMENGER SYNDROME	0.00297619	0.11165519116410627
MOSAIC MONOSOMY X	0.00297619	0.11165519116410627
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.00297619	0.11165519116410627
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00297619	0.11165519116410627
EBSTEIN ANOMALY	0.00297619	0.11165519116410627
ELLIS-VAN CREVELD SYNDROME	0.00297619	0.11165519116410627
HEART DEFECTS-LIMB SHORTENING SYNDROME	0.00297619	0.11165519116410627
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00297619	0.11165519116410627
CARDIAC-UROGENITAL SYNDROME; CUGS	0.00297619	0.11165519116410627
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00297619	0.11165519116410627
MONOSOMY X	0.00297619	0.11165519116410627
BRACHYDACTYLY, TYPE E, WITH ATRIAL SEPTAL DEFECT, TYPE II	0.00297619	0.11165519116410627
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.00297619	0.11165519116410627
CONGENITAL TOTAL PULMONARY VENOUS RETURN ANOMALY	0.00297619	0.11165519116410627
FAMILIAL CUTANEOUS COLLAGENOMA	0.00297619	0.11165519116410627
AORTIC VALVE DISEASE 3; AOVD3	0.00297619	0.11165519116410627
NOONAN SYNDROME 8; NS8	0.00297619	0.11165519116410627
ALAGILLE SYNDROME	0.00297619	0.11165519116410627
ULNAR/FIBULA RAY DEFECT-BRACHYDACTYLY SYNDROME	0.00297619	0.11165519116410627
8P23.1 DELETION SYNDROME	0.00297619	0.11165519116410627
DIAMOND-BLACKFAN ANEMIA 1	0.00297619	0.11165519116410627
CONGENITAL HEART DEFECTS, MULTIPLE TYPES, 3; CHTD3	0.00297619	0.11165519116410627
THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME	0.00297619	0.11165519116410627
COLE-CARPENTER SYNDROME 2; CLCRP2	0.00275482	0.10335024098686685
AASE-SMITH SYNDROME I	0.00275482	0.10335024098686685
VACTERL ASSOCIATION, X-LINKED, WITH OR WITHOUT HYDROCEPHALUS; VACTERLX	0.00275482	0.10335024098686685
RADIAL APLASIA, X-LINKED	0.00275482	0.10335024098686685
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00275482	0.10335024098686685
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.00275482	0.10335024098686685
KLEEBLATTSCHAEDEL SYNDROME	0.00275482	0.10335024098686685
MECKEL SYNDROME	0.00275482	0.10335024098686685
B4GALT1-CDG	0.00275482	0.10335024098686685
PRIMARY CILIARY DYSKINESIA	0.00275482	0.10335024098686685
THORACOABDOMINAL SYNDROME	0.00275482	0.10335024098686685
CROUZON DISEASE	0.00275482	0.10335024098686685
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.00275482	0.10335024098686685
GENITOPALATOCARDIAC SYNDROME	0.00275482	0.10335024098686685
HB BART'S HYDROPS FETALIS	0.00275482	0.10335024098686685
VACTERL WITH HYDROCEPHALUS	0.00275482	0.10335024098686685
307010 HYDROCEPHALUS WITH CEREBELLAR AGENESIS	0.00275482	0.10335024098686685
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00275482	0.10335024098686685
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00275482	0.10335024098686685
MASA SYNDROME	0.00275482	0.10335024098686685
TEMPLE SYNDROME	0.00275482	0.10335024098686685
MEGALENCEPHALY	0.00275482	0.10335024098686685
X-LINKED DOMINANT CHONDRODYSPLASIA, CHASSAING-LACOMBE TYPE	0.00275482	0.10335024098686685
PELVIS-SHOULDER DYSPLASIA	0.00275482	0.10335024098686685
HEMIFACIAL MICROSOMIA	0.00275482	0.10335024098686685
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00275482	0.10335024098686685
RHOMBENCEPHALOSYNAPSIS	0.00275482	0.10335024098686685
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.00275482	0.10335024098686685
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.00275482	0.10335024098686685
TRISOMY 1Q	0.00275482	0.10335024098686685
TRIPLOIDY	0.00275482	0.10335024098686685
CENTRAL PRECOCIOUS PUBERTY	0.00275482	0.10335024098686685
MUSCULAR HYPERTROPHY-HEPATOMEGALY-POLYHYDRAMNIOS SYNDROME	0.00275482	0.10335024098686685
CAMPOMELIC DYSPLASIA	0.00275482	0.10335024098686685
SHORT RIB-POLYDACTYLY SYNDROME	0.00275482	0.10335024098686685
ACHONDROPLASIA	0.00275482	0.10335024098686685
ABSENT RADIUS-ANOGENITAL ANOMALIES SYNDROME	0.00275482	0.10335024098686685
CRANIOFACIAL CONODYSPLASIA	0.00275482	0.10335024098686685
ALBERS-SCHÖNBERG OSTEOPETROSIS	0.00275482	0.10335024098686685
COLE-CARPENTER SYNDROME 1; CLCRP1	0.00275482	0.10335024098686685
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00275482	0.10335024098686685
BASAL CELL NEVUS SYNDROME	0.00275482	0.10335024098686685
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00275482	0.10335024098686685
OTOMANDIBULAR SYNDROME	0.00275482	0.10335024098686685
BIEMOND SYNDROME TYPE 2	0.00275482	0.10335024098686685
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2A2	0.00275482	0.10335024098686685
ARACHNOIDITIS	0.00275482	0.10335024098686685
FAMILIAL LAMBDOID SYNOSTOSIS	0.00275482	0.10335024098686685
INIENCEPHALY	0.00275482	0.10335024098686685
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00275482	0.10335024098686685
PYCNODYSOSTOSIS	0.00275482	0.10335024098686685
CRANIOSYNOSTOSIS, SAGITTAL, WITH DANDY-WALKER MALFORMATION AND HYDROCEPHALUS	0.00275482	0.10335024098686685
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00275482	0.10335024098686685
FANCONI ANEMIA, COMPLEMENTATION GROUP R	0.00275482	0.10335024098686685
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.00275482	0.10335024098686685
PITUITARY DEFICIENCY DUE TO RATHKE CLEFT CYSTS	0.00275482	0.10335024098686685
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00275482	0.10335024098686685
HYDROLETHALUS	0.00275482	0.10335024098686685
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.00275482	0.10335024098686685
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00275482	0.10335024098686685
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00275482	0.10335024098686685
FUNCTIONING GONADOTROPIC ADENOMA	0.00275482	0.10335024098686685
LAURIN-SANDROW SYNDROME	0.00275482	0.10335024098686685
HYDROCEPHALUS-OBESITY-HYPOGONADISM SYNDROME	0.00275482	0.10335024098686685
MECKEL SYNDROME, TYPE 6; MKS6	0.00275482	0.10335024098686685
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.00275482	0.10335024098686685
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.00275482	0.10335024098686685
LETHAL OMPHALOCELE-CLEFT PALATE SYNDROME	0.00275482	0.10335024098686685
ACALVARIA	0.00275482	0.10335024098686685
TEMPLE SYNDROME	0.00275482	0.10335024098686685
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.00275482	0.10335024098686685
DYSSEGMENTAL DYSPLASIA, ROLLAND-DESBUQUOIS TYPE	0.00275482	0.10335024098686685
DIABETIC EMBRYOPATHY	0.00275482	0.10335024098686685
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.00275482	0.10335024098686685
6P22 MICRODELETION SYNDROME	0.00275482	0.10335024098686685
SHORT-RIB THORACIC DYSPLASIA 10 WITH OR WITHOUT POLYDACTYLY; SRTD10	0.00275482	0.10335024098686685
HYPOPLASMINOGENEMIA	0.00275482	0.10335024098686685
HEMANGIOBLASTOMA	0.00275482	0.10335024098686685
STEINERT MYOTONIC DYSTROPHY	0.00275482	0.10335024098686685
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.00275482	0.10335024098686685
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.00275482	0.10335024098686685
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.00275482	0.10335024098686685
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.00275482	0.10335024098686685
PAPILLARY TUMOR OF THE PINEAL REGION	0.00275482	0.10335024098686685
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00275482	0.10335024098686685
PINEOCYTOMA	0.00275482	0.10335024098686685
HYDROCEPHALUS, CONGENITAL, 3, WITH BRAIN ANOMALIES; HYC3	0.00275482	0.10335024098686685
DANDY-WALKER SYNDROME	0.00275482	0.10335024098686685
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00275482	0.10335024098686685
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00275482	0.10335024098686685
POSTERIOR MENINGOCELE	0.00275482	0.10335024098686685
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00275482	0.10335024098686685
OMPHALOCELE-CLEFT PALATE SYNDROME, LETHAL	0.00275482	0.10335024098686685
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.00275482	0.10335024098686685
VACTERL ASSOCIATION WITH HYDROCEPHALUS	0.00275482	0.10335024098686685
BIEMOND SYNDROME II	0.00275482	0.10335024098686685
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.00275482	0.10335024098686685
STROMME SYNDROME; STROMS	0.00275482	0.10335024098686685
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.00275482	0.10335024098686685
METATROPIC DYSPLASIA	0.00275482	0.10335024098686685
DIENCEPHALIC SYNDROME	0.00275482	0.10335024098686685
241800 HYPOTHALAMIC HAMARTOMASCONGENITAL HYPOTHALAMIC HAMARTOMA SYNDROME, INCLUDED; CHHS, INCLUDED	0.00275482	0.10335024098686685
CHIARI MALFORMATION TYPE II	0.00275482	0.10335024098686685
FRONTONASAL DYSPLASIA	0.00275482	0.10335024098686685
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00275482	0.10335024098686685
CENTRAL NEUROCYTOMA	0.00275482	0.10335024098686685
NEPHRONOPHTHISIS 18; NPHP18	0.00275482	0.10335024098686685
GORLIN SYNDROME	0.00275482	0.10335024098686685
BEEMER LETHAL MALFORMATION SYNDROME	0.00275482	0.10335024098686685
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
SCHINDLER DISEASE, TYPE I	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.001086973	0.040779042368001395
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.001086973	0.040779042368001395
17Q12 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
TEMPLE-BARAITSER SYNDROME; TMBTS	0.001086973	0.040779042368001395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.040779042368001395
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.001086973	0.040779042368001395
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.001086973	0.040779042368001395
HEREDITARY FOLATE MALABSORPTION	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.040779042368001395
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.001086973	0.040779042368001395
CHROMOSOME 16P13.3 DELETION SYNDROME	0.001086973	0.040779042368001395
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.040779042368001395
PONTINE TEGMENTAL CAP DYSPLASIA	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.040779042368001395
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.001086973	0.040779042368001395
ARGININEMIA	0.001086973	0.040779042368001395
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.001086973	0.040779042368001395
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.001086973	0.040779042368001395
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.001086973	0.040779042368001395
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
POTOCKI-LUPSKI SYNDROME	0.001086973	0.040779042368001395
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.001086973	0.040779042368001395
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.040779042368001395
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.001086973	0.040779042368001395
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.040779042368001395
CEDNIK SYNDROME	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.001086973	0.040779042368001395
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.040779042368001395
MEVALONIC ACIDURIA	0.001086973	0.040779042368001395
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.001086973	0.040779042368001395
N-ACETYLASPARTATE DEFICIENCY; NACED	0.001086973	0.040779042368001395
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.001086973	0.040779042368001395
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.001086973	0.040779042368001395
ALG11-CDG	0.001086973	0.040779042368001395
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.001086973	0.040779042368001395
XQ21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.040779042368001395
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.001086973	0.040779042368001395
GABA-TRANSAMINASE DEFICIENCY	0.001086973	0.040779042368001395
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.001086973	0.040779042368001395
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.001086973	0.040779042368001395
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.001086973	0.040779042368001395
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.001086973	0.040779042368001395
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.001086973	0.040779042368001395
ADAMS-OLIVER SYNDROME 2; AOS2	0.001086973	0.040779042368001395
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.040779042368001395
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.001086973	0.040779042368001395
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.001086973	0.040779042368001395
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.040779042368001395
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.040779042368001395
GLASS SYNDROME	0.001086973	0.040779042368001395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.001086973	0.040779042368001395
DPAGT1-CDG	0.001086973	0.040779042368001395
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.001086973	0.040779042368001395
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.001086973	0.040779042368001395
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.001086973	0.040779042368001395
XP21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.001086973	0.040779042368001395
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.001086973	0.040779042368001395
LISSENCEPHALY 4	0.001086973	0.040779042368001395
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.040779042368001395
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.001086973	0.040779042368001395
DYSTONIA-APHONIA SYNDROME	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.001086973	0.040779042368001395
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.001086973	0.040779042368001395
ELEJALDE DISEASE	0.001086973	0.040779042368001395
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.001086973	0.040779042368001395
LEIGH SYNDROME; LS	0.001086973	0.040779042368001395
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.001086973	0.040779042368001395
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.001086973	0.040779042368001395
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA, CBLA TYPE	0.001086973	0.040779042368001395
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.001086973	0.040779042368001395
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.001086973	0.040779042368001395
LANDAU-KLEFFNER SYNDROME	0.001086973	0.040779042368001395
PEHO SYNDROME; PEHO	0.001086973	0.040779042368001395
ISOLATED GLYCEROL KINASE DEFICIENCY	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.001086973	0.040779042368001395
SSR4-CDG	0.001086973	0.040779042368001395
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.001086973	0.040779042368001395
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.040779042368001395
MEHMO SYNDROME; MEHMO	0.001086973	0.040779042368001395
RAYNAUD-CLAES SYNDROME; MRXSRC	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.040779042368001395
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.001086973	0.040779042368001395
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.001086973	0.040779042368001395
GM2-GANGLIOSIDOSIS, AB VARIANT	0.001086973	0.040779042368001395
SULFOCYSTEINURIA	0.001086973	0.040779042368001395
PITUITARY STALK INTERRUPTION SYNDROME	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.001086973	0.040779042368001395
PYRUVATE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001086973	0.040779042368001395
KETOADIPICACIDURIA	0.001086973	0.040779042368001395
VICI SYNDROME; VICIS	0.001086973	0.040779042368001395
ARGININOSUCCINIC ACIDURIA	0.001086973	0.040779042368001395
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.001086973	0.040779042368001395
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.001086973	0.040779042368001395
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.001086973	0.040779042368001395
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.001086973	0.040779042368001395
PALLISTER-HALL SYNDROME	0.001086973	0.040779042368001395
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.040779042368001395
AICARDI-GOUTIÈRES SYNDROME	0.001086973	0.040779042368001395
MAPLE SYRUP URINE DISEASE	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.001086973	0.040779042368001395
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.001086973	0.040779042368001395
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.001086973	0.040779042368001395
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.040779042368001395
ADENYLOSUCCINASE DEFICIENCY	0.001086973	0.040779042368001395
POTOCKI-SHAFFER SYNDROME	0.001086973	0.040779042368001395
WYBURN-MASON SYNDROME	0.001086973	0.040779042368001395
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.001086973	0.040779042368001395
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.040779042368001395
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.001086973	0.040779042368001395
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 1; HPE1	0.001086973	0.040779042368001395
HARTNUP DISORDER	0.001086973	0.040779042368001395
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.001086973	0.040779042368001395
GAUCHER DISEASE, TYPE II	0.001086973	0.040779042368001395
FOLATE MALABSORPTION, HEREDITARY	0.001086973	0.040779042368001395
LATHOSTEROLOSIS	0.001086973	0.040779042368001395
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.001086973	0.040779042368001395
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.001086973	0.040779042368001395
COACH SYNDROME	0.001086973	0.040779042368001395
CITRULLINEMIA, CLASSIC	0.001086973	0.040779042368001395
GRISCELLI SYNDROME, TYPE 1	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.001086973	0.040779042368001395
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.001086973	0.040779042368001395
STT3B-CDG	0.001086973	0.040779042368001395
STT3A-CDG	0.001086973	0.040779042368001395
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.001086973	0.040779042368001395
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001086973	0.040779042368001395
NARP SYNDROME	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.001086973	0.040779042368001395
SALLA DISEASE	0.001086973	0.040779042368001395
ALSTRÖM SYNDROME	0.001086973	0.040779042368001395
SRD5A3-CDG	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.001086973	0.040779042368001395
FILIPPI SYNDROME	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.001086973	0.040779042368001395
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.001086973	0.040779042368001395
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.001086973	0.040779042368001395
PIERPONT SYNDROME	0.001086973	0.040779042368001395
ISOVALERIC ACIDEMIA	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.001086973	0.040779042368001395
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.001086973	0.040779042368001395
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.001086973	0.040779042368001395
PHACE ASSOCIATION	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.001086973	0.040779042368001395
RUVALCABA SYNDROME	0.001086973	0.040779042368001395
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.001086973	0.040779042368001395
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.001086973	0.040779042368001395
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.001086973	0.040779042368001395
SEVERE CANAVAN DISEASE	0.001086973	0.040779042368001395
NIEMANN-PICK DISEASE, TYPE C2	0.001086973	0.040779042368001395
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.001086973	0.040779042368001395
SIALURIA	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.040779042368001395
LEBER CONGENITAL AMAUROSIS	0.001086973	0.040779042368001395
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.001086973	0.040779042368001395
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.040779042368001395
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.001086973	0.040779042368001395
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.040779042368001395
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 104; MRX104	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 103	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.001086973	0.040779042368001395
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 101; MRX101	0.001086973	0.040779042368001395
20Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
DISTAL MONOSOMY 1Q	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.001086973	0.040779042368001395
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.001086973	0.040779042368001395
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.040779042368001395
SHUKLA-VERNON SYNDROME; SHUVER	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.001086973	0.040779042368001395
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.001086973	0.040779042368001395
19P13.13 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.001086973	0.040779042368001395
DISTAL TRISOMY 17Q	0.001086973	0.040779042368001395
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.001086973	0.040779042368001395
TIMOTHY SYNDROME; TS	0.001086973	0.040779042368001395
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.040779042368001395
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.001086973	0.040779042368001395
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.040779042368001395
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.001086973	0.040779042368001395
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.001086973	0.040779042368001395
PELIZAEUS-MERZBACHER DISEASE	0.001086973	0.040779042368001395
WAISMAN SYNDROME; WSMN	0.001086973	0.040779042368001395
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.040779042368001395
GLYCEROL KINASE DEFICIENCY; GKD	0.001086973	0.040779042368001395
FUCOSIDOSIS	0.001086973	0.040779042368001395
LUSCAN-LUMISH SYNDROME; LLS	0.001086973	0.040779042368001395
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.001086973	0.040779042368001395
EAST SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.001086973	0.040779042368001395
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.001086973	0.040779042368001395
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.001086973	0.040779042368001395
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.001086973	0.040779042368001395
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.040779042368001395
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.001086973	0.040779042368001395
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.040779042368001395
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.001086973	0.040779042368001395
GRISCELLI SYNDROME TYPE 1	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.001086973	0.040779042368001395
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.001086973	0.040779042368001395
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001086973	0.040779042368001395
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.001086973	0.040779042368001395
ADULT-ONSET DYSTONIA-PARKINSONISM	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.040779042368001395
CITRULLINEMIA TYPE II	0.001086973	0.040779042368001395
MOSAIC TRISOMY 14	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.001086973	0.040779042368001395
HYDRANENCEPHALY	0.001086973	0.040779042368001395
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.001086973	0.040779042368001395
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.001086973	0.040779042368001395
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.001086973	0.040779042368001395
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.001086973	0.040779042368001395
COWDEN SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.001086973	0.040779042368001395
22Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
KEUTEL SYNDROME	0.001086973	0.040779042368001395
ZTTK SYNDROME; ZTTKS	0.001086973	0.040779042368001395
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.001086973	0.040779042368001395
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.001086973	0.040779042368001395
MATERNAL PHENYLKETONURIA	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.001086973	0.040779042368001395
15Q11Q13 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.001086973	0.040779042368001395
JOUBERT SYNDROME 30; JBTS30	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.001086973	0.040779042368001395
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.001086973	0.040779042368001395
SCHIZENCEPHALY	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001086973	0.040779042368001395
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.001086973	0.040779042368001395
SOTOS SYNDROME	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.001086973	0.040779042368001395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.001086973	0.040779042368001395
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.001086973	0.040779042368001395
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.001086973	0.040779042368001395
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.040779042368001395
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.001086973	0.040779042368001395
CHROMOSOME 1P35 DELETION SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 16P13.2 DELETION SYNDROME	0.001086973	0.040779042368001395
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.001086973	0.040779042368001395
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.001086973	0.040779042368001395
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.001086973	0.040779042368001395
TAY-SACHS DISEASE	0.001086973	0.040779042368001395
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.001086973	0.040779042368001395
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.040779042368001395
DUANE RETRACTION SYNDROME	0.001086973	0.040779042368001395
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.040779042368001395
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.001086973	0.040779042368001395
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.001086973	0.040779042368001395
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.001086973	0.040779042368001395
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.001086973	0.040779042368001395
ACROMELIC FRONTONASAL DYSPLASIA	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.001086973	0.040779042368001395
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.001086973	0.040779042368001395
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.040779042368001395
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.001086973	0.040779042368001395
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.001086973	0.040779042368001395
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.040779042368001395
CLASSIC PHENYLKETONURIA	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.001086973	0.040779042368001395
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.001086973	0.040779042368001395
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.001086973	0.040779042368001395
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.001086973	0.040779042368001395
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.001086973	0.040779042368001395
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.001086973	0.040779042368001395
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.040779042368001395
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.040779042368001395
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.001086973	0.040779042368001395
VICI SYNDROME	0.001086973	0.040779042368001395
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.001086973	0.040779042368001395
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.001086973	0.040779042368001395
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.001086973	0.040779042368001395
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.040779042368001395
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.001086973	0.040779042368001395
ALG1-CDG	0.001086973	0.040779042368001395
ALG3-CDG	0.001086973	0.040779042368001395
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.040779042368001395
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.001086973	0.040779042368001395
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.001086973	0.040779042368001395
GALLOWAY-MOWAT SYNDROME	0.001086973	0.040779042368001395
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.001086973	0.040779042368001395
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.040779042368001395
HARTNUP DISEASE	0.001086973	0.040779042368001395
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.001086973	0.040779042368001395
2P21 MICRODELETION SYNDROME	0.001086973	0.040779042368001395
CHROMOSOME 5Q12 DELETION SYNDROME	0.001086973	0.040779042368001395
INFANTILE REFSUM DISEASE	0.001086973	0.040779042368001395
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.001086973	0.040779042368001395
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.001086973	0.040779042368001395
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.040779042368001395
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.040779042368001395
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.001086973	0.040779042368001395
3Q29 MICRODUPLICATION SYNDROME	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.001086973	0.040779042368001395
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.001086973	0.040779042368001395
WEBB-DATTANI SYNDROME; WEDAS	0.001086973	0.040779042368001395
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.001086973	0.040779042368001395
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001086973	0.040779042368001395
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.001086973	0.040779042368001395
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.040779042368001395
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.001086973	0.040779042368001395
MICRO SYNDROME	0.001086973	0.040779042368001395
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.001086973	0.040779042368001395
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.001086973	0.040779042368001395
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.001086973	0.040779042368001395
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.040779042368001395
CANAVAN DISEASE	0.001086973	0.040779042368001395
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.040779042368001395
AICARDI-GOUTIERES SYNDROME 7	0.001086973	0.040779042368001395
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.001086973	0.040779042368001395
LISSENCEPHALY 8; LIS8	0.001086973	0.040779042368001395
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.040779042368001395
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.001086973	0.040779042368001395
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.001086973	0.040779042368001395
INFANTILE LIVER FAILURE SYNDROME 1	0.001086973	0.040779042368001395
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.001086973	0.040779042368001395
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.001086973	0.040779042368001395
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.040779042368001395
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.001086973	0.040779042368001395
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.001086973	0.040779042368001395
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA TYPE 7	0.000545554	0.020467085824608922
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.000545554	0.020467085824608922
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.020467085824608922
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000545554	0.020467085824608922
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000545554	0.020467085824608922
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.000545554	0.020467085824608922
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.000545554	0.020467085824608922
TARP SYNDROME; TARPS	0.000545554	0.020467085824608922
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA TYPE 29	0.000545554	0.020467085824608922
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.020467085824608922
GERODERMA OSTEODYSPLASTICA	0.000545554	0.020467085824608922
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.000545554	0.020467085824608922
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.000545554	0.020467085824608922
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.020467085824608922
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.000545554	0.020467085824608922
TONNE-KALSCHEUER SYNDROME; TOKAS	0.000545554	0.020467085824608922
SWEENEY-COX SYNDROME; SWCOS	0.000545554	0.020467085824608922
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.020467085824608922
MECKEL SYNDROME 13; MKS13	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME XVI; OFD16	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 106; MRX106	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME VIII; OFD8	0.000545554	0.020467085824608922
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.020467085824608922
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.000545554	0.020467085824608922
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000545554	0.020467085824608922
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.020467085824608922
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.020467085824608922
JOUBERT SYNDROME 10	0.000545554	0.020467085824608922
MENTAL RETARDATION, X-LINKED 99	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.000545554	0.020467085824608922
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.020467085824608922
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000545554	0.020467085824608922
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.000545554	0.020467085824608922
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.000545554	0.020467085824608922
JOUBERT SYNDROME 32; JBTS32	0.000545554	0.020467085824608922
OCCIPITAL HORN SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME VI	0.000545554	0.020467085824608922
ALPHA-MANNOSIDOSIS	0.000545554	0.020467085824608922
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.000545554	0.020467085824608922
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.020467085824608922
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.020467085824608922
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.020467085824608922
CEREBELLAR ATAXIA, CAYMAN TYPE	0.000545554	0.020467085824608922
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.000545554	0.020467085824608922
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.020467085824608922
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.000545554	0.020467085824608922
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.020467085824608922
RAHMAN SYNDROME	0.000545554	0.020467085824608922
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000545554	0.020467085824608922
JOUBERT SYNDROME 31; JBTS31	0.000545554	0.020467085824608922
HOLMES-GANG SYNDROME	0.000545554	0.020467085824608922
COLE-CARPENTER SYNDROME	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.020467085824608922
TOLUENE EMBRYOPATHY	0.000545554	0.020467085824608922
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.020467085824608922
SEPTOOPTIC DYSPLASIA	0.000545554	0.020467085824608922
OCULOSKELETODENTAL SYNDROME; OCSKD	0.000545554	0.020467085824608922
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000545554	0.020467085824608922
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.020467085824608922
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000545554	0.020467085824608922
TRANSKETOLASE DEFICIENCY	0.000545554	0.020467085824608922
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.000545554	0.020467085824608922
ALSTROM SYNDROME; ALMS	0.000545554	0.020467085824608922
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.020467085824608922
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000545554	0.020467085824608922
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.020467085824608922
MICROPHTHALMIA, SYNDROMIC 3	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.020467085824608922
AUSTRALIA ANTIGEN	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 1; BBS1	0.000545554	0.020467085824608922
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.000545554	0.020467085824608922
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.000545554	0.020467085824608922
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000545554	0.020467085824608922
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000545554	0.020467085824608922
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000545554	0.020467085824608922
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000545554	0.020467085824608922
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.020467085824608922
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.020467085824608922
CRANIOTELENCEPHALIC DYSPLASIA	0.000545554	0.020467085824608922
CHAR SYNDROME	0.000545554	0.020467085824608922
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.020467085824608922
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000545554	0.020467085824608922
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.020467085824608922
CINCA SYNDROME	0.000545554	0.020467085824608922
CODAS SYNDROME	0.000545554	0.020467085824608922
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.020467085824608922
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.000545554	0.020467085824608922
AURICULOCONDYLAR SYNDROME	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.000545554	0.020467085824608922
PEDIATRIC-ONSET GRAVES DISEASE	0.000545554	0.020467085824608922
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.020467085824608922
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020467085824608922
MARINESCO-SJÖGREN SYNDROME	0.000545554	0.020467085824608922
ALG6-CDG	0.000545554	0.020467085824608922
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.000545554	0.020467085824608922
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.020467085824608922
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.000545554	0.020467085824608922
CHROMOSOME 18P DELETION SYNDROME	0.000545554	0.020467085824608922
ATELOSTEOGENESIS TYPE III	0.000545554	0.020467085824608922
MONOSOMY 18P	0.000545554	0.020467085824608922
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.000545554	0.020467085824608922
48,XYYY SYNDROME	0.000545554	0.020467085824608922
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608922
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.000545554	0.020467085824608922
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.000545554	0.020467085824608922
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.000545554	0.020467085824608922
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.000545554	0.020467085824608922
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.020467085824608922
17P11.2 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000545554	0.020467085824608922
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.020467085824608922
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.020467085824608922
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.000545554	0.020467085824608922
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000545554	0.020467085824608922
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.000545554	0.020467085824608922
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000545554	0.020467085824608922
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000545554	0.020467085824608922
JAWAD SYNDROME	0.000545554	0.020467085824608922
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.020467085824608922
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.020467085824608922
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.000545554	0.020467085824608922
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000545554	0.020467085824608922
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.000545554	0.020467085824608922
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.020467085824608922
NAVAJO NEUROHEPATOPATHY	0.000545554	0.020467085824608922
MARINESCO-SJOGREN SYNDROME; MSS	0.000545554	0.020467085824608922
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.020467085824608922
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME IX; OFD9	0.000545554	0.020467085824608922
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.020467085824608922
PELLAGRA-LIKE SYNDROME	0.000545554	0.020467085824608922
FETAL HYDANTOIN SYNDROME	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.000545554	0.020467085824608922
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.020467085824608922
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.020467085824608922
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 3B	0.000545554	0.020467085824608922
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.020467085824608922
REVESZ SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.000545554	0.020467085824608922
ISOLATED PLAGIOCEPHALY	0.000545554	0.020467085824608922
DISTAL TRISOMY 18Q	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000545554	0.020467085824608922
6Q16 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.000545554	0.020467085824608922
DISTAL TRISOMY 6P	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.000545554	0.020467085824608922
RIGID SPINE SYNDROME	0.000545554	0.020467085824608922
ZEBRA BODY MYOPATHY	0.000545554	0.020467085824608922
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.020467085824608922
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000545554	0.020467085824608922
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000545554	0.020467085824608922
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.020467085824608922
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000545554	0.020467085824608922
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
HYDROXYKYNURENINURIA	0.000545554	0.020467085824608922
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608922
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.000545554	0.020467085824608922
TEMTAMY SYNDROME	0.000545554	0.020467085824608922
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.000545554	0.020467085824608922
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.020467085824608922
ARIMA SYNDROME	0.000545554	0.020467085824608922
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.020467085824608922
RICHARDS-RUNDLE SYNDROME; RRNS	0.000545554	0.020467085824608922
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.020467085824608922
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.000545554	0.020467085824608922
SENIOR-LOKEN SYNDROME 9	0.000545554	0.020467085824608922
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.000545554	0.020467085824608922
NEPHRONOPHTHISIS 11; NPHP11	0.000545554	0.020467085824608922
CHROMOSOME 4Q21 DELETION SYNDROME	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.000545554	0.020467085824608922
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000545554	0.020467085824608922
WARSAW BREAKAGE SYNDROME; WABS	0.000545554	0.020467085824608922
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.020467085824608922
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000545554	0.020467085824608922
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000545554	0.020467085824608922
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.020467085824608922
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.020467085824608922
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.020467085824608922
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.000545554	0.020467085824608922
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.020467085824608922
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.000545554	0.020467085824608922
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.020467085824608922
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.000545554	0.020467085824608922
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.020467085824608922
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.020467085824608922
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000545554	0.020467085824608922
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.020467085824608922
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000545554	0.020467085824608922
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.000545554	0.020467085824608922
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.000545554	0.020467085824608922
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.020467085824608922
CONGENITAL VARICELLA SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 6	0.000545554	0.020467085824608922
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000545554	0.020467085824608922
WOLMAN DISEASE	0.000545554	0.020467085824608922
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.000545554	0.020467085824608922
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000545554	0.020467085824608922
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.000545554	0.020467085824608922
AL-RAQAD SYNDROME; ARS	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.020467085824608922
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.020467085824608922
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.020467085824608922
MEVALONIC ACIDURIA; MEVA	0.000545554	0.020467085824608922
USHER SYNDROME TYPE 1	0.000545554	0.020467085824608922
CRANIOSYNOSTOSIS 6; CRS6	0.000545554	0.020467085824608922
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.020467085824608922
HEREDITARY OROTIC ACIDURIA	0.000545554	0.020467085824608922
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.020467085824608922
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.000545554	0.020467085824608922
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.020467085824608922
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.020467085824608922
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.020467085824608922
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.020467085824608922
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.020467085824608922
JOUBERT SYNDROME 7	0.000545554	0.020467085824608922
JOUBERT SYNDROME 8	0.000545554	0.020467085824608922
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.020467085824608922
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608922
TRISOMY 9P	0.000545554	0.020467085824608922
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.000545554	0.020467085824608922
BRAIN-LUNG-THYROID SYNDROME	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.020467085824608922
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.020467085824608922
MIETENS SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.000545554	0.020467085824608922
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.000545554	0.020467085824608922
ALAZAMI SYNDROME; ALAZS	0.000545554	0.020467085824608922
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000545554	0.020467085824608922
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.020467085824608922
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000545554	0.020467085824608922
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.020467085824608922
EAR-PATELLA-SHORT STATURE SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.000545554	0.020467085824608922
14Q22Q23 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 21	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.000545554	0.020467085824608922
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.020467085824608922
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000545554	0.020467085824608922
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.000545554	0.020467085824608922
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.000545554	0.020467085824608922
HARTSFIELD SYNDROME; HRTFDS	0.000545554	0.020467085824608922
ISOLATED COMPLEX I DEFICIENCY	0.000545554	0.020467085824608922
16P11.2P12.2 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.020467085824608922
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000545554	0.020467085824608922
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.000545554	0.020467085824608922
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.020467085824608922
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.000545554	0.020467085824608922
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.020467085824608922
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.020467085824608922
STEEL SYNDROME; STLS	0.000545554	0.020467085824608922
XQ27.3Q28 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000545554	0.020467085824608922
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000545554	0.020467085824608922
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000545554	0.020467085824608922
2Q32Q33 MICRODELETION SYNDROME	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000545554	0.020467085824608922
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000545554	0.020467085824608922
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 8; BBS8	0.000545554	0.020467085824608922
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.020467085824608922
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.000545554	0.020467085824608922
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.020467085824608922
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.020467085824608922
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.020467085824608922
OTOFACIOCERVICAL SYNDROME	0.000545554	0.020467085824608922
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
CULLER-JONES SYNDROME; CJS	0.000545554	0.020467085824608922
CHROMOSOME 15Q25 DELETION SYNDROME	0.000545554	0.020467085824608922
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.020467085824608922
IMMUNODEFICIENCY 23; IMD23	0.000545554	0.020467085824608922
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.000545554	0.020467085824608922
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.020467085824608922
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.020467085824608922
OCULO-PALATO-CEREBRAL SYNDROME	0.000545554	0.020467085824608922
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.000545554	0.020467085824608922
SECKEL SYNDROME 8; SCKL8	0.000545554	0.020467085824608922
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.020467085824608922
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000545554	0.020467085824608922
JOUBERT SYNDROME 15	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.020467085824608922
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.000545554	0.020467085824608922
OPITZ G/BBB SYNDROME	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000545554	0.020467085824608922
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.020467085824608922
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.000545554	0.020467085824608922
RING CHROMOSOME 12 SYNDROME	0.000545554	0.020467085824608922
ROIFMAN SYNDROME; RFMN	0.000545554	0.020467085824608922
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.020467085824608922
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000545554	0.020467085824608922
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.000545554	0.020467085824608922
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 28	0.000545554	0.020467085824608922
JOUBERT SYNDROME 27	0.000545554	0.020467085824608922
THAUVIN-ROBINET-FAIVRE SYNDROME	0.000545554	0.020467085824608922
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000545554	0.020467085824608922
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.000545554	0.020467085824608922
ABETAL34V AMYLOIDOSIS	0.000545554	0.020467085824608922
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.020467085824608922
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.020467085824608922
NOONAN SYNDROME 2; NS2	0.000545554	0.020467085824608922
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.020467085824608922
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.020467085824608922
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000545554	0.020467085824608922
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.000545554	0.020467085824608922
HYPOTONIA-CYSTINURIA SYNDROME	0.000545554	0.020467085824608922
YOU-HOOVER-FONG SYNDROME; YHFS	0.000545554	0.020467085824608922
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.000545554	0.020467085824608922
LIG4 SYNDROME	0.000545554	0.020467085824608922
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.020467085824608922
17P13.3 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.000545554	0.020467085824608922
CREE MENTAL RETARDATION SYNDROME	0.000545554	0.020467085824608922
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.000545554	0.020467085824608922
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000545554	0.020467085824608922
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.000545554	0.020467085824608922
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.020467085824608922
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000545554	0.020467085824608922
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.000545554	0.020467085824608922
LOWRY-MACLEAN SYNDROME	0.000545554	0.020467085824608922
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000545554	0.020467085824608922
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.020467085824608922
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000545554	0.020467085824608922
WEAVER SYNDROME	0.000545554	0.020467085824608922
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.000545554	0.020467085824608922
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.020467085824608922
PEROXISOME BIOGENESIS DISORDER 10B	0.000545554	0.020467085824608922
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.020467085824608922
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.020467085824608922
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.000545554	0.020467085824608922
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.020467085824608922
OPTIC ATROPHY 11; OPA11	0.000545554	0.020467085824608922
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.000545554	0.020467085824608922
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000545554	0.020467085824608922
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000545554	0.020467085824608922
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.000545554	0.020467085824608922
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.020467085824608922
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.020467085824608922
ARTERIAL TORTUOSITY SYNDROME	0.000545554	0.020467085824608922
FARBER DISEASE	0.000545554	0.020467085824608922
CURRY-JONES SYNDROME	0.000545554	0.020467085824608922
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.020467085824608922
DIAPHANOSPONDYLODYSOSTOSIS	0.000545554	0.020467085824608922
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.000545554	0.020467085824608922
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.020467085824608922
SENIOR-LOKEN SYNDROME	0.000545554	0.020467085824608922
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.000545554	0.020467085824608922
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.020467085824608922
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.000545554	0.020467085824608922
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000545554	0.020467085824608922
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000545554	0.020467085824608922
CEREBROFACIOARTICULAR SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 26	0.000545554	0.020467085824608922
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000545554	0.020467085824608922
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.020467085824608922
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.020467085824608922
DUPLICATION OF THE PITUITARY GLAND	0.000545554	0.020467085824608922
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.020467085824608922
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.020467085824608922
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000545554	0.020467085824608922
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000545554	0.020467085824608922
7P22.1 MICRODUPLICATION SYNDROME	0.000545554	0.020467085824608922
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.020467085824608922
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.000545554	0.020467085824608922
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.000545554	0.020467085824608922
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.020467085824608922
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.020467085824608922
LAMB-SHAFFER SYNDROME	0.000545554	0.020467085824608922
MICROVILLUS INCLUSION DISEASE	0.000545554	0.020467085824608922
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000545554	0.020467085824608922
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000545554	0.020467085824608922
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000545554	0.020467085824608922
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.020467085824608922
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.000545554	0.020467085824608922
FRIAS SYNDROME	0.000545554	0.020467085824608922
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.000545554	0.020467085824608922
ROBERTS SYNDROME	0.000545554	0.020467085824608922
JOUBERT SYNDROME 25	0.000545554	0.020467085824608922
LARSEN-LIKE SYNDROME	0.000545554	0.020467085824608922
LASSA FEVER	0.000541419	0.020311956543392476
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.020311956543392476
ALG2-CDG	0.000541419	0.020311956543392476
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.000541419	0.020311956543392476
DERMOTRICHIC SYNDROME	0.000541419	0.020311956543392476
DPM1-CDG	0.000541419	0.020311956543392476
MPDU1-CDG	0.000541419	0.020311956543392476
ANGELMAN SYNDROME	0.000541419	0.020311956543392476
RABIES	0.000541419	0.020311956543392476
HADDAD SYNDROME	0.000541419	0.020311956543392476
MYASTHENIA GRAVIS	0.000541419	0.020311956543392476
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.020311956543392476
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.020311956543392476
FAMILIAL THROMBOCYTOSIS	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.000541419	0.020311956543392476
SCRUB TYPHUS	0.000541419	0.020311956543392476
PFEIFFER SYNDROME TYPE 3	0.000541419	0.020311956543392476
SECONDARY SYRINGOMYELIA	0.000541419	0.020311956543392476
RAPID-ONSET DYSTONIA-PARKINSONISM	0.000541419	0.020311956543392476
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.020311956543392476
ONDINE SYNDROME	0.000541419	0.020311956543392476
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.020311956543392476
HEREDITARY METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.020311956543392476
NIPAH VIRUS DISEASE	0.000541419	0.020311956543392476
SANDHOFF DISEASE	0.000541419	0.020311956543392476
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.020311956543392476
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.020311956543392476
ALG9-CDG	0.000541419	0.020311956543392476
PROTEUS SYNDROME	0.000541419	0.020311956543392476
MOGS-CDG	0.000541419	0.020311956543392476
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.020311956543392476
FRAGILE X SYNDROME	0.000541419	0.020311956543392476
COG8-CDG	0.000541419	0.020311956543392476
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.020311956543392476
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.020311956543392476
SMITH-FINEMAN-MYERS SYNDROME	0.000541419	0.020311956543392476
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.020311956543392476
SJÖGREN-LARSSON SYNDROME	0.000541419	0.020311956543392476
MIXED CONNECTIVE TISSUE DISEASE	0.000541419	0.020311956543392476
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.020311956543392476
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 3	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.000541419	0.020311956543392476
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.020311956543392476
ADRENOMYODYSTROPHY	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.020311956543392476
POSTENCEPHALITIC PARKINSONISM	0.000541419	0.020311956543392476
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.020311956543392476
FETAL GAUCHER DISEASE	0.000541419	0.020311956543392476
CONGENITAL MYASTHENIC SYNDROME	0.000541419	0.020311956543392476
INSULINOMA	0.000541419	0.020311956543392476
NORRIE DISEASE	0.000541419	0.020311956543392476
DEND SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.020311956543392476
PRIMARY CUTIS VERTICIS GYRATA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.000541419	0.020311956543392476
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.020311956543392476
GRISCELLI SYNDROME TYPE 2	0.000541419	0.020311956543392476
SAETHRE-CHOTZEN SYNDROME	0.000541419	0.020311956543392476
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.000541419	0.020311956543392476
MEHMO SYNDROME	0.000541419	0.020311956543392476
RECURRENT ACUTE PANCREATITIS	0.000541419	0.020311956543392476
CAMOS SYNDROME	0.000541419	0.020311956543392476
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.020311956543392476
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.020311956543392476
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.020311956543392476
XERODERMA PIGMENTOSUM	0.000541419	0.020311956543392476
SCLERODERMA	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.020311956543392476
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.020311956543392476
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.020311956543392476
SYSTEMIC SCLEROSIS	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.020311956543392476
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.020311956543392476
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.000541419	0.020311956543392476
3-HYDROXYISOBUTYRIC ACIDURIA	0.000541419	0.020311956543392476
RETT SYNDROME	0.000541419	0.020311956543392476
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.000541419	0.020311956543392476
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.020311956543392476
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.020311956543392476
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.020311956543392476
GURRIERI SYNDROME	0.000541419	0.020311956543392476
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.020311956543392476
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.020311956543392476
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.000541419	0.020311956543392476
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.020311956543392476
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.000541419	0.020311956543392476
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.020311956543392476
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS 2	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.020311956543392476
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.020311956543392476
GLYCINE ENCEPHALOPATHY; GCE	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.020311956543392476
LATHOSTEROLOSIS	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.020311956543392476
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.020311956543392476
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.000541419	0.020311956543392476
GAUCHER DISEASE, PERINATAL LETHAL	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.020311956543392476
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.020311956543392476
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.020311956543392476
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.020311956543392476
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.020311956543392476
CLARK-BARAITSER SYNDROME	0.000541419	0.020311956543392476
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.000541419	0.020311956543392476
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.020311956543392476
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 102	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 47	0.000541419	0.020311956543392476
FABRY DISEASE	0.000541419	0.020311956543392476
HHHH SYNDROME	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.020311956543392476
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.020311956543392476
INCONTINENTIA PIGMENTI; IP	0.000541419	0.020311956543392476
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 1	0.000541419	0.020311956543392476
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.000541419	0.020311956543392476
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.000541419	0.020311956543392476
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.000541419	0.020311956543392476
MICROPHTHALMIA, SYNDROMIC 1	0.000541419	0.020311956543392476
311450 PALLISTER W SYNDROME;;W SYNDROME	0.000541419	0.020311956543392476
CYCLIC VOMITING SYNDROME	0.000541419	0.020311956543392476
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.020311956543392476
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.020311956543392476
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.020311956543392476
WARBURG MICRO SYNDROME 3; WARBM3	0.000541419	0.020311956543392476
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.020311956543392476
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.020311956543392476
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.000541419	0.020311956543392476
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.000541419	0.020311956543392476
SECKEL SYNDROME 7; SCKL7	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.000541419	0.020311956543392476
COWDEN SYNDROME 5; CWS5	0.000541419	0.020311956543392476
COWDEN SYNDROME 6; CWS6	0.000541419	0.020311956543392476
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.020311956543392476
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.000541419	0.020311956543392476
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.020311956543392476
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.000541419	0.020311956543392476
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.020311956543392476
PERRAULT SYNDROME 3	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.020311956543392476
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.020311956543392476
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.000541419	0.020311956543392476
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.020311956543392476
GLUTAMINE DEFICIENCY, CONGENITAL	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.020311956543392476
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.000541419	0.020311956543392476
PACHYGYRIA, FRONTOTEMPORAL	0.000541419	0.020311956543392476
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.000541419	0.020311956543392476
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.020311956543392476
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.020311956543392476
LISSENCEPHALY 3; LIS3	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.000541419	0.020311956543392476
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.000541419	0.020311956543392476
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.000541419	0.020311956543392476
EPISODIC ATAXIA, TYPE 6	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.020311956543392476
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.020311956543392476
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.020311956543392476
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.000541419	0.020311956543392476
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.000541419	0.020311956543392476
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.000541419	0.020311956543392476
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.020311956543392476
RETINITIS PIGMENTOSA 59; RP59	0.000541419	0.020311956543392476
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.020311956543392476
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.020311956543392476
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.000541419	0.020311956543392476
SNEDDON SYNDROME	0.000541419	0.020311956543392476
STURGE-WEBER SYNDROME	0.000541419	0.020311956543392476
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.020311956543392476
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.020311956543392476
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.020311956543392476
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.000541419	0.020311956543392476
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.020311956543392476
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.000541419	0.020311956543392476
ASPARTYLGLUCOSAMINURIA; AGU	0.000541419	0.020311956543392476
AUTISM	0.000541419	0.020311956543392476
SECKEL SYNDROME 1; SCKL1	0.000541419	0.020311956543392476
BANGSTAD SYNDROME	0.000541419	0.020311956543392476
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.020311956543392476
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.000541419	0.020311956543392476
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.020311956543392476
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.020311956543392476
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.020311956543392476
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.000541419	0.020311956543392476
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.000541419	0.020311956543392476
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.020311956543392476
CROME SYNDROME	0.000541419	0.020311956543392476
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.000541419	0.020311956543392476
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.000541419	0.020311956543392476
DIAMINOPENTANURIA	0.000541419	0.020311956543392476
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.020311956543392476
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.000541419	0.020311956543392476
DYSOSTEOSCLEROSIS	0.000541419	0.020311956543392476
PARIETAL FORAMINA	0.000541419	0.020311956543392476
1P36 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.020311956543392476
2Q33.1 DELETION SYNDROME	0.000541419	0.020311956543392476
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.020311956543392476
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.020311956543392476
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.020311956543392476
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.020311956543392476
PAPILLORENAL SYNDROME	0.000541419	0.020311956543392476
COPPER DEFICIENCY, FAMILIAL BENIGN	0.000541419	0.020311956543392476
DARIER-WHITE DISEASE; DAR	0.000541419	0.020311956543392476
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.020311956543392476
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.020311956543392476
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.020311956543392476
EPILEPSY, READING	0.000541419	0.020311956543392476
FLYNN-AIRD SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.020311956543392476
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.020311956543392476
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.000541419	0.020311956543392476
HUNTINGTON DISEASE; HD	0.000541419	0.020311956543392476
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.020311956543392476
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.020311956543392476
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.020311956543392476
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392476
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.020311956543392476
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.020311956543392476
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.000541419	0.020311956543392476
OCULOCEREBROCUTANEOUS SYNDROME	0.000541419	0.020311956543392476
224250 DYSMYELINATION WITH JAUNDICE	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.020311956543392476
ATKIN-FLAITZ SYNDROME	0.000541419	0.020311956543392476
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.000541419	0.020311956543392476
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.020311956543392476
NEURAMINIDASE DEFICIENCY	0.000541419	0.020311956543392476
PHENYLKETONURIA	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.020311956543392476
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.020311956543392476
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.020311956543392476
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.020311956543392476
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.020311956543392476
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.000541419	0.020311956543392476
TAY-SACHS DISEASE; TSD	0.000541419	0.020311956543392476
THREONINEMIA	0.000541419	0.020311956543392476
THYROCEREBRORETINAL SYNDROME	0.000541419	0.020311956543392476
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
XYLOSIDASE DEFICIENCY	0.000541419	0.020311956543392476
ZUNICH NEUROECTODERMAL SYNDROME	0.000541419	0.020311956543392476
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.020311956543392476
LISSENCEPHALY, X-LINKED, 1; LISX1	0.000541419	0.020311956543392476
LISSENCEPHALY, X-LINKED, 2	0.000541419	0.020311956543392476
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.000541419	0.020311956543392476
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.020311956543392476
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.020311956543392476
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.020311956543392476
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.000541419	0.020311956543392476
VISCERAL STEATOSIS, CONGENITAL	0.000541419	0.020311956543392476
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.000541419	0.020311956543392476
FOUNTAIN SYNDROME	0.000541419	0.020311956543392476
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
BERNARD-SOULIER SYNDROME	0.000541419	0.020311956543392476
GLUTARIC ACIDEMIA I; GA1	0.000541419	0.020311956543392476
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
HYPER-BETA-ALANINEMIA	0.000541419	0.020311956543392476
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.020311956543392476
HYPERLYSINEMIA, TYPE I	0.000541419	0.020311956543392476
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.020311956543392476
HYPERPROLINEMIA, TYPE II	0.000541419	0.020311956543392476
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.020311956543392476
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.020311956543392476
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.000541419	0.020311956543392476
KEUTEL SYNDROME; KTLS	0.000541419	0.020311956543392476
KIFAFA SEIZURE DISORDER	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.020311956543392476
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.000541419	0.020311956543392476
MAPLE SYRUP URINE DISEASE; MSUD	0.000541419	0.020311956543392476
MARDEN-WALKER SYNDROME	0.000541419	0.020311956543392476
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.000541419	0.020311956543392476
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.020311956543392476
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.020311956543392476
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.020311956543392476
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.020311956543392476
9Q21.13 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
MOYNAHAN SYNDROME	0.000541419	0.020311956543392476
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.020311956543392476
LINEAR VERRUCOUS NEVUS SYNDROME	0.000541419	0.020311956543392476
14Q12 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
LINEAR NEVUS SEBACEUS SYNDROME	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.020311956543392476
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.020311956543392476
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.020311956543392476
OROFACIODIGITAL SYNDROME TYPE 1	0.000541419	0.020311956543392476
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.020311956543392476
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.020311956543392476
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
MICROFORM HOLOPROSENCEPHALY	0.000541419	0.020311956543392476
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.020311956543392476
TYROSINEMIA TYPE 2	0.000541419	0.020311956543392476
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.020311956543392476
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.020311956543392476
PORENCEPHALY	0.000541419	0.020311956543392476
PROLACTINOMA	0.000541419	0.020311956543392476
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.020311956543392476
QAZI-MARKOUIZOS SYNDROME	0.000541419	0.020311956543392476
RAMON SYNDROME	0.000541419	0.020311956543392476
ISOLATED BILIARY ATRESIA	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.020311956543392476
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.020311956543392476
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.020311956543392476
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.020311956543392476
MOYAMOYA DISEASE	0.000541419	0.020311956543392476
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.020311956543392476
MOMO SYNDROME	0.000541419	0.020311956543392476
NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.020311956543392476
PITT-HOPKINS-LIKE SYNDROME	0.000541419	0.020311956543392476
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.020311956543392476
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.000541419	0.020311956543392476
5Q35 MICRODUPLICATION SYNDROME	0.000541419	0.020311956543392476
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.020311956543392476
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.020311956543392476
SANJAD-SAKATI SYNDROME	0.000541419	0.020311956543392476
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.000541419	0.020311956543392476
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.020311956543392476
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.020311956543392476
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.000541419	0.020311956543392476
CITRULLINEMIA TYPE I	0.000541419	0.020311956543392476
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.020311956543392476
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.020311956543392476
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.000541419	0.020311956543392476
AICA-RIBOSIDURIA	0.000541419	0.020311956543392476
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020311956543392476
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.000541419	0.020311956543392476
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.020311956543392476
PINEOBLASTOMA	0.000541419	0.020311956543392476
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.020311956543392476
MICROSPORIDIOSIS	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.000541419	0.020311956543392476
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.020311956543392476
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.020311956543392476
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.020311956543392476
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.020311956543392476
CLASSIC HOMOCYSTINURIA	0.000541419	0.020311956543392476
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.000541419	0.020311956543392476
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.020311956543392476
HYPERPROLINEMIA TYPE 1	0.000541419	0.020311956543392476
MALAN OVERGROWTH SYNDROME	0.000541419	0.020311956543392476
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.020311956543392476
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.020311956543392476
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.000541419	0.020311956543392476
HYPOPHOSPHATASIA	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
PGM3-CDG	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.000541419	0.020311956543392476
ADENYLOSUCCINATE LYASE DEFICIENCY	0.000541419	0.020311956543392476
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.020311956543392476
SLC39A8-CDG	0.000541419	0.020311956543392476
LEIGH SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.020311956543392476
ETHYLMALONIC ENCEPHALOPATHY	0.000541419	0.020311956543392476
WHIM SYNDROME	0.000541419	0.020311956543392476
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392476
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.020311956543392476
LIPOID PROTEINOSIS	0.000541419	0.020311956543392476
MILLER-DIEKER SYNDROME	0.000541419	0.020311956543392476
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.020311956543392476
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
ATYPICAL RETT SYNDROME	0.000541419	0.020311956543392476
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.020311956543392476
NOCARDIOSIS	0.000541419	0.020311956543392476
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.000541419	0.020311956543392476
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.000541419	0.020311956543392476
LUJO HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
EBOLA HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
RIFT VALLEY FEVER	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.000541419	0.020311956543392476
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.020311956543392476
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.000541419	0.020311956543392476
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.020311956543392476
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.020311956543392476
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.000541419	0.020311956543392476
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.020311956543392476
TAKAYASU ARTERITIS	0.000541419	0.020311956543392476
THYROCEREBRORENAL SYNDROME	0.000541419	0.020311956543392476
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.020311956543392476
VIRAL HEMORRHAGIC FEVER	0.000541419	0.020311956543392476
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.020311956543392476
WORSTER-DROUGHT SYNDROME	0.000541419	0.020311956543392476
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.020311956543392476
GALACTOSIALIDOSIS	0.000541419	0.020311956543392476
GM1 GANGLIOSIDOSIS	0.000541419	0.020311956543392476
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.020311956543392476
GLIOBLASTOMA	0.000541419	0.020311956543392476
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.020311956543392476
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.020311956543392476
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA 47; SCA47	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.000541419	0.020311956543392476
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.020311956543392476
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.000541419	0.020311956543392476
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.000541419	0.020311956543392476
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.000541419	0.020311956543392476
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.000541419	0.020311956543392476
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.020311956543392476
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.020311956543392476
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.000541419	0.020311956543392476
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.020311956543392476
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.020311956543392476
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.000541419	0.020311956543392476
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.020311956543392476
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.000541419	0.020311956543392476
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.020311956543392476
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.020311956543392476
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.020311956543392476
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.020311956543392476
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.020311956543392476
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.020311956543392476
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.020311956543392476
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.020311956543392476
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.020311956543392476
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.000541419	0.020311956543392476
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.000541419	0.020311956543392476
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.020311956543392476
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.000541419	0.020311956543392476
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.020311956543392476
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.020311956543392476
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.000541419	0.020311956543392476
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.000541419	0.020311956543392476
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.000541419	0.020311956543392476
SUDDEN CARDIAC FAILURE, INFANTILE	0.000541419	0.020311956543392476
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.000541419	0.020311956543392476
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.000541419	0.020311956543392476
PSEUDO-TORCH SYNDROME 2	0.000541419	0.020311956543392476
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.000541419	0.020311956543392476
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.000541419	0.020311956543392476
ROMANO-WARD SYNDROME	0.000541419	0.020311956543392476
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.020311956543392476
HENNEKAM SYNDROME	0.000541419	0.020311956543392476
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.020311956543392476
ROSAÏ-DORFMAN DISEASE	0.000541419	0.020311956543392476
2Q24 MICRODELETION SYNDROME	0.000541419	0.020311956543392476
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.020311956543392476
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.020311956543392476
DISTAL TRISOMY 15Q	0.000541419	0.020311956543392476
CENTRAL DIABETES INSIPIDUS	0.000541419	0.020311956543392476
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.000541419	0.020311956543392476
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.020311956543392476
COCKAYNE SYNDROME	0.000541419	0.020311956543392476
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.020311956543392476
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.020311956543392476
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.020311956543392476
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.020311956543392476
FAMILIAL MULTIPLE LIPOMATOSIS	0.000541419	0.020311956543392476
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.020311956543392476
ENDOCARDIAL FIBROELASTOSIS	0.000541419	0.020311956543392476
PULMONARY ARTERIOVENOUS MALFORMATION	0.000541419	0.020311956543392476
CRIGLER-NAJJAR SYNDROME	0.000541419	0.020311956543392476
FRYNS SYNDROME	0.000541419	0.020311956543392476
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.000541419	0.020311956543392476
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.020311956543392476
EPISODIC ATAXIA TYPE 6	0.000541419	0.020311956543392476
HALL-RIGGS SYNDROME	0.000541419	0.020311956543392476
HARROD SYNDROME	0.000541419	0.020311956543392476
CYSTATHIONINURIA	0.000541419	0.020311956543392476
HUNTINGTON DISEASE-LIKE 1	0.000541419	0.020311956543392476
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.020311956543392476
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.020311956543392476
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.020311956543392476
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.020311956543392476
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.000541419	0.020311956543392476
BETA-MANNOSIDOSIS	0.000541419	0.020311956543392476
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.020311956543392476
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.000541419	0.020311956543392476
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.020311956543392476
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.020311956543392476
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.000541419	0.020311956543392476
BOWEN-CONRADI SYNDROME	0.000541419	0.020311956543392476
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.000541419	0.020311956543392476
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.020311956543392476
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.020311956543392476
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.020311956543392476
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.000541419	0.020311956543392476
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.020311956543392476
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.000541419	0.020311956543392476
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.020311956543392476
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.000541419	0.020311956543392476
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.020311956543392476
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.020311956543392476
RING CHROMOSOME 10 SYNDROME	0.000541419	0.020311956543392476
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.020311956543392476
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.000541419	0.020311956543392476
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.020311956543392476
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.000541419	0.020311956543392476
CRISPONI SYNDROME	0.000541419	0.020311956543392476
FAMILIAL BENIGN COPPER DEFICIENCY	0.000541419	0.020311956543392476
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.020311956543392476
